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Dedication 
The empirical basis of objective science has nothing abso-
lute about it. Science does not rest upon solid bedrock. 
The bold structure of its theories rises, as it were, above 
a swamp. It is like a building erected on piles. The piles 
are driven down from above into the swamp, but not down to 
any natural or given base; and if we stop driving the piles 
deeper, it is not because we have reached firm ground. We 
simply stop when we are satisfied that the piles are firm 
enough to carry the structure, at least for the time being. 
K.R. Popper. 
The Logic of Scientific Discovery, 
Hutchinson, London, 1972, p. 111. 
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ADA 
AET 
ADCC 
ALS 
A~ 
- Adenosine deaminase 
- Aminoethylisothiouronium bromide 
- Antibody dependent cellular cytotoxicity 
- Anti-lymphocyte serum 
- Agammaglobulinemia 
B2M - Beta-2-microglobulin 
C3-R - Receptor for the third factor of the complement 
system 
CML - Cell mediated lympholysis 
ConA - Concanavelin A 
CVID - Common variable immunodeficiency disease 
E - Sheep red blood cells (SRBC) 
EAET - AET treated SRBC 
E0 x - Ox red blood cells 
E+ - E-rosette-forming (T) lymphocytes 
E- - E-rosette-negative cells 
Fe-R - Receptor for the Fe part of immunoglobulins (IgM,IgG) 
H-2 - Mouse MHC. (regions: K,D,I) 
HLA - Human MHC (regions: A,B,C,D/DR) 
HTLA - Human thymus lymphocyte antigen 
Ia - Immune response associated MHC determinant 
cigM - Cytoplasmatic immunoglobulin (class: M) 
sig - Surface immunoglobulin (M,A,G) 
MHG - Major Histocompatibility Complex 
MLR - Mixed lymphocyte reaction 
NAG - Non adherent cells 
NSE - ~-Naphthyl esterase (non sepcific esterase) 
PBL - Peripheral blood lympho-mononuclear cells 
PFC - Hemolytic plaque forming cells 
OA-
SRBC - Ovalbumin-coated-SRBC 
PHA - Phytohemagglutine 
PPD - Purified protein derivate of Mycobacterium tubercu-
losis 
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PWM - Pokeweed mitogen 
SCID - Severe combined immunodeficiency disease 
SDS - Sodium dodecylsulfate 
SpA - Staphylococcal protein A 
STA - Formalinized Staphylococcus aureus Cowan I strain 
TCPC - T~colony precursor cells 
TdT - Terminal deoxyribonucleotidyl Transferase 
TNP-
SRBC - Trinitrophenyl treated SRBC 
T-res- Theophylline-resistant T-lymphocytes 
T-sens-Theophylline-sensitive T-lymphocytes 
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1. AIM OF THE INVESTIGATIONS 
8 
Concepts of the immune system in man change along 
with models based on experimental research (52). In the 
past three decennia the function of human lymphocytes~ 
their differentiation pathways and their disorders have 
been unraveled by a close collaboration between animal 
and human immunologists. 
The analysis of nexperiments of nature", immunodefi-
ciency diseases in man, has not only proven (or rejec-
ted) models developed for the human immune system, but 
also generated new directions for investigation (13). 
At the same time our understanding is still fragmentary 
and hence treatment of immunodeficiency diseases in 
Children still in its infancy. Current therapeutic 
trials are based upon the classical model of the human 
immune system (15). 
In this model lymphocytes are divided into two com-
partments: T lymphocytes and B lymphocytes. Both origi-
nate from bone marrow stem cell(s) (76) and differenti-
ate along separate pathways. Immunodeficiency diseases 
are analyzed within this framework and are viewed as 
differentiation blocks within two separate cell-line-
ages. 
A newer concept ·is based on the central role of T 
lymphocytes in immuneresponsiveness, either in humoral 
immunity or in cellular immunity (5,25,33,38,79). T lym-
phocytes regulate the maturation of B lymphocytes to an-
tibody producing and secreting cells. Within the T lym-
phocyte population T-helper cells and T-suppressor cells 
can be distinguished. Recent data indicate the existence 
of a third subpopulation ofT cells, namely amplifier 
T lymphocytes, which stimulate suppressor T cell precur-
sors to become suppressor effectors and stimulate helper 
T cell preGursors to become helper effector cells (32). 
Helper-cells for the activation of cytotoxic T cells 
("killer" cells) have been demonstrated ( 38). In this 
newer concept, still mainly based on experimental data, 
the immune system is viewed as an intricate regulatory 
network of cellular and cell-mediated interactions. This 
implies recognition between cells. Lymphocytes carry 
cognition and recognition sites on their membrane. These 
lymphocyte membrane determinants became prime ·target for 
investigation and a third concept emerged (6,62). 
Gene products of the major histocompatibility complex 
(MHC), expressed on the cell membrane, were shown to 
have ioportant roles in the immuneresponse (66). Some of 
these products are involved in the killing of virus-in-
fected cells (110). Others are involved in the develop-
ment of the humoral and cellular immuneresponse against 
certain antigens ( 62). In the -interactions between T 
lymphocytes and macrophages (69,85,99) the role of MHC 
products has been demonstrated. The role of MHC products 
in T-B cell and T-T (e.g., T suppressor cell-T helper 
cell) interaction has not yet been established, certain-
ly not in huillan lymphocyte T-B and T-T interaction (46, 
53,54,89,95,104,109). 
This interest in lymphocyte membrane determinants al-
so stimulated interest in the actual function of the 
membrane. The capping of surface receptors has been sug-
gested to be involved in lymphocyte activation and pos-
sibly so in the interaction between cells (28,80,87). 
A picture emerges of a T cell dependent immune sys-
tem, which is regulated or guided by the MHC products. 
Hithin this framework direct investigation of B lym-
phocytes necessitates special conditions. Mitogenic (po-
lyclonal) B cell activators are direct probes for B 
lymphocytes and enable functional studies on B lympho-
cytes, without the intervention ofT lymphocytes (17). 
The investigations presented are within this scope. The 
three models described are interwoven, but the fabric is 
not finished. The development of functional and marker 
9 
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assays will enable further delineation of the immune 
system in man. The use of such tools in analysis of im-
munodeficiency will provide further insight in the nor-
mal immuneresponse and the underlying causes of immuno-
deficiency diseases in children. 
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2. INTRODUCTION TO THE IMMUNE SYSTEM AND IMMUNODEFICIENCY 
DISEASE IN MAN x 
2.1. The immune system = 2 x 1012 lymphocytes 
Any biological phenomenon can be explained at many 
different levels, ranging from its molecular and gene-
tic basis through cellular and tissue events, to ef-
fects in the whole animal. Ruling theories in immuno-
logy are framed in terms of cells rather than mole-
cules. The central cells in specific immune response 
are the lymphocytes. The function of lymphocytes was 
unknown until surprisingly recently. Antibody mole-
cules, present in the blood serum imm.uno.gl-e-bulin 
fraction, had been discovered since 1890, but the 
cells synthesizing these molecules were unknown. Lym-
phocytes were described as "phlegmatic spectators 
watching the turbulent activities of the phagocytes" 
(81). Although ever since, reports had been pubJished 
showing immunoglobulins in the cytoplasm of lympho-
cytes, the evidence was not accepted until the intro-
duction of the immunofluorescence technique. The plas-
ma cells were shown to contain specific antibodies, 
which had been anticipitated since plasma cells had 
been shown to secrete immunoglobulins in vitro (31). 
It was demonstrated, that plasma· cells originate from 
lymphocytes (15). When lymphocytes were drained out 
the thoracic duct a severe immunodeficiency became 
manifest (43). By labeling and reinjection of the 
thoracic duct cells the recirculation of lymphocytes, 
was discovered (42). The route from blood to lymph 
xPresented in part at the Second Advanced Course on 
Pediatric Pathology, 8-12 September 1980, Utrecht, 
The Netherlands. 
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lay in the lymph nodes and Peyer's patches and from 
there, via lymphatic vessels, back to the blood and 
again to the lymph nodes and Peyer's patches. They 
did not enter the thymus, although this organ is 
crowded with lymphocytes. The number of lymphocytes 
obtained by thoracic duct drainage is huge. In man, 
recirculation of lymphocytes has been demonstrated 
(75). Altogether the human immune system is estimated 
to encompass 2 x 1012 lymphocytes (52), in volume as 
large as liver or brain. Lymphocytes are disperses 
through all organs, tissues and interstitial fluids 
(except the brain). Large concentrations are found in 
specialized lymphoid organs. From the developmental 
and functional viewpoints the lymphoid system can be 
divided into four compartments: 
1. the stem cell pool: bone marrow lymphoid precursor 
cells (71); 
2. the central lymphoid organs: bone marrow and thy-
mus (63,72); 
3- the peripheral lymphoid organs or structures: lymph 
nodes, white pulp of the spleen, gut-associated 
lymphoid tissue (tonsils, Peyer's patches), bron-
chus-associated lymphoid tissue (18); 
4. the circulating pool: lymphocytes in blood- and 
lymph (42). 
Although the circulating pool contains not more than 
5% of all lymphocytes (34), the continuous exchange 
with lymphoid tissues implies that blood contains 
virtually all mature lymphocyte subpopulations. This 
has made investigation of the immune system in man 
highly accessible, by the use of perip~eral blood. 
lymphocytes. 
Studies on lymphocytes derived from peripheral 
lymphoid tissues (tonsil, spleen) and in thoracic duct 
have shown differences compared with peripheral blood 
lymphocytes. These differences could still be ex-
plained by different ratios between lymphocyte sub-
populations (21). Thusfar no unknown functions of 
lymphocytes, limited to peripheral lymphoid tissues 
have been revealed. However~ this does not exclude 
specialized functions in localized environments or 
rather, important roles of the local environment on 
lymphocyte function (21,100,101,paper 6.7). Apart 
from being dispersed and circulating, lymphocytes 
are also in another sense in a dynamic state: there 
is a continuous decay of lymphocytes and a differen-
tiation of new lymphocytes from lymphoid progenitors 
(1,71,76). 
2.2. Differentiation of T- and B-lymphocytes 
Some thirty years ago it was not only the function 
of lymphocytes which was unknown, but also of some 
complete organs: the thymus and the bursa of birds. 
This lack of knowledge was tested by taking out these 
organs---------and no function could be demonstrated 
because no defect became manifest. 
Miller, investigating the role of the thymus in 
mouse leukemia development, started taking out thy-
muses-----without any effect. However, when the organ 
was taken out immediately after birth, severe immuno-
deficiency became manifest (63). Likewise the func-
tion of the bursa has been unraveled. When the bursa 
was taken out immediately after birth or even more 
evident, when birds were bursectomized in ovo (by 
treatment with testosteron) the development of plas-
ma cells and the production of antibodies was severe-
ly hampered (40,44,65). 
These experiments indicated two separate lympho-
cyte compartments within the lymphoid system. 
a) Cellular (or cell-mediated) immunity, responsible 
for delayed type hypersensitivity, for the rejection 
of foreign grafts and for the defense against some 
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kinds of infections (certain viruses, bacteria, para-
sites and fungi) which can occur independently of hu-
moral antibody production. Cellular immunity is me-
diated by the thymus-dependent or T lymphocytes and 
is transferable by lymphocytes (20,107). 
b) The bursa-dependent or B lymphocytes, which mature 
to plasma cells secreting antibodies. The antibodies 
have a prime role in the defense against infectious 
agents. The immunesera which display these characte-
ristics can confer passive immunity to normal non-
immune recipients. This broad category of immuneres-
ponse is designated humoral immunity. 
Both T and B lymphocytes are descendants of a bone 
marrow stem cell, which is called pluripotent, becau-
se it gives rise to the myeloid, erythroid and mega-
karyocytic series as well (76). The BandT lympho-
cyte-axis might already be separated at the bone mar-
row lymphoid precursor cell stage (1). From that 
stage on.two pathways of differentiation originate 
one to pre-thymic T preCursors, post-thymic T precur-
sors, intrathymic T cells and post-thymic T cells 
(37,58,97) and the other to pre-B cells, .B lympho-
cytes and finally plasma cells. Mammals have no bursa 
but they do manufacture B lymphocytes in their bone 
marrow (hence the designation: bone marrow derived 
B-lymphocytes). Further maturation of B lymphocytes 
to plasma cells is induced by antigen and is effectu-
ated in the peripheral lymphoid organs (100,101), but 
also in the bone marrow (7,49,102). In the spleen 
this process is initiated in the peripheral, periar-
teriolar lymphocyt sheaths (101) and in lymph nodes 
in the superficial cortex (100). The bone marrow 
plasma cells, hardly recognized as an important site 
of antibody formation, however prove to be the major 
source of plasma immunoglobulins (49) and antibodies 
(7). The hypothetical model of B celldifferentiation 
and maturation is presented in Figure 1. 
Fig. 1. Hypothetical model of stages in B-cell 
differentiation 
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Cell 
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Legend: See text. The numbers refer to differentiation 
blocks given in Table 1. Modified scheme from 
E.R. Pearl (73). 
?re-B cells contain small amounts of cytoplasmic 
Igrl! ( cigM). Their existence in man has been demon-
strated in diseases with a differentiation block af-
ter this pre-B cell stage (73). At not yet clearly 
defined stages of dirferentiation various determi-
nants and receptors are acquired. The Ia determinant~ 
an HLA-D/DR related common B cell determinant~ is 
probably present from the immature B cell stage on 
(45). The C3-receptor (C3-R), a receptor for the 
third~factor Of the complement system, is expressed 
on immature and mature B lymphocytes (86). The Fe re-
ceptor for the Fe part of immunoglobulins and the 
EBV receptor is a receptor for Epstein Barr virus. 
B lymphocytes~ defined as surface-immunoglobulin 
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bearing lymphocytes, carry first s-IgM (57). Later on 
all classes of immunoglobulins can occur. Individual 
B lymphocytes carry one or more classes of immunoglo-
bulin and only one type of light chain (74). After 
further mat~ration to plasma cells individual cells 
secrete antibody molecules of one or more classes, 
but of only one specificity (48,70). This is funda-
mental to the understanding of antigen specific hemo-
lytic plaque assays in which amongst many inactive B 
lymphocytes and amongst cells secreting antibodies 
with other specificities single antibody secreting 
cells can be detected. The human antigen specific 
plaque forming cells (PFC) referred to in paper 6.3 
secrete IgM antibody specific for ovalbumin-coated 
sheep red blood cells (OA-SRBC). Antigenic activation 
induced in vitro is under strict T cell control (5, 
25). Whenever the assay is performed using other an-
tigens than the antigen presented to the lymphocytes 
in the induction phase no PFC response is detected. 
Thus a single cell produces antibody of only one spe-
cificity and is directed to only one antigenic deter-
minant. 
The second type of PFC response described in paper 
6.2 is induced by mitogenic activation of lymphocytes. 
Polyclonally activated B lymphocytes secrete one out 
or many different antibody specificities. The speci-
ficity for trinitrophenylated SRBC (TNP-SRBC) is com-
mon. At any rate,in mice,the frequency of TNP reac-
tive B lymphocytes is estimated 1 : 60 - 1 : 230 B 
lymphocytes after·polyclonal activation (3,8). The 
feasability of in vitro induction of antibody forma-
tion stresses another important characteristic of the 
immune system. The lymphocyte system is autonomous, 
it does not need a local environment. This is true 
for mature lymphocytes who have ·acquired antigen re-
ceptors. Depletion of antigen binding lymphocytes 
from lymphocytes activated by this antigen has been 
shown to reduce the responsiveness of the remaining 
lymphocytes to that antigen (59). At present the sur-
face immunoglobulins on the membrane of B lymphocytes 
are thought to be antigen receptors. 
Antigen reactive cells are also found in the T 
lymphocyte population and represent a fairly mature 
T cell stage (14). T cells do not carry immunoglobu-
lin. The nature of the antigen receptor on T cells 
is still a matter of debate. The HLA encoded determi-
nants~ having an immunoglobulin-like part in their 
structure~ have been suggested to be associated with 
the T cell antigen receptor (9,47,80,91). 
In T cell differentiation the local environment of 
the thymus plays a crucial role (37,78,97). In ani-
mals~ studies have centered around the athymic nude 
mice. Nude mice have T precursor cells in their bone 
marrow (108). Neonatal thymic grafts in nude mice 
lead to reconstitution: host immunoincompetent pre-T 
cells will differentiate to immunocompetent T cells 
(97). The thymus has an "endocrine" function as well. 
Thymic tissue enclosed in cell impermeable diffusion 
chambers can reconstitute thymectomized mice but not 
nude mice (97). Thus it has been suggested that thy-
mic epithelium is obligatory for reconstitution in 
nude mice. 
In man these various factors can be analyzed using 
bone marrow cells .or blood lymphocytes from immunode-
ficiency patients with differentiation defects in the 
T cell lineage (37). One can distinguish a prethymic 
T precursor cell originating from the bone marrow~ 
which can be induced by direct contact with thymic 
epithelium to differentiate to postthymic T precursor 
cells (C3 receptor positive, TdT positive, ADA posi-
tive, E rosette-negative~ mitogen response negative). 
Factors produced by thymic epithelium and cAMP modu-
19 
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lating agents will induce further maturation to intra-
thymic T cells (TdT positive, ADA positive, E rosette 
forming at 37°C, theophyllin resistant, mitogen re-
active, T helper, MLR-responding) and postthymic T 
cells (TdT low, ADA-low?, E rosette forming at 4°c, 
IgM receptor and IgG receptor positive, mitogen re-
active, T helper, T suppressor, Ia positive (some); 
see for a discussion: Gelfand, E.W., Dosch, H.M. et 
al., 37). "Thymic hormones'' induce maturation proba-
bly at the intrathymic T cell stage, whereas antige-
nic activation leads to fully immunocompetent T cells. 
At present it is unknown whether separate T cell pre-
cursor populations follow different differentiation 
pathways to post thymic T cells. Evidence for two pa-
rallel lines of T cell differentiation in the thymus 
of mice has been presented (61,88). After leaving the 
thymus, the postthymic T cells migrate into the T 
cell dependent areas in the peripheral lymphoid or-
gans:(the periarteriolar lymphocyt sheaths of the 
spleen and paracortical zones of the lymph nodes (7, 
11,12,22,24,49). Here, the T cells can be activated 
by antigen. In vitro, the last phase of T cell diffe-
rentiation can be induced by antigen and mitogen and 
can be measured by proliferation assays or assays for 
helper activity (paper 6.2). 
In man T lymphocytes have the characteristic ca-
pacity of forming rosettes with sheep red blood cells 
(E-rosettes) (36). E resetting enables the isolation 
of T cells by separation of E resetting cells from 
the rest of the cells on density gradients. E rosette 
formation can be modulated by various substances one 
of which is theophyllin (60). When T cells are incu-
bated with theophyllin some T cells become unable to 
bind sheep red blood cells (the theophyllin sensitive 
T cells: T-sens) and others keep their rosette for-
ming capacity (the theophyllin resistant T cells: 
T-res). By theophyllin incubation of E resetting T 
cells both populations can be separated on density 
gradients. Analysis by the OA specific 
PFC response has revealed distinct functions: T-sens 
lymphocytes have suppressor activity and T-res have 
helper activity in the induction phase of the OA-PFC 
response (90). 
The majority of the recirculating cells are T 
cells. B cells are far more sessile in peripheral lym-
phoid organs (34). This explains the high percentage 
of T cells in peripheral blood and lymph, when com-
pared with lymph nodes and spleen (21). Recently, mo-
noclonal antibodies against various T cell subsets 
and T cell precursors have been developed (78). These 
monospecific reagents recognize membrane determinants, 
which are characteristic for certain stages of T cell 
differentiation. It was already evident that cell 
surface antigen patterns change gradually during T 
cell differentiation, although subsets can now clear-
ly be distinguished by these antisera (78). These 
marker assays used in combination with the effects of 
various inductive environmentS or substances have 
enabled further analysis of immunodeficiency diseases. 
Within the T and B cell differentiation concept all 
the assays described are viewed as differentiation 
markers. Thus an antigenic or mitogenic response, in 
fact a functional characteristic of lymphocytes, is 
used as an indicator of maturity of lymphocytes. 
This statement is merely made to demonstrate the 
way of looking at the immune system within this con-
cept. It has already been disclosed that along with 
their differentiation and maturation lymphocytes 
acquire different functions. 
21 
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Table 1: Immunodeficiency diseases classified as 
presumed differentiation and maturation 
defects along the B lymphocyte lineage 
1.x Pre-B cell deficiency: 
- Immunodeficiency associated with thymoma 
- Severe combined immunodeficiency 
- Varied immunodeficiency (hypogammaglobulinemia) 
- Kappa chain deficiency 
- X-linked agammaglobulinemia 
2. B cell deficiency: 
- Congenital agammaglobulinemia 
- Varied immunodeficiency (hypogammaglobulinemia) 
- Severe combined immunodeficiency 
- Ig deficiency with IgM production and without 
+ + 
sigG - and sigA B cells 
3. Mature B cell deficiency: 
- Varied hypogammaglobulinemia with or without 
autoantibodies to B lymphocytes 
Failure of terminal differentiation of: 
4. All B lymphocytes: 
- Transcobalamin II deficiency 
- Immunodeficiency with Ataxia teleangiectasia 
+ + 5. sigG and sigA - lymphocytes 
- Ig deficiency with increased IgM 
+ 6. sigA lymphocytes 
- Selective IgA deficiency 
x The numbers refer to the differentiation blocks 
shown in Fig. 1. 
The table indicates the presumed level of defect in 
B cell differentiation. The same type of analysis of 
immunodeficiencies caused by defects in the T cell 
axis is shown in Table 2. 
2.3. Immunodeficiency diseases in children 
In the delineation of T and B cell differentiation 
"nature's own experiments" have played a major role. 
In 1952 Bruton described a child suffering from se-
vere bacterial infections, who had no immunoglobulins 
(12). This disease, agammaglobulinemia, was classi-
fied as the analogue of the bursectomized birds dis-
ease: both lacked serum immunoglobulins and plasma 
cells. Agammaglobulinemia can be' inherited (X-linked) 
and the bursectomy experiment settled the idea 
of a genetic defect of the differentiation of 
(pre-B cells to) B-lymphocytes. Various antibody de-
ficiencies have now been discovered and classified 
as differentiation disorders along the B cell axis 
(Table 1) (83). 
Table 2: Immunodeficiency diseases classified as 
differentiation defects along the T cell 
lineage 
Defect 
Pluripotent stem cell 
Lymphoid stem cell 
Clinical designation 
Reticular dysgenesia 
Severe combined immunodefi-
ciency 
Pre-thymic T precursor Severe combined immunodefi-
Thymic T cell 
Postthymic T cell 
ciency 
DiGeorge's syndrome 
Immunodeficiency with Ataxia 
teleangiectasia 
Common variable immunodefi-
ciency 
The DiGeorge syndrome, an absence of the thymus, 
stands as a prime example of a T cell differentiation 
defect by lack of inductive environment (50). It is 
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evident that most of the T celldifferentiation defects 
are accompanied by B cell defects. Severe combined 
immunodeficiency (SCID), a combination ofT and B cell 
deficiency, has been shown to be a heterogeneous group 
of disorders along with further characterization of 
various steps in the induction of T cell differentia-
tion (Table 3) (37). 
Table 3: Severe combined immunodeficiency and presumed 
defects 
Stage of differentiation Target for induction of 
differentiation 
bone marrow I bone mar-
row microenvironment 
thymic epithelium 
epithelial factors 
thymic hormones 
lymphoid stem cell 
pre-thymic T precursor 
post-thymic T precursor and 
intra-thymic T cell 
post-thymic T precursor 
Not only external (differentiation induction) factors 
can be deficient in SCID; a heterogeneous group of 
intrinsic T cell ·defect·s can miinick severe combined 
immunodeficiency. Examples are the adenosine deamina-
se deficiency, an enzyme defect in purine ~etabolism, 
which is associated with a severe combined immunode-
ficiency (39), and the membrane capping disorder des-
cribed in paper 6.6. The designation combined (T plus 
B cell) defect, has been reevaluated along with this 
further classification. Some SCID patients do have B 
lymphocytes; however terminal maturation is nearly 
always absent. At present only the lymphoid stem cell 
defect is viewed as a real combined immunodeficiency 
in the sense of a defect of the anlage of both lympho-
cyte lineages. Two points emerge from these analyses 
of immunodeficiency diseases. First, the studies on 
immunodeficiency have a leading role in the delinea-
tion of the human immune system. Recently the seren-
dipitous findings of enzyme defects in purine metabo-
lism causing various immunodeficiencies has opened a 
whole new area of investigation and even promises 
tools for regulation of the immune response (13,26). 
Second, the classification of immunodeficiency rests 
on the basis of the differentiation model of two se-
parate compartments within the immune system: the T 
cell axis and the B cell axis. However this model 
lacks one of the most important advancements in un-
derstanding immunity namely the central, directive 
role of T cells in regulating humoral immune respon-
ses. For example, the B lymphocyte defect in most of 
the combined immunodeficiencies is presently seen as 
the result of the T cell defect and not as a defect 
in the B cell lineage. The basis of a more functional 
approach in the classification of immunodeficiencies, 
in which markers on lymphocytes are seen as indica-
tors of lymphocyte functions, will be discussed. 
2.4. Functional prooerties of T cells 
Investigation of lymphocytes derived from-various 
immunodeficiency patients parallel to studies on iso-
lated normal donor lymphocyte subpopulations have re-
vealed many functional properties of human lympho-
cytes, limited to T cells or T cell subpopulations 
(Table 4). 
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Table 4: In vitro functional properties ofT lym-
phocytes 
Proliferative responses: 
1. to soluble antigens: PPD, Tetanus toxoid 
2. to particulate antigens: Candida albicans 
3. to cell surface antigens: MLR-response 
4. to lectins and other mitogens: PHA, PHM, ConA, 
spA. 
Cytotoxic responses : CML, ADCC 
Mediator production : Helper and suppressor factors 
Regulatory functions: Helper T cells and suppressor 
T cells in T-T, T-B and T-ma-
crophage interaction. 
r1odified after Reinherz, E.L. (79): 
PPD = purified protein derivate of mycobacterium 
tuberculosis 
MLft = mixed lymphocyte reaction 
PHA = Phytohaemagglutinin 
PWM = Pokeweed mitogen 
ConA = Concanavalin A 
spA = Protein A derived from Staph. aureus 
CML = Cell mediated lympholysis 
ADCC = Antibody dependent cellular cytotoxicity 
In MLR, lymphocytes from two individuals are mixed: 
the reciprocal aggression of these cells leads to pro-
liferation of the T cells. The stimulating antigenic 
determinant is encoded-by the HLA-D locus. Expression 
of this structure is largely on B cells, but some T 
cells also carry this determinant and do stimulate 
very strongly (paper 6.3). Mitogens such as PHA, ConA, 
spA and PIVM activate a large population of lympho-
cytescytes, primarily T cells (79). After activation 
T cells develop helper activity for B cells leading 
to B cell proliferation and B cell maturation to 
plaque forming cells and plasma cells (51,96; paper 
6.2). Especially studies on PWM induced activation of 
lymphocytes have shown that T cells produce helper 
factors which are obligatory mediators in B lympho-
cyte activation by P\iM (51,96). The mitogens are not 
selective for either helper T cells or suppressor T 
cells. By irradiation 3 however, suppressor T cell ac-
tivity can be eliminated (paper 6.2). The net effect 
of the balance between activation of helper T cells 
and suppressor T cells is dependent on the mitogen 
used (and the assay used). ConA activation ofT cells 
leads to a suppressive effect on B cell activation, 
whereas the net effect of PHA, PWM and spA activation 
is help. Although the mitogens are nonselective, the 
activated subpopulations of T cells, T helper cells 
and T suppressor cells, are different. Already before 
activation they can be distinguished by surface 
markers. After isolation their different functional 
instruction can be demonstrated (5,14,25,78,79). The 
helper T cells involved in the induction of antibody 
formation are found in the theophyllin resistant T 
cell (T-res) population (90). The suppressor T cells 
involved in the prevention or inhibition of B cell 
maturation are found in the theophyllin sensitive T 
cell (T-sens) population (90). 
In general, B cell triggering by antigen requires 
help of T cells. The T helper cell activity is con-
ferred to B cells either by direct contact or by the 
release of helper factors, which stimulate the B 
cells to respond (22,32,33,68). The immunoregulatory 
unit consists of an interplay between two antagonists: 
helper T cells and suppressor T cells. The suppressor 
T cells act either directly on B lymphocytes or inhi-
bit T helper cell activity (38). In this cellular 
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interaction model macrophages present the antigen to 
T cells and probably to B cells (29,69,85,99). Antigen 
serves as the signal for activation. Thus, the immune 
system is a functional network of interacting cells 
which is modulated by external antigen. 
Since cell interaction requires recognition of 
membrane structures, the emphasis on cell interactions 
has made the cell membrane a main target for structu-
ral studies. It has become clear that, apart from an-
tigen receptors at the cell surface, lymphocyte re-
cognition also involves membrane molecules that are 
products of genes of the major histocompatibility 
complex. 
2.5. Role of gene products of the major histocompatibility 
complex (MHC) in the immune response 
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T cells seem to be particularly responsive to anti-
gens that are presented on the surface of macrophages. 
The interaction of T cells with macrophages however 
is .subject to a crucial restriction: T cells will 
only be activated if the macrophage, besides presen-
ting the antigen, will carry a certain MHC determi-
nant on its surface (69, 84, 92). Likewise T helper 
cells will fail to help another lymphocyte in an anti-
genic response if this lymphocyte carries a foreign 
MHC determinant (29,46,53,54,62,66,95,104). This so 
called MHC restriction phenomenon has also been de-
monstrated in the killing of target cells. Virus in-
fected target cells will only be attacked by cytoto-
xic T cells if the cytotoxic cell and the target cell 
share at least one MHC determinant (63,110). T cells 
are presumed to be educated to this MHC-restricted 
behaviour when passing through the thymus, although 
instruction at an earlier stage is debated (111). 
In mice, the MHC region contains immune response 
genes, coding for the level of the immune response 
against certain antigens (67) and for the switch from 
IgH to IgG synthesis (93). Low responses to one anti-
gen can be accompanied by good responses to another 
antigen. Immune response genes can influence antigen 
presentation by macrophages and antigen recognition 
by T helper cells (91). Suppressor genes for immune 
responsiveness have also been linked to the MHC re-
gion (6). 
In man, certain r1HC alleles or closely linked 
genes not yet recognize~predispose to a variety of 
diseases, with or without an immunopathological basis 
(19). MHC restriction has been demonstrated in cyto-
toxic reactions to virus infected cells (63) and 
other targets (41). Macrophage-T cell interaction is 
also subject to MHC restriction, in this case encoded 
by the HLA-D region within the HHC (92). The role of 
the HHC gene products in T-B cell and T-T cell inter-
action in man is still elusive, mainly because the 
assays necessary for these investigations are lacking. 
In mitogenic activation assays no MHC restriction can 
be demonstrated. In fact, unrestricted interaction 
between T and B lymphocytes is evident (paper 6.2, 
6.7). The human HHC, designated HLA, is a complex of 
genes located on the short arm of chromosome six (103) 
and is codi.ng for cell surface glycoproteins common 
to almost all somatic cells: the HLA-A, B and C anti-
gens. It also includes genes coding for differentia-
tion antigens which are found largely on B lymph~­
cytes: the HLA-D/DR antigens (4). The designation ma-
jor histocompatibility complex is derived from the 
fact that incompatibility for HLA is associated with 
the development of strong immune responses to trans-
plants and with uncontrollable graft versus host 
responses to bone marrow infusions. Seven major loci 
can be distinguished within the MHC and dozens of 
alleles are known to exist. Gene products of the A 
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and B loci are thought to be analogous to mouse H-2D 
and H-2K which code for target cell determinants in-
volved in cytotoxic reactions (4,6,41,63). HLA-D/DR 
determinants are analogous to mouse H-21 region anti-
gens who represent immune response genes. In man, 
the HLA-A, -B and -c determinants and other possibly 
closely linked determinants maY also represent immune 
response genes (2). HLA-A and -B determinants are 
cell surface receptors for certain antigens (47). 
HLA-D/DR related immune response associated Cia-
like) structures are found on a small percentaee of 
circulating T lymphocytes (paper 6.3). After activa-
tion of T lymphocytes (by mitogens or antigens) al-
most all T lymphoblasts carry the Ia determinant (30, 
56). Also when T cells are grown in colonies, a large 
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percentage expresses the Ia determinant (paper 6.4). 
The Ia-positive T lymphocytes belong to the T-sens 
population (paper 6.3) shown to have a suppressor 
function in the development of the in vitro PFC res-
ponse (90). 
Thus a picture emerges of a possible feed back me-
chanism in the development of the immune response in 
man: along with activation and proliferation~ suppres-
sor T cells increase in number, which is -reflec-
ted by the increase in Ia positive T cells and which 
may indicate a prevention of overshoot of the immune 
response. 
2.6. Functional prooerties of B lymphocytes 
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As has been stated the T lymphocytes play a central 
role in the immune system: "Man is a T dependent ani-
mal". The T cell regulates the B lymphocyte matura-
tion to antibody producing cells. This is true for 
almost all known antigens and mitogens. Some excep-
tions do exist: Nocardia-water-soluble-mitogen (11), 
Epstein-Barr virus (55) and (Protein A carrying) Sta-
phylococcus aureus (35,82, paper 6.1). They activate 
a large population of B lymphocytes, hence the desig-
nation: polyclonal B cell activators (17). Although 
B cells are directly activated by these mitogens a 
secondary regulatory influence of T cells on the B 
cell proliferation is likely and actually demonstra-
ted (98). However this does not exclude the possibi-
lity to investigate human B lymphocyte functions of 
normal donors and in immunodeficiency patients, 
using these B cell mitogens. 
2.7. Reevaluation of immunodeficiency diseases 
The discovery of the regulatory role of T lymphocytes 
in B cell activation and maturation has changed the 
model by which immunodeficiency diseases are analysed. 
The 11 classical" concept of inborn errors of differen-
tiation of the T cell and/or B cell lineage is now 
intermingled with a concept of dysregulation. Waldmann 
has described some patients with hypogammaglobulinemia 
in which T cells l'tere responsible for suppression of 
B cell maturation (105)- These studies have been ex-
tended and a whole set of B cell disorders are now 
distinguished, ransing from severe suppression by T 
cells to the originally postulated intrinsic B cell 
differentiation defect (106). In these studies almost 
exclusivelY. a T dependent mitogen (PWM) has been uti-
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lized. 
Antigen specific immune response assays in vitro 
provide a more (patho)physioloeical picture of the 
in vivo situation. In the OA-SRBC in vitro PFC res-
ponse, Dosch has shown that congenital agammaglobulin-
emia patients (who had no circulating B lymphocytes) 
were able to produce and secrete specific antibody 
(23,25). Excessive suppressor cell activity in these 
patients was shown to inhibit B cell antibody secre-
tion (24). Thus, these patient do have pre-B cells 
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with a full maturation capacity which is however sup-
pressed by T lymphocytes. The balance between helper 
T cell activity and suppressor T cell activity is 
tipped to excessive suppressor activity. 
This implies that if this suppressor activity can 
be modulated in the sense that excess activity is 
prevented, patients must be able to develop B lympho-
cytes and to secrete antibodies. This has indeed been 
demonstrated (27). 
These findings would imply that the neonatally 
bursectomized chickens are no longer the animal model 
for at least part of the agarnrnaglobulinernias. This is 
not true. Following bursectomy, suppressor T cells 
develop, which can be transferred to syngeneic chick-
ens, which then become rapidly agamrnaglobulinemic 
(10,44). These findings suggest that the crucial 
question of whether excessive suppressor T cell acti-
vity is cause or effect of agammaglobulinemia, can be 
investigated by animal experiments. 
To summarize, durine the past thirty years close 
collaboration between mice immunologists and human 
immunodeficiency investigators has led to a concept 
of the human immune system which anticipates that 
immunoprophylaxis and immunotherapy may become reali-
ty in the near future. 
3. INTRODUCTION TO THE. INVESTIGATIONS 
The investigation of immunodeficiency diseases in man 
parallel to animal experiments enables the delineation 
of human lymphocyte subpopulations, their characteris-
tics and their functional properties (chapter 1). Chap-
ter 2 contains an introduction to basic aspects of spe-
cific immunity in man. Changing concepts of lymphocyte 
differentiation, lymphocyte interactions, and lymphocyte 
activation are emphasized. Along with new concepts, im-
munodeficiency diseases need to be re-analysed. The ana-
lysis in its turn is of value to proof (or reject) the 
concepts. A widely used method of investigation of lym-
phocytes, the mitogenic lymphocyte transformation test, 
is presented in paper 6.1. Many mitogens primarily acti-
vate T lymphocytes. Staphylococcus aureus Cowan-1 strain 
(STA) is a T cell independent polyclonal B lymphocyte 
activator. Studies in various immunodeficiency diseases 
and on various lymphoid tissues are reported. The STA 
responsive B cell is further delineated. The investiga-
tions were performed in comparison with protein A (a 
soluble(membran~ protein derived from Staph. aureus) and 
other known T cell mitogens. 
These studies have led to a reevaluation of some 
functional properties of T and B lymphocytes in mitoge-
nic lymphocyte transformation assays, described in paper 
6.2. In the presence ofT cell mitogens, helper T cells 
are generated which enable cocultured B lymphocytes to 
respond to these mitogens and to differentiate into IgM 
secreting (direct) hemolytic plaque forming cells (PFC). 
The tissue distribution of helper cell activity and the 
occurrence of helper T cells in various immunodeficiency 
diseases is analysed. Suppressor T cell activity induced 
by mitogens is demonstrated in the PFC assay. 
Suppressor T cells in mice have been shown to carry 
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immune response locus associated determinants (Ia) (62). 
In paper 6.3 Ia+-positive human T cells are demonstrated 
within the suppressor T cell population (designated as 
theophyllin-sensitive, because of their inability to 
bind sheep red blood cells in the presence of theophyl-
lin). The presence of Ia+-T-cells, detected by indirect 
immunofluorescence, is confirmed by studies showing that 
the theophyllin sensitive T cell subpopulation stimula-
ted allogeneic lymphocytes (MLR). The stimulatory capa-
city of this T cell subpopulation is ten times stronger 
than the stimulatory capacity of B cells, when calcu-
lated on the basis of Ia+-lymphocytes. 
When T cells are activated by mitogens the number of 
Ia+-T cells increases rapidly. After some days in culture 
a large part of the T lymphoclasts carry the Ia determi-
nant (56). In paper 6.4 T cell growth in semisolid micro-
cultures, containing mitogen (PHA) conditioned medium, 
is described. These colony-forming T-lymphoblasts origi-
nate from the theophyllin sensitive T cell population 
in peripheral blood. A large fraction of the colony-for-
ming T-lymphoblasts carry the Ia determinant and they 
stimulate in MLR. 
The Ia determinants are products of gene loci, inser-
ted in the major histocompatibility complex (MHC). The 
human MHC, designated HLA, contains seven major l.oci. 
HLA-A and B determinants are recognition structures, as-
sociated with antigen recognition either in the induction 
phase of the immune response or in the effector phase of 
cytotoxic reactions. The chance observation of lack of 
expression of HLA-A and B determinants on lymphocytes 
associated with a combined immunodeficiency is described 
in paper 6. 5. 
Another membrane defect of lymphocytes associated 
with severe combined immunodeficiency is presented in 
paper 6.6. Abnormal lymphocyte capping in a immunodefi-
cient patient supports the theory that plasma membrane 
cytoskeleton interactions have a role in the expression 
of specific immunity. 
In paper 6.7 other HLA deficient patients, with a 
type of immunodeficiency remarkably like the one des-
cribed in paper 6.5~ are presented. Furthermore, the HLA 
deficient lymphocytes are compared with the abnormally 
capping lymphocytes with regard to their functional pro-
perties in vitro. Possible implications for their in 
vivo behaviour are discussed. 
Chapter 4 summarizes the studies and discusses 
their contricution to the analysis of immunodeficiency 
in children. 
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4. DISCUSSION AND SUMMARY 
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The recirculation of lymphocytes to and from various 
lymphoid organs and the autonomy of lymphocytes have 
made the immune system highly accessible for investiga-
tion. Many functions of lymphocytes and a large part of 
lymphocyte differentiation and maturation can be studied 
on peripheral blood lymphocytes. Since the discovery of 
the central role of T-lymphocytes in immunity, the un-
derstanding of the regulatory circuits behind specific 
immune responses has rapidly expanded. The analysis of 
immunodeficiency diseases in man has played, and still 
plays, an important role in the dissection of the human 
immune system. These nexperiments of nature" not only 
confirm (or disprove) the models developed by animal 
research, but also lead to new ways of looking at the 
immune system. A recent example is the discovery of pu-
rine metabolism enzyme defects associated with immunode-
ficiency, which initiated studies on the molecular ma-
chinery in the lymphocyte. In this thesis the immune 
system is still framed in terms of cells, their func-
tions and membrane characteristics. In chapter 2 the 
chanGing concepts of the immune system and the basis of 
the current classification of immunodeficiency diseases 
are outlined. Recent modifications of the classification 
of immunodeficiencies are indicated. The immune system 
is divided into two compartments: T lynphocytes and B 
lymphocytes, both originating from bone marrow stem 
cells. Immunodeficiency diseases are analysed in terms 
of differentiation defects along the T cell lineage, 
the B cell lineage or both. This model, although still 
usefull, is now incomplete, and is in fact only part of 
the truth. For instance, what was originally presumed to 
be a differentiation defect of B lymphocytes, agammaglo-
bulinemia, turned out to be sometimes due to an imba-
lance between T helper and T suppressor cells. Excessive 
T suppressor activity can be eliminated so that B lym-
phocytes can differentiate and mature into antibody se-
creting cells. 
In paper 6.1 this is further substantiated. A poly-
clonal B cell mitogen, Staph. aureus Cowan I strain (STA) 
can induce proliferation of human B lymphocytes which 
have a deficiency of one of the steps of terminal B cell 
maturation. The presence of sig+ B lymphocytes is requi-
site. Lymphocytes of patients with congenital agammaglo-
bulinemia (without B cells) had no response to STA, 
whereas lymphocytes from hypogammaglobulinemic patients 
(with B cells) had a normal response to STA. Another 
example, severe combined immunodeficiency (SCID), was 
originally thought to represent a deficiency of lymphoid 
stern cells, leading to combined absence of T and B lym-
phocytes. However, some SCID patients do have sig+ B 
which do not mature into plasma cells because of the 
lack of T cell help. In these cases the defect proba-
bly resides in one of the thymic stages of T cell 
differentiation. The positive response to STA acti-
vation (except in the cases with a inborn defect of pu-
rine metabolism) indicates a normal maturation capacity 
of B lymphocytes in SCID. Paper 6.1 further describes 
the preparation of the polyclonal B cell activator STA, 
the culture conditions for human B cell activation, the 
tissue distribution of STA responsive cells throughout 
the immune system, and the delineation of the STA respon-
sive lymphocyte subset within the B lymphocyte popula-
tion. Leakage of protein A (spA), the major cell wall 
protein carried by STA, distUrbs the selectivity of the 
mitogen for B lymphocytes. Protein A was shown to acti-
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vate T cells, to the same extent as other T cell mite-
gens (PHA, ConA). Culture conditions are important: hu-
man IgG, especially IgG1, but not IgG3, inhibited the 
STA response in a dose-dependent fashion, by blocking 
the mitogenic sites on the STA-bacterium. STA responsive 
lymphocytes were found in the circulating pool and in 
all peripheral lymphoid tissues tested (human tonsil 
cells, spleen cells), but not in the thymus. The height 
of response appears to be determined by the absolute 
numbers of B lymphocytes per culture. Lymphocyte subpo-
pulations were purified by isolation techniques and ana-
lysed for STA responsiveness. The lymphocytes stimulated 
by STA were characterized: E rosette negative, C3 recep-
tor positive, STA receptor positive~ Ia positive and 
likely sig positive. Taken together~ the STA responsive 
cell fulfills the criteria of a fairly mature B lympho-
cyte. The investigations in various immunodeficiency 
diseases, either of the B cell lineage or the T cell li-
neage~ confirmed this conclusion. 
In these investigations the STA mitogenicity was com-
pared with lymphocyte activation induced by T cell mite-
gens (spA, PHA, ConA). Responses were measured at the B 
cell level, in a proliferation assay as well as by a 
plaque forming cell (PFC) assay. The interaction between 
T and B lymphocyte<; was target of the studies described 
in paper 6.2. Normally, the mitogenic transformation of 
B lymphocytes is hidden behind redundant T cell respon-
ses. By irradiation ofT lymphocytes, transformation of 
T cells is blocked and radioresistant T helper activity 
can be demonstrated as follows: T and B lymphocytes are 
isolated, the T cells are irradiated, mixed with B lym-
phocytes and subsequently a T cell mitogen is added. 
After a culture period of 80 hours the activation of the 
B lymphocytes is measured. All T cell mitogens induced 
(irradiated) T cells to provide help to the B cells, 
which enabled the B cells to proliferate and differenti-
ate into IgM PFC. Irradiation not only allows the mea-
surement of B cell proliferation but also blocks T sup-
pressor cell activity. Thus the balance between T cell 
help and T cell suppression, which regulates the B lym-
phocyte response, is predominated by T helper activity, 
probably because suppression becomes manifest after 
proliferation only. In the PFC response the balance 
could be investigated using non-irradiated T cells. 
With all mitogens the induced helper T cell activity 
outweighed suppressor cell activity, except after ConA 
stimulation. Helper cell activity was found in the T 
cell fraction of the circulating pool, in thymus and in 
peripheral lymphoid tissues. Bone marrow cells had no 
helper activity. SCID patients lacked the mitogen-in-
duced helper activity. Their B cells responded when T 
helper cells from normal individuals were added. This 
again shows that these patients have B cells which can 
respond normally. The opposite situation was found in 
patients with various humoral immunodeficiencies: helper 
cell activity was present. The data indicate that the 
helper T cells belong to a fairly mature T cell popula-
tion. He1per cell function is acquired at the intrathy-
mic stage. Cell-cell interaction in T cell-mitogen, but 
not in B cell-mitogen stimulated cultures was demonstra-
ted in mixing experiments of irradiated T cells and nor-
mal B cells. This was performed by varying the numbers 
of cells in one of the lymphocyte populations (ratios 
from 1 : 50 to 1 : 1) and by linear regression analysis 
of cellnumber: mitogen relationships. This confirmed the 
T cell independence of STA re-sponses. Two general con-
clusions can be made: 1) polyclonal B activators provide 
a valuable tool for further analysis of immunodeficiency 
diseases as well as for the analysis of the normal im-
mune response and 2) the studies exemplify the cellular 
network regulating the immune response in man, and show 
that helper T cell activity is lacking in some combined 
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immunodeficiencies. 
The T suppressor cells analysed in an antigen speci-
fic human PFC response belong to a·subset ofT lympho-
cytes, designated as theophyllin sensitive (T-sens) be-
cause they are unable to bind sheep red blood cells in 
the presence of theophyllin. This characteristic enables 
the isolation of this T cell subpopulation. In paper 6.3 
the expression of Ia on T-sens lymphocytes is demonstra-
ted. First the isolation procedure of T-sens lymphocytes 
is described. Peripheral blood mononuclear cells (PEL) 
were depleted of adherent cells. The non-adherent lym-
phocytes were incubated with theophyllin and sheep red 
blood cells, which enabled the isolation of the theo-
phyllin resistant T cells (T-res). The left-over cells 
were depleted of C3 receptor positive cells (B-lympho-
cytes). The lymphocytes left over after this second de-
pletion were analyzed by marker tests and shown to be E 
rosette positive, sig negative, C3 receptor negative, 
and NSE negative (NSE is a stain for monocytes). This 
T-sens population contained 25 to 45% Ia positive cells, 
demonstrated by immunofluorescence with a heterologous 
antiserum. It was calculated that about 5% of PBL-T cells 
carried the Ia determinant. The presence of Ia determi-
nants on T-sens lymphocytes was further demonstrated 
after radioactive .labeling of T-sens and immunoprecipi-
tation of the solubilized membrane structures by the 
anti Ia-serum. A double marker study on T-sens lympho-
cytes visualized the Ia determinant on E-rosetting cells. 
Nhen the T-sens lymphocytes were used as stimulator 
cells in a mixed lymphocyte culture (MLR) with unrela-
ted donor PBL as responder cells, the T-sens were shown 
to be potent stimulators, 3-5 times stronger than equal 
numbers of B lymphocytes. The T-res lymphocytes did not 
stimulate. lihen calculated on the basis of the numbers 
of Ia positive cells in the B cell and T-sens population, 
the stimulatory capacity of Ia+-T-sens was shown to be 
10 times stronger than those or (Ia+) B lymphocytes. 
The MLR studies, detecting the HLA-D determinant, 
and the immunofluorescent studies, detecting an HLA-D 
related Ia determinant both indicate the expression of 
MHC encoded regulatory gene products on a human T lym-
phocyte subpopulation. Hhen T lymphocytes are activated 
Ia+ T cells rapidly expand. Within some days of culture 
almost all T lymphoblasts carry the Ia determinant. This 
was further analyzed by the T cell colony assay descri-
bed in paper 6.4. T-colony precursor cells in PBL were 
detected in a microculture system using PHA conditioned 
medium dissolved in semisolid culture medium, containing 
fetal calf serum. The T colony precursor cells were the-
ophyllin sensitive T lymphocytes and could also be found 
in peripheral lymphoid tissues. Thymus and thoracic duct 
cells did not contain T colony precursors, while bone 
marrow had very low numbers. This tissue distribution 
suggested that T colony precursor cells are fairly ma-
ture T lymphocytes. The T colony cells were identified 
by surface marker studies: they were E rosette positive 
(theophyllin resistant and stable resetting at 37°C), 
had no sig and did not have receptors for IgM, IgG or C3. 
When whole cultures (T colony cells plus other lympho-
cytes) were analyzed, 40-80% of the cells were Ia+ posi-
tive. The cultured lymphocytes did stimulate in MLR as 
well. Some SCID patients were inveStigated and shown 
to have a deficiency in T colony precursor cells, even 
after reconstitution with thymic epithelial tissue im-
plants. The studies of the T cell Ia marker on circula-
ting T lymphocytes and of tne growth of ra• T cells in 
the colony culture system clearly indicate that the Ia 
determinant is a differentiation marker. The response 
of allogeneic lymphocytes to this T cell subpopulation 
also indicates that the T cell Ia determinant serves as a 
cognition structure in cellular interactions. 
Products of genes of the major histocompatibility. 
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complex (MHC) are, in various ways, involved in lympho-
cyte recognition. The human MHC, the HLA complex, en-
codes two classes of determinants. The Ia-related or 
HLA-D/DR antigens are involved in co-recognition where-
by an antigen is "seen 11 along with an accompanying HLA-
D/DR antigen on the macrophage surface. The Ia-related 
HLA antigens do not have Beta-2 microglobulin (B2M) as 
their common molecular subunit. The other class of HLA 
determinants, HLA-A, -B and -c, anchors to B2M on the 
cell surface and relates primarily to T cell antigen re-
cognition either in the induction phase of the immune 
response or in the effector phase in target cell kil-
ling. In paper 6.5 an "experiment of nature" is presen-
ted, namely the association between a failure of lympho-
cyte membrane HLA-A and -B determinants expression and 
combined immunodeficiency. The investigations indicate 
a possible role of the HLA-A and -B determinants in the 
recognition of antigen by T lymphocytes. The role of 
B2M in the anchorage of HLA-A and -B determinants on 
the lymphocyte membrane was substantiated. Circulating 
T cells lacked B2M whereas T cells in lymphoid tissues 
showed B2M, but more in between the T cells than really 
fixed to the membrane. It was speculated that the basic 
defect lay in B2M fixation to the membrane, leading to 
failure of expression of HLA-A and B antigens, in its 
turn leading to a defective immune response to antigens, 
but not to mitogens. Other patients with a remarkably 
identical immunodeficiency associated with HLA-A and 
-B expression failure have been described and are pre-
sented in papPr 6.7. The "HLA-null" disease appears to 
represent a postthymic T cell defect especially in the 
response to antigens. 
In the immune response not only the determinants on 
the lymphocyte surface are important but also the inte-
grity of the membrane-cytoskeleton interactions. An 
"experiment of nature", indicating a role of membrane 
receptor capping in the development of the immune res-
ponse, is presented in paper 6.6. This patient had a 
severe combined immunodeficiency (SCID). Marker tests 
showed normal numbers and distribution of T and B lym-
phocytes. Furthermore~ the patient had normal immuno-
globulin levels, an unusual phenomenon in SCID. These 
immunoglobulins had no antibody activity against the 
various viral and bacterial antigens tested. Mitogenic 
T cell proliferation was absent. The explanation for 
the discrepancy between the presence of mature T cells 
and the absence of T cell functions was found in a mem-
brane abnormality. Receptors for mitogens were demon-
strated on both T and B lymphocytes, but the surface 
receptor capping phenomenon following ligand-receptor 
interaction was disturbed. Lateral mobility of cell 
surface receptors for ConA was increased, leading to 
unusually fast accumulation of receptor bound ConA in 
the surface caps. The STA response of B lymphocytes was 
normal, indicating a normal B lymphocyte maturation ca-
pacity, which was anticipated (paper 6.1), but was un-
expected because B lymphocyte also displayed the in-
creased ConA capping phenomenon. An explanation was 
found in the rigid structure of the STA bacterium 
carrying the mitogenic protein A molecules, which pro-
bably prevent·s increased capping and thus allow.s the 
normal transduction of the proliferation signal. Mito-
gen induced helper T cell activity of SCID-T cells was 
absent (paper 6.7), when tested on normal B cells. Pa-
tient B lymphocytes responded to T cell helper activity 
induced by mitogenic activation of normal T lymphocytes. 
These findings support the theory that plasma membrane 
cytoskeleton interactions have a role in the expression 
of specific immunity. 
In paper 6.7 a comparison between both types of immu-
nodeficiency diseases associated with membrane defects 
has been made. In both the immune response defect had 
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been postulated to be a defect in the response of T 
cells to antigens, caused by their membrane defect. It 
was striking that both phenotypically combined immuno-
deficiencies, both with defective antigenic T cell res-
ponses to antigens, had such a completely different his-
tology of the peripheral lymphoid organs. The hypothe-
sis was raised that HLA determinants and/or B2M, which 
were normally expressed in the capping disorder, play a 
crucial role in the homing of lymphocytes to peripheral 
iymphoid organs. Furthermore some indication emerged 
that in vitro studies on the circulating pool of lympho-
cytes do not necessarily reflect local situations in 
the peripheral lymphoid organs. 
In summary the studies indicate a network of cell 
interactions in the human immune response. Lymphocyte 
membrane structures encoded in the HLA complex play an 
important but still elusive role. This holds for mem-
brane receptor cytoskeleton interaction as well. B lym-
phocyte mitogens were valuable tools in the investiga-
tion of these immunodeficiency diseases. The classical 
lymphocyte differentiation model by which immunodefi-
ciency diseases were analyzed is interwoven with a con-
cept of a regulatory unit consisting of subpopulations 
of T lymphocytes. Histocompatibility antigens encoded 
by the MHC play a major role in the interactions be-
tween T lymphocytes, possibly between T and B lympho-
cytes and between T lymphocytes and macrophages. Some 
indications of the role of human MHC products emerged 
from studies in two types of membrane defects associa-
ted with combined immunodeficiency. 
The newer models derived from in vivo and in vitro 
studies on the cell interactions in the immune response, 
on the role of membrane determinants in these interac-
tions, and especially on the defects in immuDe respon-
siveness in immunodeficiencies may eve·ntually lead to 
immunoprophylaxis and immunotherapy for patients with 
immunological diseases. 
4.2. SAMENVATTING 
Hoofdstuk 1 
Het doel van de onderzoekingen was ee~ verdieping van 
het inzicht in het humane immuunsysteem door a) ont-
wikkeling van nieuwe(re) analysemethoden, en b) toe-
passing van deze methoden bij het onderzoek van irnmu-
nodeficienties. Door een beter inzicht wordt uitbrei-
ding van de mogelijkheden tot beinvloeding van irnmuun-
stoornissen bij kinderen nagestreefd. 
Hoofdstuk 2 
Drie modellen voor het humane immuunsysteern worden ge-
introduceerd: 
1) een ontogenetisch model, waarbij twee compartimen-
ten binnen het immuunsysteem worden onderscheiden: 
de thymus-afhankelijke cellulaire immuunreactivi-
teit en de thymus-onafhankelijke humorale irnmuun-
reactiviteit. De dragers van deze twee vormen van 
immuunreactiviteit zijn respectievelijk de T-lym-
focyten en de B-lymfocyten. 
2) een cellulair interactie model, waarbij de T lym-
focyt een centrale regelende functie heeft, zowel 
in de cellualire als in de humorale immuunreacti-
viteit. Hierbij wordt een functioneel onderscheid 
gemaakt tussen T helper en T suppressor lymfocyten. 
3) een model waarbij de belangrijkste histocompatibi-
liteits (MHC) determinanten functioneren als gids 
voor o.m. de T lymfocyten. Antigeen presentatie 
door macrophagen aan T lymfocyten verloopt aanzien-
lijk beter wanneer beide cellen elkaar herkennen 
via de MHC determinant. Voorwaarde is een zekere 
mate van identiciteit van de determinanten op bei-
de cellen. De "killing" door T lymfocyten van met 
virus geinfecteerde cellen verloopt eveneens beter 
wanneer "killer" en "target" tenminste identiek 
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zijn voor een deel van de MHC determinanten. 
De drie modellen sluiten elkaar niet uit, integendeel, 
ze ZlJn met elkaar vervlochten. Er zijn echter nog ve-
le onduidelijkheden, zeker met betrekking tot het hu-
mane immuunsysteern. 
De analyse van immunodeficientie ziekten wordt in 
eerste instantie volgens het eerste model verricht. 
Sornmige humorale deficienties blijken echter niet te 
berusten op een defect in de aanleg van B lyrnfocyten 
doch blijken te berusten op een buitensporige suppres-
sor T eel activiteit. De in principe normaal aanwezige 
B eel reactiviteit kan in vitro aangetoond worden. 
Onderzoek met behulp van B eel mitogenen kan verdere 
inforrnatie hierover verschaffen. 
Artikel 6.1 
Een polyclonaal B eel rnitogeen, Staphylococcus aureus 
Cowan I (STA) activeert humane B lymfocyten van sorn-
mige patienten met humorale immunodeficienties. Voor-
waarde is dat ze circulerende membraan-immunoglobuli-
ne-positieve (sig+) lymfocyten hebben. Sommige patien-
ten met een gecombineerde ~+B) immunodeficientie blij-
ken sig+-B lymfocyten te hebben~die geactiveerd kunnen 
worden door STA. De kweekomstandigheden van de lyrnfo-
cyten transforrnatietest met STA worden besproken. Hu-
maan IgG1, doch niet IgG3, blokkeert de mitogene acti-
viteit van STA. Op STA reagerende lymfocyten komen 
voor in perifeer blood en in alle perifere lymfoide 
organen, doch niet in de thymus. De op STA reagerende 
lymfocyt blijkt E rosette negatief (non-T), C3 recep-
tor positief~ STA receptor positief, Ia-positief en 
waarschijnlijk sig-positief. Door lymfocyten van pa-
tienten met verschillende immunodeficienties te onder-
zoeken op STA reactiviteit kan de conclusie bevestigd 
worden~ dat STA een vrij ver ontwikkelde B lymfocyt 
activeert. 
Artikel 6.2 
De STA reactiviteit van lymfocyten werd vergeleken met 
de reactiviteit ten opzichte van bekende T eel mitoge-
nen. Na bestraling van T lymfocyten kan de door T eel 
mitogenen geinduceerde helper activiteit van T lyrnfo-
cyten gedemonstreerd worden door de proliferatie en/ 
of IgM secretie van (onbestraalde) B lymfocyten te 
meten. Bestraling van T lymfocyten heeft een tweele-
dig effect: a) de trans forma tie ·van T lymfocyten wordt 
geblokkeerd, zodat de transforrnatie van alleen de B 
lymfocyten gemeten kan worden, en b) de suppressor 
activiteit van T lyrnfocyten wordt uitgeschakeld, zo-
dat de helperactiviteit apart gemeten kan worden. Bij 
een hemolytische plaque vormende eel (PFC) analyse 
storen onbestraalde T lymfocyten niet, zodat hiermee 
de balans tussen helper en suppressor activiteit gerne-
ten kan worden. De T eel fraeties in perifeer blod~ 
in de thymus en in perifere lymfoide organan~ hadden 
alle de door mitogeen geinduceerde helper aetiviteit. 
Normale beenmergcellen en perifeer bloedlymfocyten 
van SCID patienten vertoonden geen helperactiviteit. 
In de onderzochte humorale immunodeficienties was de 
helperactiviteit aanwezig. Door middel van mengexpe-
rimenten waarbij het percentage van T of B lymfocyten 
gevarieerd werd~ kon worden aangetoond dat de T. eel 
mitogenen interacties tussen twee (of meer) cellen 
bewerkstelligen terwijl STA slechts een celpopulatie 
aetiveert. Op zich wederom een bewijs voor de T eel 
onafhankelijkheid van de STA reactiviteit. De balans 
tussen helper aetiviteit en suppressor activiteit, 
zeals gerneten met de PFC methode~ is alleen na acti-
vatie met het T eel mitogeen ConA verschoven in de 
richting van een suppressief effect. 
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Artikel 6.3 
Suppressor T cellen, zeals deze geanalyseerd werden in 
een antigeen specifieke PFC methode, behoren tot een 
bepaald deel van de T lymfocyten, de theophylline sen-
sitive T lymfocyten (T-sens). De isolatie van T-sens 
lymfocyten kan onder andere geschieden door verwijde-
ring van theophylline resistente T lymfocyten (T-res) 
gevolgd door verwijdering van C3 receptor positieve 
lymfocyten. De analyse van mernbraankenmerken, van de 
overgebleven cellen (E rosette positief en -negatief 
voor sig, C3-R en NSE) bevestigde dit. De T-sens po-
pulatie bevat 25-45% Ia-positieve T lymfocyten en 
heeft een hoge stimulatoire capaciteit in een gemeng-
de lymfocytenkweek (MLR). Berekend op basis van het 
+ aantal Ia lymfocyten, is de MLR stimulatie 10 maal 
zo sterk als die van B lymfocyten. 
Artikel 6.4 
Na activatie van T lymfocyten neemt het relatieve 
aantal Ia+-T lymfocyten snel toe. Mitogen geconditio-
neerd medium wordt gebruikt om T eel kolonies te la-
ten groeien. Een boog percentage van de gek't'reekte 
cellen draagt dan de Ia determinant. De gekweekte 
cellen stimuleren in een MLR. De kolonievormende T 
lymfocyten zijn afkomstig van de T-sens populatie in 
perifeer bleed. 
Artikel 6.5 
De rol van HLA de·terminanten, met name van HLA-A en 
-B determinanten, in de immuunreactiviteit van de 
mens, w.ordt ·bel·icht door een "experiment· of nature", 
een gecombineerde immunodeficientie geassocieerd met 
de afwezigheid van HLA-A en -B antigeen op de lymfo-
cyten. De verankering van HLA-A en-B antigenen op de 
lymfocytenrnembraan vindt plaats in combinatie met 
Beta-2-microglobuline (B2M). De lymfocytenmembraan 
van T lymfocyten vertoonde een gestoorde B2M fixatie. 
Alle tot nu toe beschreven patienten (artikel 6.7) 
hadden een af te grenzen type immunodeficientie. Hier-
bij is met name de antigenenherkenning van T lymfo-
cyten gestoord. 
Artikel 6.6 
De belangrijke rol van niet alleen membraandeterminan-
ten doch ook van de integriteit van de lymfocytenmem-
braan zelf, wordt gedemonstreerd aan de hand van een 
ander 11 experiment of nature". Een stoornis in de late-
rale mobiliteit van de ConA receptors op de lymfocyten-
membraan blijkt geassocieerd te zijn met een gecombi-
neerde immunodeficientie. Met betrekking tot membraan-
deterrninanten lijken de T lyrnfocyten volledig gediffe-
rentieerd te zijn doch de bijbehorende ontwikkeling 
van hun functies blijkt afwezig. 
Artikel 6.7 
Beide types van immunodeficientie geassocieerd met 
membraandefecten werden vergeleken. Er bleek een dui-
delijk verschillende histologie van de perifere lym-
foide organen te bestaan. Een mogelijke rol van HLA 
determinanten en/of B2M bij de migratie van lymfocy-
ten naar de perifere lymfoide organen werden bespro-
ken. 
De onderzoekingen leiden tot de volgende conclusies: 
Immunodeficientieziekten kunnen niet alleen volgens 
het ontogenetische model worden geanalyseerd, doch 
ook aan de hand van cellulaire interactiemodellen. 
Daarin staan met name T lymfocyten subpopulaties en 
hun activiteiten centraal, en vormen polyclonale B 
eel mitogenen een waardevolle aanvulling bij het on-
derzoek. B2M geassocieerde HLA determinanten blijken 
een rol te spelen in de cellulaire reacties en moge-
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lijk ook bij de migratie van lymfocyten. 
Een meer functionele analyse van de immuunreactiviteit 
bij de mens waarvan de beschreven onderzoekingen deel 
uitmaken, zal verdere mogelijkheden openen voor immu-
noprophylaxe en immunotherapie bij pati&nten met im-
munologische stoornissen. 
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The staphylococenl cell wall component protein A 
(SpA) and formalinized. Cowan I strain Staphylococcal 
organisms (SfA) were compared with the lectins phy-
tohemagglutinin. concanavalin A. and pokeweed mito-
gen for their ability to trigger proliferation of normal 
human lytnphocytes., lymphocyte subpopulations. and 
cells from patients with primary immune deficiency dia-
enses. SpA was found to be a potent T cell mitogen. very 
similar to the other lectins tested. It failed to stimulate 
pwifi-ed. non-T cellri and peripheral blood lymphocytes 
from patients with different forms of severe combined 
immunodeficiency disease (SCID). STA. treated to pre-
vent the leakage of soluble SpA during culture, exclu-
sively stimulated non-T cells: the responding cell popu-
lation was characterized to be E-rosette negative but 
positive for C3 receptors, surface Ia. a receptor for STA 
itself. and likely carried surface immunoglobulin. Nor-
mal responses to STA were found in patients with the 
adenosine de3Jilinase..positive form of scm. In 18 pa-
tients with humoral immune deficiency syndromes. the 
presence ofSTA responses was con-elated with the pres--
ence of circulating, surface immunoglobulin-bearing 
cells. A commercial STA preparation was rendered B 
cell specific after reformalinization. a procedure that 
eliminated the shedding of soluble SpA under culture 
conditions. 
Mitogenic activation of lymphocytes is an important tool in 
both diagnostic and experimental immunology. rn contrast to 
rodents. virtually all rnitogens tested in man result in T cell 
proliferation. whereas purified B lymphocytes are triggered to 
no more than marginal increases i.n thymidine uptake or differ-
entiation into immunoglobulin-producing cells. Exceptions 
have been described and include water-soluble extracts from 
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Nocardia and live Epstein·Ba..'Pl' virus {1, 2). On the other hand. 
there is a much wider experience with indirect or T cell-de-
pendent B cell activation by pokeweed mitogen {PWMl" {re-
viewed in 3). However, the dependence on T lymphocyte~:~ or 
their products limits the applic.ntion of PWM: for example, the 
absence of responses in a given patient may not only indicate a 
primary B cell deficiency but the absence of appropriate 
"helper" T cells or the presence of suppres.--or cells that may be 
abnormal in function or quantity (4}. 
~ently, Cowan I strain Staphylococci (ST A) and its soluble 
cell wall product. protein A (SpA}, have been described to be 
mitogenic for both B and T cells (5-10). Since among these 
reportS controversy exists with respect to culture condltions 
and cell lineage specificity, we have reevaluated the properties 
and requirements for ST A and SpA-induced mitogenesis. In 
the present study, we used lymphocytes from norrn.als and 
patients with clifferent forms of immunodeficiency. Our data 
delineate the cell lineage specificity in the mitogenic properties 
of ST A and SpA: ST A exclusively stimulates B lymphocytes 
that appear to bind ST A and carry surface immunoglobulin 
(slg) as well as CJ receptors; SpA. in contr.:Lst. is a T cell 
mitogen, equal in potency to phytohemagglutinin (PHAl or 
concanavalin A (Con A). The experimental requirements for 
both mitogens are strikingly different, although both seem to 
involve the protein A moiety. Thus, the T cell triggering site of 
SpA appears not to be accessible on bacterial cell walls and is 
distinct from the immunoglobulin binding site of the molecule. 
In controst. binding of IgGl to ST A interfered with its mitogenic 
effect. 
MATEruALS AND METHODS 
Cell wurce and preparations. Mononuclear cells from pe-
ripheral blood, tonsil, or thymus were obtained by density 
separation on Ficoll-Hypaque. If indicated. further purification 
utilized E-rosette depletion on Ficoll gradients as described 
(11). STA-binding cells were enriched in tonsil cell suspensions 
by a similar rosette depletion procedure using erythrocyte-IgG-
ST A complexes. These were prepared by incubating (30 min at 
37°C) 1 X 1011 STA particles with 1 x 109 erythrocyte-IgG 
complexes. The latter were formed using ox red blood cells and 
Abbrevintioll.$ used in this paper: ADA. adenosine delllilinase: Ay. 
aglli:I:Uil.ll.giobulinemin: CVID. common vnriable immunodeficiency dis-
elllle: C3", complement ro~~ette-fonning celh: E". E-rosette-fonning IT) 
lymphocytes; PBL. peripheral blood !ympho-mononuclen.r cell:;: PWM, 
pokeweed mito~:en; SCID, severe combined immunodeficiency disense: 
ll!g, su.rfo.ce immunoglobulin (G, M. D); SpA. Staphylococcal protein~ 
STA. formalinized StaphylocfXXu.~ fJ.Ureus (Cowun Il; STA", STA· 
binding Ct'lls. 
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a rabbit IgG antibody. Red cell.:tgG complexes were formed at 
low antibody concentrations and did not result in the depletion 
of Fc,IOICI receptor-bearing tonsillar B lymphocytes. STA was 
removed from ST A-binding cells on a third Ficoll gradient after 
incubation (90 min at 4 °C) in the presence of 50% AB serum. 
Complement (C3) receptor-bearing cells were isolated from 
adherence depleted PBL by using C3-coated yeast particles for 
rosette depletion on Ficoll gradients (12). 
Patients. The majority of patients studied have been reported 
previously (11, 13, 14). In vivo, all were incapable of s~c 
antibody formation. Three of the patients with severe combined 
immunodeficiency disease (SCID) and normal. levels of adeno-
sine deami.nase (ADA.,.) were shown to have the intrathymic 
form of the disease (15) with normal to elevated numbers of 
slg-positive lymphocyteS; one patient (case 6) presented with a 
variant SCID secondary to a cytoskeletal abnormality (14). The 
two patients IIVith SCID and ADA deficiency (ADA-) lacked 
detectable (B or Tl lymphocytes (15. 16). Patients with agam~ 
maglobulinemia (Ay) lacked circulating or tissue B lymphocyteS 
and plasma cells (11. 13). All but two patients with common 
variable immunodeficiency disease (CVID) bad up to normal 
numbers of circulatory B lymphocytes and varying degrees of 
hypog:unmaglobulinemia or. as in one case. hypei'gllll11DUgloJ>. 
ulinemia, but lacked serum antibody activity. All patientS were 
receiving y-globulin or plasma replacement therapy at the time 
of study. 
Tissue culture conditions and reagents. Cultures were main-
tained for 80 to 90 hr in flat-bottom Micro test-II plates (Falcon 
Plastics, Oxnard, Calif.) in supplemented RPMI 1640 (GIBCO. 
Grand Island. N. Y.) and were harvested after a 4-hour pulq,e 
with 1 ji.Ci JH-thymidine and counted in a scintillation counter. 
All cultures contained 10% fetal calf serum (FCS. GIBCO. batch 
14-144). Where indicated. pooled human AB serum was added 
in varying :unounts. In one series of experiments, an aliquot of 
this AB serum pool w35 depleted of immunoglobulin by using 
either insolubilized protein A (Pharmacia. Ltd .• Montreal, Que-
bec) or &p~bound purified sheep antibody to human IgG 
or an IgM-specific immunosorbent. The latter were a gift from 
Dr. B. Underdown (University of Toronto. Toronto. Ontario). 
Human IgG1 and IgG3 myeloma proteins were a gift from Dr. 
W. Pruzanski (Wellesley Hospital, Toronto. Ontario). 
Mitogens. PHA and PWM: were obtained from Difco Labo-
ratories (St. Louis. Mo.) and purified SpA from Pbarmacia, 
(Montreal, Quebec). Staphylococci (Cowan strain!) were a gift 
from Dr. B. Barber (University of Toronto, Toronto. Ontario). 
One bacterial colony was grown in 10 ml culture brOth overnight 
at 37"C and then propagated in 41 aerated mass cultures as 
described (li). Staphylococcal organisms were harvested and 
washed by centifugation, characterized by routine bacteriologic 
procedures, and killed and hardened by fonnalinization (130 
min at 23"C) in 1.4% formaldehyde and 5 min boiling. Stock 
suspensions of 1 X 10" killed organisms/ml RPMI 1640 were 
stored at -20"C. This batch {ST A~ Toronto) was used through-
out this study. It was found not to shed SpA during 3 days of 
culture at 37"C as tested by binding of radioiodinated IgG. A 
second batch of ST A was purchased (Pansorbin. Batch 830 187, 
Cnlbiochern-Behring Corp .. La Jolla. Calif.) ISTA-Cal). Pre-
pared for use in radioimrnunoprecipitation assays. this prepa-
ration had a high binding capacity for IgG. but there was also 
significant shedding of SpA if incubated for 3 days under culture 
conditions. An aliquot was therefore reformalinized for 60 min. 
This reduced its binding capacity for IgG and virtually elimi-
nated SpA shedding. 
Data analysis. Data were obtained as cpm thymidine incor-
poration and the means for triplicate cultures are given ::1:: 1 
S.D. Quench. as estimated by H~number.s. indicated no signifi-
cant differences between test tllld control samples in tlllY given 
experiment tllld was disregarded. When data from different 
experiments were pooled. results of each were expressed as a 
fraction of the maximal responses obtained in each e~riment 
or in the appropriate cell population with the mitogen indicated. 
Graphic and statistical analysis used Plot 10 based software on 
a Tektronix microcomputer. All t-tests were two-tailed. 
RESULTS 
Requirements for mitogt!ni.c responses to STA and SpA 
Cultures of 2 x 1!1 normal peripheral blood lympho-mononu-
clear cells (PBL) were incubated with varying concentrations 
ofST A or SpA. When cultures contained 10% pooled AB serum. 
consistent proliferative responses were only observed with SpA. 
These responses were roughly the same as controls stimulated 
with PHA (7 to 10 X 10'' cpm). In contrast. no significant 
responses were observed in' cultures stimulated with ST A. 
However, when cultures were supplemented with FCS instead 
of AB serum, a significtlllt mitogenic effect of ST A was found 
(2 to 4 x 10" cpm us 2 to 5 x 1Q'l cpm in unstimulated controls). 
These differences are analyzed in Figure 1, where cultures 
containing 10% FCS received increasing amounts of AB :serum. 
AB serum inhibited the ST A responses in a dose--dependent 
fashion. In seven ~xperiments, SpA and PHA responses were 
little affected. At high concentrations of AB serum. mean values 
tended to be somewhat lower for SpA respoases; the increased 
variability precluded delineation of a significant difference to 
cultures containing FCS alone (p > 0.1). 
Protein A bas a lectin-like binding capacity for several species 
of proteins including immunoglobulins (17-19). High affinity 
binding is found for IgG1, IgG2. tllld IgG4 and little binding to 
IgG3. The effect of AB serum could be mimicked by purified 
serum IgG (data not shown). We therefore tested the effect of 
IgG 1 tllld IgG3 myeloma proteins on STA~induced proliferation. 
As shown in Figure 2. the addition of IgG1, but not IgG3, 
resulted in abrogatioa of the ST A response. This suppression 
was dose dependent (r .. 0.91); PHA and SpA responses were 
at best only marginally affected. 
:; 
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Fijfurc 1. Effect of AB 3enliii ::w.pplementution on the proliferative 
respoMe to PHA. SpA. and ST A. Cultures of 2 x 10" normal PBL were 
maintained in 200 .W RPMI-1640 pl111:1 10% !eta! call serum and the AB 
serum concentration indicated. Data fror.:1 four experiments were 
pooled and expr~ aa a function of the maximal response to the 
appropriate mitogen (cpm lH-thymidine incorporation. means ~ 1 
S.D.) ob.servcd in each ~ent. 
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These findings suggested that IgG, by attaching to protein A 
binding sites on STA. could abrogate its mitogenic activity. 
This was directly tested in blocking experiments where ST A 
was pretreated with either AB serum. or FCS, thoroughly 
washed, and then used as a stimulator. In addition, AB serum 
was used after absorption with insolubilized SpA or specific 
immunoabsorbents for IgM or IgG. Myeloma proteins served 
as a supprestJ.ive (lgGl) or noosuppressive (lgG3) control IgG-
coated STA failed to elicit proliferative responses: as shown in 
Figure 3, the suppressive moiety in AB serum could be removed 
with insolubilized anti-IgG or Sepharose-SpA but not with the 
anti-IgM immunoabsorbent. In face of the failure of SpA re-
sponses to be affected in the same fashion. these data suggested 
a different mode of action of STA and SpA and the possibility 
of different responding itarget") lymphocyte populations., only 
one of which (the STA-responsive) required access to the lectin-
like binding site (9). The absence of blocking effects of IgG or 
AB serum on SpA responses suggested that the lectin-like 
binding site for a serum protein such as IgG was distinct from 
the mitogenic region of the SpA molecule and conceivably 
inac«:!~Sible on fon:oalinized ST A. 
Tissue distribution. of mitogenic responses. With c~lls from 
91 diff~rent donors. the tissu~ distribution of mitogenic re-
sponses to STA and SpA was compared with those ofth~ T cell 
mitogens PHA. Con A, and PWM (Tabl~ D. As a c~ntral 
lymphoid organ thymus was chosen, containing almost exclu~ 
sively (>95%) c~lls of T lineag~; tonsil served as a source of 
more mature cells containing about two-thirds B cells and one--
third T lymph()Cj"teS; in addition. PBL w~re used consisting of 
two-thirds T lymphocytes and on~~ third non~ T cells (20), 
PHA. PWM. and Con A had similar response profiles. with 
the highest values in PBL. followed by tonsil and thymus. ST A 
responses generally were highest in tonsil, somewhat low~r in 
PBL. but consistently absent in thymus. In contrast. SpA 
elicited vigorous proliferativ~ responses in thymocyteS and 
closely paralleled the oth~r T cell mitogens. In agreement with 
the suggestion of differences in th~ mitogenic properties of ST A 
/JS SpA, these- results suggested differences in the tissue distri~ 
bution of the cell populations responding to ST A and SpA. 
~vely. 
Mitogen. responses in purified lymphocyte su.bpopu.lation.s. 
The question of different target cell populations responding to 
..• 
.. , 
200 20 2.0 
11'0 lg0 A00~0/0JlTUite 
Figurr 2. Effe<:t of different IgG su~ on the proliferative re--
3PODBe to STA. Cult\u"es of2 x 10" nomutl PBL were maintained in 200 
}1.1 RPMI-1640 containing 10% feW calf >Jerum. VarioWJ concentnltiOflll 
of purified myelorn. protein. were added at the beginning of culture. 
Pooled data from three el:periment.s are e:z;pressed 83 a fraction of 
maxU:nal re:JPQDSeS ob.erved in each experiment. Maximal 1"1!'5poMeS 
were fotmd in control cult\u"e$ without added IgG. 
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Figure3. Mitogenicity of STA preparntions preincubated 12 hi:' at 
4°C) with different AB serum so\IX'Ces {solid collmur.s) or purified IgG 
myelOlllll proteioo (stippkd columns). The different AB sera were 
obtained as describOO in Matt:rials <Wi Metiuxis by using imm.unoab-
sorbents with the specificitit:$ indicated Fetn.i calf .'!etwn, trented in 
parallel. served 113 CQntrol (opt:n cclwn.ns). FoUowing incubation, STA 
were 'washed and. used for thf.' stimulation of nonnal PBL in cultureg 
containing 10% fetal calf' serum. Respofl8es (meWll! ; l S.D.) nre 
e:z;pressed as a fraction of 1Il!1Xi.mcl. re>5panse~ that were observed in 
cultlu'e:l stimulated with untreated STA. 
ST A or SpA was addressed in c~ll separation experiments. 
Observations in purified lymphocyte subpopulation.s from PBL 
and tonsil cells were similru"and have been pooled in Tab!~ ll. 
T cells. purified as E~rosette forming c~lls (>95% E .. ) showed 
vigorous responses to stimulation with PWM, Con A. PHA •. and 
SpA but lacked a response to ST A. The converse was true for 
cultures of E~rosette d~pleted (E-) cell populations, which 
contained 90% or more C3 rec~ptor and surface Ia~bearing B 
lymphocytes: ther~ was a consistently good response in these 
populations to stimulation \\'ith STA. whereas no response was 
observed with the T cell mitogens Or SpA. More deto.iled cell 
dilution experiments and regression analysis will be presented 
in the accompanying paper (21). 
To further defin~ the populations of responding cells, w~ 
tested positively selected peripheral B lymphocyteS (C3~) and 
C3·re-ceptor negative c~lls (C3-). The C3.,. preparations con-
tained no E-rosette forming cells. and virtuaily ail cells carried 
surfac~ Ia and more than 60% bad easily detectable surfac~ 
IgM/IgD. These c~lls responded exclusively to stimulation with 
STA {Table Ul. C3- populations contained up to >90% E-
rosette forming c~lls. virtually no C3 receptor and surface IgM/ 
lgD bearing cells. and w~re responsive to PHA. Con A. PWM, 
and SpA. These results sugg~sted that the ST A-responsive c~ll 
population was a C3 receptor-positive. Ia-bearingcell. and likely 
expressed slg. 
By using a sandwich technique, ST A was bound to ox ~ryth­
rocyte-lgG complexes. and this reagent was then used in a 
rosette-depl~tion procedur~ for the d~pletion of ST A binding 
cells. Approximately 30 to 40% of tonsil cells sedimented to-
geth~r with this complex. and only these celh r~sponded to 
ST A (Table !I), indicating that th~ responsive cell population 
bears accessible STA receptors. Taken tog~ther. these data 
suggested a clear .-cut dichotomy between SpA and ST A mito-
genicity. with the latter acting exc\usiv~ly on B lymphocyte-;: 
and the former selectiv~ly stimulating T cells. 
Mitogen. responses in patient.s with primary immune defi· 
ciency disorders. The results presented characterized ST A as 
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TABLE I 
Ti.-.sue distribution of mitogen responses" 
C..U Mark .. r {%) MitOKcn Add"" (cpm X 10 
T;....uc {Nl 
E C3 STA SpA PHA Con A PWM 
Thymus (10} >95 <3 0.7:!: 0.4 0.8:!: 0.6 48 ± 17 31 ± 14 39:!: 15 30 :I: 17 
HTC (29) 33 ± 4 62± 9 0.4 :t 0.3 37 :t II 69 ± 24 74 ± 21 65 ± 21 20 ::t 10 
PBL (52) 71 :t 6 23 :t 4 0.3 :t 0.2 26 :t 9 92:!: 26 ll2 :t 31 89 :t 24 44 ± 17 
"Mononucl~o.r cellil (2 X 10" /weU} from thymus, toru<il, or periphcrnl blood wcrc stimulated with the mitogen indicated for SO to 90 hr in 200 
jll RPMI-1640 supplemented with 10% fetal cnlf serum. Pool~d results (menn :t 1 S.D.) are given as cpm (XI0-·1}. The distribution (mean%:!: 1 
S.D.} ofE nnd complement (C3) rosette-forming cell'< was obtained as referred to in Mar.eriaL~ and Method.~. N, number ofindividunl experiments. 
TABLE II 
Mitogen re:>pon..-<e.'< in purified lymphocyte ."<ubpopulativn..~" 
C..ll Mark<'r l'-'l Mito)'!<'n Add..d {cpm X 10··'1 
C..U Population INI 
E C3 STA SpA PHA Con A PWM 
w (13) >95 <3 0.3 ± 0.2 0.9 ± 0.6 68 ± 21 72± IS 59± 19 38::!: I2 g- <3 87 ± 6 0.6 :t 0.4 41 ± 18 2±1 2:!: I 2±1 2±1 
C3• (4) <3 >95 0.5 ± 0.4 38 :t I6 3±1 2±1 <2 <2 
C3 90 ± 4 <3 0.4 ± 0.2 5±3 72 ± 16 81 ± 23 64 ± 15 49:!: 20 
STA• (3) <3 >95 9±6 81 ± 19 8±3 11 ± 4 6±< 13 ± 5 STA 54± 18 36:tll 2± 1 3±1 74 ± 8 72 ± 13 68±8 52± 15 
"Purifit.'<llymphocyte subpopulntion...; were obtained as described in MateriaL"< and Met.lwds and the separated cclhl {I X 101'/well) were 
cultured and annlyzed u...; indicated in the le~:end of Table I. R• /E-, E-rosette-forming or non-E-rosette-forming cells obtained by &rosette 
depletion of PBL or tonsil; C3 .. /C3', C {C3) receptor positive or negntive cells obtained by depletion of PBL; STA.,./STA-, cells binding or not 
binding to STA, obtain(.-d from toru<il by r0>1ette depletion with erythrocyk~lr:G.STA complexes. N, number of individu.nl experiments. 
TABLE III 
Mitof(en re~ponse~ in '''uere combined immunodeficiency (SCID)" 
Mitogen Add<'d {cpm X 10' 1) 
""" 
Oiao:no.W. I 
STA I 
-
SpA PHA PWM 
1 ADA -SCID I 0.2 ± 0.1 0.4 ± 0.2! 0.6 ::!: 0.4 0.5 :t 0.3 0.4 ± 0.3 
2 0.1 ±0.1 0.2:!: 0.1 0.3 :t 0.1 0.3::!: 0.2 0.2 ± 0.1 
3 I ·r±0.1 26±1 2.4 ± 0.4 1.8±0.6 1.5±0.3 
4 IADA·..scm o.6::!:0.1
1
24::t:3 1.4:!: 0.3 1.5 ± 0.4 0.9 ± 0.2 
5 I 0.4::!:0.~ 1 16±8 1.7 ± 0.6 1.2 ± 0.7 1.5:!: 0.8 6 0.7:!:0.3 34+5 1.9 .... 1.1 1.4 ± 0.8 2.3 ± 0.9 
0 
' PBL (w X 10 /weU} from pnt1Cnts WJth severe combmed unmuno-
deficiency (SCID) were cultured and annly-/.cd O..'< indicnted in the legend 
of Tnble L ADA •1 ADA- denot~ the presence or nb.sence in these 
patients of adenosine denminnse. Ench patient was studied on :~t leru<t 
four occa.~ioru~ and result.~ have been pooled. 
a B cell mitogen and SpA as a T cell mitogen. This conclusion 
wa..'> tested in patients with immune deficiency (Table III). The 
two patients with ADA-deficiency (ADA- SCID) presented 
with a virtual absence of lymphocytes but elevated numbers of 
monocytoid cell'< (16}. None of the mitogens were capable of 
eliciting a proliferative respon..<:e in PBL. The three patients 
with the intrathymic form of (ADA.,.) SCID lacked T lympho-
cytes but presented with normal to elevated numbers of slg.,. B 
lymphocytes {15). PBL from these patients showed normal 
responses to ST A but no proliferation to any of the other 
mitogens. This confrrmed the cell lineage specificity of ST A us 
SpA and underlined the T cell independence of the ST A-
induced B cell response. 
Following the same protocol, 18 patients with primary anti-
body deficiency and intact T cell function were studied. In 
Table IV, these patients are ordered according to the presence 
or absence of slg.,. B lymphocytes. This was done to stres.." the 
absolute correlation {r ... 1.0) between the presence of slg.,. B 
cells and the presence ofST A responses. In contrast, all patients 
had positive T cell mitogenic responses, including SpA. There 
was no significant correlation between ST A and SpA respon...:;es. 
or SpA respon...:;e and the presence or absence of slg.,. B lympho-
cytes. 
Mitogenicity of different STA preparations. One difficulty 
previously encountered when testing different compounds for 
B cell mitogenicity was the large variability between different 
batches. Although all data presented were obtained with one 
batch of STA (prepared by us), we studied a commercially 
available ST A preparation in parallel. This preparation {ST A-
Cal) was found to shed soluble SpA under culture conditions 
and was therefore reformalinized (see Materials and Method.~). 
This treated ST A preparation and the untreated batch were 
tested in cultures of purified tonsillar T and B cells or PBL 
from selected patients (Table V). As shown, no clear-cut di· 
chotomy was found between r~onses to SpA and untreated 
ST A-Cal in any of the experiments. In contrlll."t, when ST A-Cal 
was treated to prevent SpA leakage, the results with this 
preparation were similar to those obtained with our own ST A 
preparation. 
DISCUSSION 
Polyclonallymphocyte mitogens have been invaluable tools 
in immunobiology, since they seem able to recall and set into 
motion parts of the programming of those lymphocyte subpop· 
ulations which they activate. Thus. they can provide informa· 
tion about lymphocyte triggering and activation, serve as 
markers of lymphocyte lineage, and reveal the functional rep· 
ertoire, such as immunoglobulin production or helper and sup-
pressor cell activities {3, 4). When compared with rodents. 
human B lymphocytes seem to be less susceptible to direct 
mitogenic activation or polyclonal initiation of differentiation 
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TABLE IV 
Mito~cn rcspon..~cs i4 antibody deficiency syndrome.,·" 
Mitogen Added kpm x 10· 'I 
c.~ Dia~mo,;~ !!lg 
:'ITA SpA PHA PWM 
Ay 0.6:;!:; 0.2 1.4 :!: 0.8 170 ± 22 70::!: 23 70:!: 27 
8 Ay 0.8 ± 0.5 1.8 ± 0.9 99 ± 12 78::!: 19 37 ± 11 
9 Ay 0.5:!: 0.2 0.4 :!: 0.2 llO ± 18 41::!: 5 35 ± 7 
lO Ay 0.4 ::!:0.2 0.3::!: 0.2 116:!:.7 73 ± 1 40 ± 10 
ll Ay 0.3 ± 0.1 1.2:;!; 0.4 71 :!: lO 78 :i: 3 61 ±8 
12 Ay 0.4 ± 0.1 0.8 :t 0.2 115:!: 8 51 ±4 42::!: 4 
13 Ay 0.5 ± 0.1 1.3 ± 0.3 175 ± 9 64; 6 82 ± 9 
14 Ay 0.4::!: 0.1 0.7::!: 0.1 92 ± 16 39 ± 2 35 .;1;: 6 
15 Ay 0.7 ± 0.1 l.l :t 0.3 62:!: 7 4H6 32 :t 5 
16 CVID 0.8 :l: 0.1 1.1 ± 0.3 125;!; 15 115 :t 10 75 ± 14 
17 CVID 0.5 ± 0.2 0,6 :t 0.1 68 ::t: 5 48 ± 4 42 ± 10 
Menn values: 0.6 ± 0.2 1.0 ± 0.5 110 ± 40 67:!: 16 50± 18 
18 Ay + 0.7 :t 0.1 11 ± 2 89 ± 7 31 :t 7 39 ± 6 
19 Ay + 0.7 ± 0.3 37 :t 9 83 ;t 5 51 ±8 29±4 
20 CVID + 0.9 :t 0.2 9±2 86:!:: 7 127 ± 10 21 ±5 
21 CVID + 0.4 ± 0.2 13 :t 3 90 ± 5 67 ± 5 40 :t 11 
22 CVID + 0.8 :t 0.4 43 ± 13 79 :t 22 "±8 35:!;: 6 
23 CVID + 0.5 ± 0.4 19±3 62 ± 6 59± 12 34 ± 7 
24 CVID + 0.3 ± 0.1 49 ± 8 108 ± 8 72 ± 9 47 ± 5 
Mean value:>: + 0.6 ± 0.2 26 ± 4 85 ± 14 70 ± 30 35 ± 8 
"Prolif'emtive re::~ponscs of pat.:.:-nt PBL (2 X IO''fwell} to ::~timulation with the mito)::Nl:< indicat(-d, (:;e..• k•gend Table I}. Patient<~ have been 
grouped according to the pre~~ence or ab,;cnee of surface immunoglobulin (slf:") positive B lymphQC)'to;":<, Each patient Wl.l.'! Ktudied on at least thrct" 
occm<ions nnd results were pooled. Ay, agammaglobulinemia: CVID, common variabl<.> immunod<.>fieien<.>y di.~en.._'O(>. 
TABLE V 
Mito;zcnicity of diffcrcn.t STA-prcparations" 
C.,ll Di.nf(l'lw.i.< Sourc<:" 
PBL 
E' Normal 
E. 
Ay 
PBL CVID 
SCID 
Mito~~n Add<>d (cpm x \0' 1 ) 
STA Comm~r<:ia! ST A 
Uo· Formalin· SpA (TorontD) ~·'"' irA'<! 
0.3::!; 0.1 23 ± 2 49::!; 3 29 ±4 87::!; 9 
0.2::!; 0.1 Ll ± 0.6 26 ± 7 0.9:;!;: 0.6 79 ± 10 
0.5 ± 0.3 32 ± 2 34 ±4 35 ± 3 1.3 ± 0.6 
0.4±0.2 0.6±0.3 39±5 1.0±0.2 68±7 
0.6±0.2 9.6±1 57±8 10±1 7'2±9 
0.6±0.3 17±2 19±3 18±2 1.4:!:0.5 
"Three STA-prepnrntions lll'e compared in their mitogenicity for 
un.-«!pnratcd normal and patient PBL and purified T and B lymphocytci:\ 
from tonsil. The three STA prcparntions nrc described in MateriaL~ 
and Methods. Cultures were treated m< indicated in the legend ofTablc 
1. 
into immunoglobulin-secreting plasma cells. 
In the experiments presented, we have demonstrated ST A 
and SpA to be selective lymphocyte mitogens and confmned 
their specificity in studies of patients with different immuno-
deficiency dio;;eases. Our fmdings indicate that ST A is able to 
activate B lymphocytes. whereas SpA was a potent and selec-
tive T cell mitogen. Studies of the culture requirements indi-
cated a role for the protein A moiety not only in T cell triggering 
but also in the mitogenic effect of ST A on B lymphocyteS. 
Thus. the inhibitory effect on only ST A responses of normal 
human serum and IgG 1 (but not IgG3) indicated that both ih(! 
presence of bound IgG and access to the lectin-like IgG binding 
site on the protein A molecule are irrelevant forT cell activation 
by SpA. By the same token. access to this lectin-like binding 
site, and/or the absence of bound IgG are required for the B 
cell response to ST A. It is unclear whether these differences 
reflect distinct and alternative triggering events in B and T 
lymphocytes or whether the inhibitory effect of ST A·bound 
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IgG is due to post-activation events such as Fc-domain-medi-
ated suppression of induced B cell respon.o;;es. Although in 
preliminary studies IgG-coated ST A did not interfere with 
either SpA-induced T cell proliferation or PWM-induced B cell 
proliferation. IgG-mediated inhibition would have some prece-
dence (22) and cannot be ruled out at present. 
The cell lineage specificity of ST A and SpA respon....:;es did 
not (only) reflect different response spectrn at the level of B 
and T lymphocytes but was expres..~ at the molecular level a...:: 
well: SpA failed to trigger B lymphocytes no matter whether 
these populations were physically purified or obtained from 
patients with the appropriate cellular immunodeficiency. If B 
and T cell stimulation by ST A or SpA reflect the presence of 
distinct mitogenic sites on these agents, then this would allow 
several conclusions to be drawn concerning the triggering event." 
involved: a) the T cell stimulating domain of the SpA molecule 
is not accessible on formalinized ST A and may be buried in the 
cell wall; alternatively. the mechanL..::m ofT cell triggering by 
SpA requires the molecule to be soluble, permitting. for ex:un-
ple. its uptake and subsequent activation of the cell; b) B cell 
activation by ST A requires the stimulating protein A molecule 
to be in...:;oluble and conceivably in a certain (rigid) steric con-
formation; alternatively. STA cell walls may contain a second 
structure that by providing a "second signal" (23) is fulfilling a 
requirement for B cell triggering. 
The result...:: of cell separntion experiment." nnd patient studies 
indicate that the ST A-responsive populations likely express In-
determinants. C, and ST A receptors. The absolute correlation 
of the presence of slg.,_ cells with the expression of ST A respon-
siveness in patients with antibody deficiency syndromes does 
not neces....::arily indicate the presence of slg on all responding 
cells, but may rather be indicative of the stages of maturation 
that have to be completed before the acquisition of ST A reac-
tivity. This notion is reinforced by the fmding of slg on only a 
minority (<40%) of the positively selected STA·binding cells 
and the failure in preliminary experiments to abrogate ST A 
respon.o;;es through pretreatment with anti-immunoglobulin re-
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agents. Surface immunoglobulin. in particular sigG. has been 
implied in B cell triggering and may represent an attractive 
candidate for the structure recognized by STA. However. our 
experiences do not support this po..-;._-.;ibility, including the failure 
to detect by immunofluorescence and rndioimmunochemlcal 
procedures, slgG on SCID B lymphocytes (ca....es 3 through 6) 
and on appreciable proportion.'! of normal peripheral blood B 
cells (24). In addition, the possib!ity of B cell stimulation via 
sig determinants is still controversial after more than a decade 
of direct experimental attempt..; (reviewed in 25). STA-respon· 
sive cell'! bind to ST A and can thereby be separated from 
unresponsive B cells (Table II). suggesting that the binding 
avidity i..;; considerable. Thi.; i..;; difficult to explain as an entirely 
IgG-mediated event, since even if IgG were expressed on all of 
these cells (approximately 60% of all C3-bearing B cells), the 
number of sigG-molecules must be very small to escape detec-
tion after surface radioiodination (24). On the other hand, there 
may well be other protein A binding surface structures, includ-
ing histocompatibility-related alloantigens {19). Although dif-
ficult to formally disprove, we feel that slgG i..;; not r<.--quired for 
B cell triggering by ST A. The physical depletion by ST A of 
only 30 to 40% of B cell.; and noT lymphocytes suggests rather 
specific receptor ligand in'teractions between STA and STA-
re::~ponsive B cell.;;. 
Cell separation experiments utilized both positive and nega-
tive selection proc<.--dures for different lymphocyte surface prop-
erties in order to avoid inadvertant co-purification of smaller 
cell populations (11). The conclusions derived were tested in 
studies of patient.'! with a variety of immunodeficiency syn-
drome:-<. Our finding:-> of normal STA-responsiveness in the 
group of ADA~ -SCID patient.-.: confmns the previous reports of 
intrinsically normal B cell function in such patient..; (15). The 
patients with primary antibody deficiency syndromes were het-
erogenous in several aspects. Multiparameter anulysi:-~ indicated 
only one significant correlation to the presence of an ST A 
respon..'!C, i.e., the presence of sig-positive lymphocytes. In some 
of the patients functional, slg-negative precursors of specific 
IgM-producing B cell-.: have been demonstrated previouBly (26). 
All of these patients (ca...;es 7 through 11) also exhibited spon-
taneous, T cell-mt:"diated suppressor cell activity. mea...;ur<.--d in 
a hemolytic plaque U.."-'iUY by their ability to reversibly interfert" 
with immunoglobulin secretion (11). The failure of these pa-
tit:"nt..; to generate a ST A respon.'!t;' may rdlect either the inter-
ference of suppres.wr cell.;; with thi..; response or the inability of 
the small population of slg-negative plaque-forming cell pre-
cursors to rellpond to ST A. Thi:> is currently Jx>ing investigated. 
The prepuration of ST A wa...;; of great importance in deter-
mining it..; B cell :-<pecificity. A commercial STA prepuration, 
which showed :-<orne shedding of soluble SpA, gave quite differ-
ent result.'! from our own preparation. When this shedding wa..; 
eliminated, the preparation wa..; rendered B cell specific. SpA 
as well a...; STA have been variously de:-<cribed as Band/or T 
cell mitogen..; by using culture conditions with or without human 
:-~erum supplement..;; (5-10). We suggest that most variations of 
findings in the different laboratories that used ST A may be 
explained by differences in ST A preparations. 
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POLYCLONAL ACTIVATION OF HUMAN LYMPHOCYTES IN VITRO 
II. Reappraisal ofT and B Cell-Specific Mitogens' 
HANS-MICHAEL DOSCH,' RUUD K. B. SCHUURMAN, AND ERWIN W. GELFAND" 
From the Dit•i.sion of lmmurwW,zy, The Re,;earch ln:<litute, Thc Ho,;pital for Sick Children, 555 Unioer,;ity Aoenuc, Toronto, OntarW, 
Canada 
The capacity of the T cell mitogens phytohemaggluti~ 
nin (PHA). concanavalin A (Con A). pokeweed mitogen 
(PWM), and Staphylococcus protein A (SpA) to induce B 
cell proliferation and differentiation was compared with 
the B cell mitogen, formalinized Staphylococcus aureus 
(STA). Lymphocyte subpopulations from normal donors 
and patients with various immunodeficiency diseases 
were studied. In the presence of the T cell mitogens, 
irradiated T cells were capable of providing a helper cell 
activity that enabled co-cultured B lymphocytes to pro~ 
lifc;rate in response to these mitogens and to differentiate 
into lgM-secreting" (direct) hemolytic plaque-forming 
cells (PFC). In the PFC response. radioresistant T-helper 
and radiosensitive T-suppressor cell activities could be 
demonstrated. T-suppressor cell activity outweighed 
helper activity only in nonirradiated co-cultures stimu-
lated with Con A. Patients with severe combined immu-
nodeficiency lacked mitogen-induced helper T cells, 
whereas patients with various forms ofhumoral immune 
deficiency were normal in this respeet. These findings 
and the tissue distribution of the helper cell activity in 
normals indicate that this T-helper activity is acquired 
early in post-thymic T cell differentiation. The data sug-
gest that experiments with celllincage-spccific lympho-
cyte mitogens should be considered in the context of 
more complex cell-cell interactions. 
Lymphocyte mitogen.o;; are convenient probes in studies of 
cellular immune function. Regardless of the species studied, 
moi'lt mitogen.-; posses.o;; specificity for the lymphocyte lineage 
stimulated and thus can serve as markers of cell origin. In 
contrast to rodent.o;;, there is a paucity of reliable B cell-specific 
mitogen.o;; in man that are able to trigger proliferative respom:es 
in the absence ofT cells. Some exception.o;; have been noted 
including water-soluble extracts from Nocardia (1), live Ep-
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stein-Barr virus (2), and more recently formalinized Staphylo-
coccus aureus Cowan I strain (STA)' (reviewed in 3). While 
testing lymphocyte mixtures from normal tissues and immu-
nodeficient patients, we observed an apparent breakdown in 
the established cell lineage specificity of the T cell mitogens 
phytohemagglutinin (PHA), concanavalin A (Con A), Staphy· 
lococcus protein A (SpA), and pokeweed mitogen (PWM). Cell 
dilution analysis of various lymphocyte mixtures indicated that 
a radioresistant T -helper cell activity could be unmasked that 
permitted co-cultured B lymphocytes to proliferate and differ-
entiate in response to these mitogens. The tissue di...:;tribution of 
this activity indicated that immature (thymic) T lymphocytes 
were particularly rich helper cell sources, Patients with severe 
combined immunodeficiency di...<:ease (SCID) without 'T lym-
phocytes lacked this uctivity, whereas patients with defective 
humoral immunity had normal helper activity. 
MATERIALS AND METHODS 
Cell sources. Ficoll-Hypuque purified mononuclear cells were 
obtuined from thymus, tonsil, bone marrow, thoracic duct,' and 
peripheral blood as described (3). E-rosette-fonning (E.) T cells 
were separated from nonrosetting cells (E-) byE-rosette deple-
tion (3). E+ cell populations contuined nt lelb't 97% E-rosette-
forming cells, no slg-bearing cells, and less than 1% complement 
receptor· (C3) beuring cells. TheE- populations contained up 
to 1 <;;. E-rosette·forming cells, greater than 80% C3 receptor-
positive cello;;, 40 to 60% of the cells were sig (lgM/IgD) positive, 
and more than 90% of the cells expres..::ed swface Ia determi-
nant.-; as measured by indirect immunofluorescence (4). Periph-
eral blood-mononuclear cells (PBL) were al..'lO obtuined from 
patient." with both the adenosine deaminase (ADA) positive 
and negative forms of SCID, agammaglobulinemia (Ay), and 
common variable immunodeficiency disease (CVID). All pa-
tient.o;; have been described in the uccompanying paper {3). 
Culture condition.~. Unless otherwi..<:e indicated, cultures of 1 
X lOr' cells/well (Microtest II plates, Falcon Plastics, Oxnard, 
Calif.) were maintained for 80 hr in supplemented RPMI 1640 
and 10% normal human serum or 10% fetal calf serum (FCS) 
(.'3). At the end of culture, cells were harvested after a 4--hrpuL<:e 
with 1/LCi "H-thymidine (specific activity 6.7 Ci!mMl. Under 
these conditions, mixed lymphocyte responses in allogeneic cell 
mixtures were not detectable, and mixtures of purified alloge-
"Abbrcvintioru~ u."<L-d in this paper. ADA, ndcno..~inl' denminm~C: Ay, 
agummn,c:lobulinemill: CVID, common vnriablc immunodcfir:iency di'l-
eru-;c; E., E-roscttc-forming (T) lymphocytes; E-, E-rosettc-neJ:~Ltive 
cell:<; PBL. peripheral blood lymphomononucl<"ar celL~; PFC, hemolytic 
plaque-forming cell.~: PWM, pokewct.-d mitogcn;SCID, severe combin<.'!l. 
immunodeficiency di.~a.~c; SpA, Staphylococcal protein A; STA, for-
malinizL-d Staphylococcu.,· aurcu.~ (Cownn 1): sig, surface immunoglob-
ulin. 
827 
69 
828 H.·M. DOSCH, R. K. B. SCHUURMAN, AND E. W. GELFAND [VOL. 125 
neic or autologous lymphocyte subpopulations showed similar 
mitogenic responses. In cell dilution experiments. 1 to 100 x l<i' 
cell..:; were cultured in the presence or absence of irradiated cells 
(2000 rads) as indicated. 
Mitogens. Mitogens ( 10 t~g/ culture) were always added at the 
beginning of culture. PHA. PWM, and Con A were purchased 
from Difco Laboratories (Detroit, MI) and SpA from Phannacia 
(Montreal. Que.). S. aureus {Cowan I) bacteria were grown and 
treated as described (3): 1 X 10~ organisms were added per 
culture. 
Miero-PFC respon.._.:;es. Micro-cultures for the assessment of 
direct hemolytic plaque-forming cell (PFC) responses towards 
picrylated sheep erythrocytes (5) were maintained as described 
above in the presence of 5% FCS. After 5 days of incubation 
they were wa...:;bed three times in the culture wells, resuspended 
in RPMI 1640, and then were transferred to fluid-pha._<;e micro-
plaque a.<lSilys in microtest II plates as described (6). 
Data evaluation. Means and standard deviations were cal-
culated from replicate values for thymidine incorporation or 
PFC :respon...;;es per culture. Results from larger series of exper-
iments were pooled after expressing respon....:;es as fractions of 
the maximal thymidine incorporation or mrucimal PFC re-
spon..o;es in the individual experiments. For stati.'ltical regression 
analysi!: as well as curve fitting, we utilized a Tektronix micro-
computer and Plot 10 based software (7, 8). 
RESULTS 
Effect.'~ of cell density on B and T cell mitogen responses. 
Before performing cell mi.xlng experiments. it was necessary to 
a..~ the role of cell density in determining the extent of 
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Figure 1. Microcultuxcs Containing the cell numbe:rs and mltogens 
indicated were lllllintnined for 80 lu' in supplemented RPMI-1640 ns 
dC~~Cn'bed in MateriaL~ andMetlwds; their DNA-synthetic activity wns 
then measured after n 4-lu' pulse with I ttCi H"-thymidine. The pooled 
dttta shown reflect result>~ from 650 PBL and 860 tonsil cell cultures. 
70 
. 
0 
~ 
. 
. 
\ 
LO 
0.5 
-~ 0.1 
0 
• -~ o.os 
~ 
" 
100 
C.,ll, p<~l Cvllvr.,(xlQ"3j 
Fi{Jurc 2. Linear regre><.~ion nnnly>:ril; of cell do..~:mitogen n-sponse 
con-elation with the dntn shown in Figure I. The pooled dntn were 
nornwlized to cxprl'!l." fructioM of maximu.l re:.<pon:<es ob!ll'rved with 
each mitogen in the individuu.l experiment.q, Curve fitting will\ done by 
Ulling Plot 10-lxl.•<cd 110ftware in u microcomputer. Vertiea.lburs indicatl' 
standard error:<. Symbol" ns in Figul'i' I: 6, SpA; 0, Con A: e. PHA: 
X, PWM:: Q STA. 
respon._..:;es to the different mitogens. One to 300 X 10'1 PBL or 
tonsil cells were stimulated with constant amounts of mitogen 
(see MateriaL.~ and Methods). Figure 1 shows data from 650 
PBL and 860 tonsil cell cultures. These were pooled and sub-
mitted to regression analysis and curve fitting. With correlation 
coefficients of greater than 0.9, results for all T cell mitogens 
were best fitted with logarithmic functions of the form y = a 
+ b log x. Analyzing the exponential part of cell dose-response 
curves (Fig. 2), a family of near p:ll'allel functions was obtained 
with slopes between 1.7 and 2.1. In contrast, cell dose effects on 
ST A re;:.ponses were best fitted with the linear function y = a 
+ b X, and the resulting respon._<:e curve had a slope of 1. This 
observation suggested that ST A respon..;;es .likely involved one 
responding cell population but that more complicated cell in· 
teractions were involved in the responses to the T cell mitogens 
(9, 10), Furthermore, the results suggested that in PBL and 
ton._'lil, pool sizes of STA-responding cells may be more than 1 
order of magnitude lower than those responding in cultures 
containing PHA, with intermediate values for the other T cell 
mitogens, 
Cell co-operation. To analyze the different responses patterns 
of B and T cell mitogens, we utilized cell mixing experiments 
and differential irradiation (Table 1). Irradiated T cells (E' .. 1 
X 10~/culture) were mixed with nonirradiated, E-rosette-ncga-
tive cell populations (E-. 1.5 X 10~/culture). In addition, PBL 
from a patient with the ADA .. form of SCID were used as a cell 
source rich in B lymphocytes but devoid ofT cells. Only ST A 
induced significant respon...;;es in E- and SCID PBL. In the 
presence ofPHA, Con A, PWM, or SpA, comparatively vigorous 
responses were observed in co-cultures of nonin-adiated E- or 
SCID PBL with irradiated T cells. 
Cellular requirements for B cell proliferation. The cellular 
requirements for the proliferative responses observed in co· 
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cultures of E- and irradiated E"'" lymphocytes were analyzed in 
cell dilution experiments. Increasing numbers (2 to 100 X 103) 
of iiTadiated peripheral blood or tonsillar T cells were added to 
a constant number (1 X 10~ cells/well) of purified E- (Fig. 3). In 
cultures t.1imulated with ST A. the addition of irradiated T cells 
had little effect. and in all experiments these cultures showed 
the highest incorporation of thymidine (3 to 5 X 104 cpm/ 
culture). Cultures of E-. stimulated with the T cell mitogens. 
showed only marginal responses when 2 to 10 X 10~ irradiated 
T cells were added. With higher numbers of added T cells, 
responses increased until a plateau was reached at between 3 
X 104 to 7.5 X 104 irradiated T cells per well. At these plateau 
values, the proliferative responses observed were a direct func-
tion of the number of E- cells added per well (Fig. 4): at a 
constant concentration of 10~ irradiated T cells/culture, the 
addition of more E- cells (but not ofT cells, Fig. 3) resulted in 
enhanced proliferation. These data demonstrated that irradi-
ated T cells, incubated in the presence of PHA, Con A, PWM, 
TABLE I 
Demonstration of T·helper activityq 
Mitogen ReMpolll«'!! (cpm x w--•) 
Mito~n hTndintl'd E• Plus Add<.><! E- SClD 
E- scm 
None <2 <2 <2 <2 <2 
PHA 5±3 <2 3±2 37 j: 8 45±8 
PWM 5±1 <2 4:t:2 29:t:ll 42 j: 6 
Con A 2±1 <2 5±2 26 j: 7 34 ±8 
SpA 4±2 <2 4±1 42 ± 12 51± 13 
STA 36 ± 6 31 j: 7 <2 43 j: 10 38±11 
n 1.5 X 10'' purified nonruU B cells (E-), 1 X I if i.t'l:'ndinted (2000 rnd) 
T celli; (E•) or 2 X to'' SCID PBL were cultUl'ed nlone or in combinution 
in the presence of the mitogen indicated, Proliferntive responses (cpm 
x 10-", X ± 1 S.D.) in 1 of 4 similnr experiments are given. 
0.9 1/'"1 ;r---r-y::::;~::14 
D 0 j'l~/-+ 
0 
0.7 J/;1 0 . 
' /J -~ 0' 0 • 0 03 £ ~~t.l o.• 
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lrrodiot.,d T·Ctoll> (~10·31 
Figure 3. Demonstrntion of T cell mitogen induced, rndioresistant 
T-helper cell activity for B cell proliferation. lncrensing numbers of 
i.rrndinted T cells were cocultured with l X 10' noni.rradinted B celLs in 
the prt.osence of either SpA {ll.), Con A {0), PHA {e) or PWM {X), 
Stimulation with STA {0) served ns a control. Proliferative responses 
in five experiments were corrected for background thymidine incorpo-
rntion ::md expres.~ed ns a fraction of the m.nximum respon.se in each 
l'Xpcriment (l7 to 38 X 10' cpm) nnd pooled. 
•. o 
,'o 
ll c.,llo (~1o·31 
Figu.re4. B cell requirement for proliferative respon.'OGI to stimuln-
tion with the T cell mitogcns SpA {ll.), Con A {0), PHA (e) or PWM 
(X) in cocultUl'es of irrndiated T (1 X 10" /well) nnd nonirrnd.intcd B 
cell<; {2 to 50 X w-';well). Dntn from five experiments were norma.li:red 
nnd pooled 1111 before (sec legend, Figure 3}. 
TABLE TI 
Tissu.e distributkm of helper activity~ 
lrrndiat..d Helper c..n Nomwl % Mnx.imum Re.lpo!W' 
Sourc<> BC.U. SpA Coo A PHA 
None + 6±1 5x3 "'1 
E- (PBL) + 8±1 7±2 h2 
E .. (PBLl 11 :t: 4 7±2 10 :t: 6 
+ 88±11 79 ±9 94 j: 10 
Thymus <5 <5 <5 
+ 100 ± 7 92 ± 14 81 :t:8 
Boncmurrow h2 5±3 6±2 
+ h2 8±1 8±8 
Thorncic duct "'1 9±3 6x1 
+ 32 ± 4 27±6 
'"" 4 
Tonsil 9±2 11 :t: 1 1h3 
+ 64 ± 3 51 j: 7 67±7 
Spleen 8±1 7±2 h3 
+ SI ± 16 ~d. 4h 5 
~ 1 X 10" i.t'l:'ndinted (2000 rad) mononuclear cells per well were tested 
all SOUl'CCS of mitogen-induced helper activity for B cell prolif('rnt:ion. 
+ denotes the addition of 1 X 10• nonn.o.l tonsillar or pcripheml blood 
B celli<. Mcnn responses (±1 S.D.) nrc expressed all a fmction of the 
mnximuxn response observed in two or more experiments. Maximum 
responses varied between 27 nnd 43 X 10" cpxn. 
and SpA, permitted the proliferation of B cells. Furthermore, 
it was possible to define limiting and saturation conditions for 
the responding B cells (Fig. 4) as well as for the cooperating T 
cells (Fig. 3). 
Tissue distribution ofT-helper cells. The tissue distribution 
of the radioresistant T·helper activity is shown in Table ll. 
Data from more than 1000 cultures are summarized 1 X lif 
irradiated cells from each tissue served as a source of helper 
cell activity for mitogenic responses of 1 X 10~ nonirradiated E-
cells from tonsiL T·helper activity was found in all tissues 
studied except normal bone marrow. The highest activity was 
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observed in thymocytes, followed by PBL and tonsil, spleen, 
and thoracic duct cells. 
Helper activity in immunodeficient patient.~. Four r.:roups of 
patients with primary immunodeficiency. who share i:he com-
mon feature of impaired spe<:ific antibody formation, were 
studied for the presence of radioresistant helper activity in PBL 
(Table III). No helper activity was found in patients with SCID. 
Normal activity was consistently observed in patients with 
either Ay or CVID. 
Dcmon.."Uration of polyclonal B cell activation. Mitogen-
stimulated microcultures were examined for the generation of 
direct hemolytic PFC specific for picrylated sheep erythrocytes 
(Table IV). Tonsillar B cells and irradiated or nonirradiated E+ 
were tested in cell mixing experiments similar to those described 
above. After 5 days incubation, unstimulated cultures contained 
virtually no spontaneous PFC. ST A induced the development 
of PFC in B cell cultures independent of the presence ofT cells. 
The T cell mitogens failed to induce the generation of PFC in 
cultures containing E+ orE- cells alone, whereas in co-cultures 
of R'" and E- cells the generation of PFC was induced by all 
mitogen.<; but Con A. Indeed. the addition of both Con A and 
ST A to B-T cell mixtures resulted in the suppression of ST A-
induced PFC respon..<:es. Consi.<;tently higher PFC re,;;pon...::es 
were observed in all cultures containing B celL<; and irradiated 
TABLE III 
Hdper cdl activity in immurwde(i.ci.cnl pati,-.nts" 
lrradial<'d H"lptor Nonn.nl <:c Maximum R"~pon>~<· IN) c.-u :'lourc<· BC"Ill. SpA Coo A PHA 
ADA" SCID {3) <5 <5 <5 
+ :i:t'2 :i± 1 <5 
ADA'SCID (2) <5 <5 <5 
+ <5 <5 <5 
Ar (5) 6>1 7±4 
,., 
+ 96%9 66± II 89 :t 7 
CVID (5) 6±2 8:;!;3 7±2 
+ 82::!: 5 90 ± 6 84::!: 9 
"See legend. Table 2. ADA. adenosine dcaminn.~e: SCID, patients 
with ~~<.-verc combined immunodeficiency di>lea:•e: Ay, patient.~ with 
congenitalagnmmnglobulinemia; CVID. patient.~ with common varinble 
immunodeficiency di-.cn._-.;,;>; N, number of patient." tc~4-d on at len.~t two 
occasions. Mean respon.-.c~ (±l S.D.l are expressed ll$ a fraction of the 
maximum re.-.ponse ob..'lerved among all co-culture~ in ~·aeh experiment. 
Maximum rcspon.-.cs varied between 22 to 40 x 1(}' epm. + denotes the 
addition of 1 X 10'' nonru:U B celh. 
T cells. The irradiation of B celb. in contrast, abrogated the 
PFC respon~. Furthermore, in cell mixtures of E- and irradi-
ated E ... cells. Con A was consistently able to induce the devel-
opment of PFC. In such co-cultures, Con A was no longer 
suppressive to STA-induced respon.'leS. Thus, cultures stimu-
lated with both Con A and ST A generated high numbers of 
PFC, and albeit somewhat more variable than cultures stimu-
lated with only one mitogen. the STA and Con A respo~ in 
these culture~ appeared additive. These duta suggest that T cell 
mitogen-induced B cell activation i.<; not restricted to prolifera-
tive responses but is accompanied by the differentiation of B 
lymphocytes into direct PFC. 
DISCUSSION 
The stAtistical analyl:>"is of a large ~eries of experiments re-
vealed the likelihood of cell-cell interactions in T cell mitogen 
but not in B cell mitogen-stimulated cultures (9, 10). The 
theoretical conclusions were confumed in cell-mixing experi-
ments of B and irradiated T celL'l. These 1:o"tudies revealed a 
mitogen-induced, radiation-resistnnt T-helper acti,rity, which 
permitted (or induced) B cells to proliferate. The lack of com-
parable effects in ST A-stimulated co-cultures provided an ap-
proprinte control for the cell-mixing experiments and not only 
reinforced the validity of the statistical analy~es, but confumed 
the T cell independence of STA respon~;es (3). 
Radiation-resistant T·helper cells were demom;trnted in dif-
ferent lymphoid tissues and certain patients with immunodefi-
ciency. Their absence in bone marrow and SCID indicated that 
early steps in thymus-dependent T cell differentiation have to 
be completed before the generation of detectable helper activity 
( 11). The demonstro.tion of normal helper activity in patients 
with defective humoral immunity i~; reminiscent of our previous 
findings in these patients of normal helper activity for ~;pecific 
in uitro PFC respon.'~es (12), although it is unclear whether the 
same cell populations are involved. 
The B cell proliferative respon.._.., were accompanied by the 
generation of direct PFC response~;, which were a.--."fiyed using 
heavily TNP-haptenated sheep erythrocytes. Whether the pro-
liferative B cell responses and the generation ofPFC are directly 
linked, coincidental or consecutive events i.-.:; unclear. Since PFC 
were not generated if B cell<: were irradiated, it is likely that 
these cells undergo cell divi.'lion once activated in the co-culture 
system. 
The nature of radioresistant T cell help and, in particular. of 
the activation proces..<:es triggered by the T cell mitogens have 
not be£-n addressed (13--18). Helper activity of irradiated T cells 
has been described for both mitogen- and antigen-driven B cell 
TABLE IV 
Dcmontllra.J.Um of milogcn-induccd hemof.vtic plaquc-(orminl! cells" 
Ct•lli<CultuJ•<'(! 
PFC R<•"po"""/Culturt• 
PHA SpA PWM Con A STA ConA+:-."TA 
E~ <5 ll ;!:: 3 <5 13;!:. 3 <5 66;!:: 19 f>l :t 12 
In-ndi.ated E- <5 <5 <5 <5 <5 7:t5 <5 
E. <5 8±2 <5 <5 <5 <5 <5 
Irmdiated E• 7:t3 6±< 6:t4 7:t:2 <5 <5 <5 
E. +E. <5 38±11 77 :t 19 89:!: 11 <5 59 :t 7 9:t6 
E' + lmu:fiated E" 8±2 107 ± 18 104:!: 16 ll5 :t 22 81 :t 10 76::: 12 136:;!; 39 
Q MicroeultW'es of 1 X 10" purified B C('I,J,:, (E") and/or 1 X 10'' T lymphocyte8 (E*) from peripheral blood or ton.'!il were inc-ubatl•d with th(' 
mitogen indicated. Irradiated C<'lls received 2000 rae!.~ before culture. After 5 days of c-ulture the c-ell~ wcr" wo..~h~-d in th(• "ulture trn~·~ and 
tran.'4feJTcd to direct. fluid phase hemolytic pl.nque as.~ys for anti-TNP sheep erythrocyte plaque~. RC!'Iult.'l from three experiments are pooled and 
expressed lll:l mean PFC re~n.'IC.'I generated per microcultW'e (:;!;1 S.D.). 
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activation in rodents and man (17, 19, 20). In the ca..'le ofPWM-
and Con A-stimulated cultures. this activity has been associated 
with soluble factors (15, 16). A soluble helper factor released 
from irradinted T cells has similarly been shown for specific 
(direct) PFC respon..'!CS toT cell-dependent antigens (17). The 
tenn "radioresistant" in the present context may be somewhat 
misleading and does not neces._<:arily imply that helper T cells 
are not triggere-d by the mitogens to proliferate: the relea..'le of 
soluble T-helper activity, for example. may be completed suf-
ficiently early in culture to be unaffected by irradiation. In the 
ca..'le of specific PFC respon..'les and PWM-induced B cell acti-
vation, soluble helper activity has indeed been found to accu-
mulate rapidly in culture supernatants within hours after anti-
gen or mitogen contact (16, 17). 
Direct PFC were detected using heavily haptenated sheep 
erythrocytes as targets. Although T cell mitogens were able to 
induce the generation of PFC, this reaction wa..-.. strictly T cell 
dependent, since purified B cell-.. alone were respon...;;ive only to 
stimulation with ST A. This underlines the primary cell lineage 
SJX>eificity of the mitogens studied. The T cell mitogens may be 
required to trigger the generation of helper activity in T lym-
phocytes: this activity (e.g., a soluble factor) may then act as a 
"B cell mitogen" akin to STA. Alternatively. both the T cell 
mitogen and T-helper activity may be required at the B cell 
level to initiate the development of PFC. We favor this second 
alternative, since we observed earlier that the generation ofT 
cell-dependent PFC required two triggering signals at the B cell 
level: binding of the activating ligand it..'lelf plus the presence of 
aT cell product (17). 
Irradiation of the T cell supplement in culture enhanced the 
number of PFC generated in respon..'le to all T cell mitogens. It 
seems likely that irradiation abrogated the development of 
mitogen-induced T-suppressor cell activity co-induced with 
helper activity. This was directly shown for Con A-induced 
PFC respon..'!es. In Con A-stimulated co-cultures of unirrad.iated 
celL-.:;, radiosensitive suppressor cell activity outweighed co--in-
duced helper function: helper activity was unmasked when 
suppres._wr cell development was prevented by irradiation. 
Considering the present data together with previous reports 
(13. 14. 17, 18, 21-27), we may extrapolate several conclusions: 
a) the absolute height of the PFC respon..'le reflects the net 
helper function induced, i.e .. the excess of helper over suppres-
sor activity generated: b) the B cell response generated in 
untreated B-T cell mixtures may not primarily reflect the 
functional B cell repertoire present in this mixture, but it may 
rather depend on the balnnce between antagonistic regulatory 
T eel! subsets activated by the particular mitogen: and c) 
nonirradiated cell mixtures would then be characterized by a 
negative restraint of B cell function. 
Taken together, the data presented suggest that experiments 
with cell lineage-specific mitogens should be considered in the 
context of more complex cell-cell interactions. 
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IDENTIFICATION OF Ia ON A SUBPOPULATION OF HUMAN T 
LYMPHOCYTES THAT STIMULATE IN A MIXED LYMPHOCYTE 
REACTION' 
RUUD K. B. SCHUURMAN, ERWIN W. GELFAND,'·' DAVID MATHESON, BARRY ZIMMERMAN,' 
AND HANS~MICHAEL DOSCH 
From the Divitlicn of Irrurwn.oloJtY, Re,;earch lnBti.!ute, Ho."J)i.!al for Sick Children. Toronlo, Ontario MSG JXB 
The delineation of discrete subpopulations of human T 
lymphocytes has permitted preliminary analyses of the 
complex cellular network regulating the immune re-
sponse in man. We previously showed that a subset ofT 
lymphocytes. designated as theophylline-sensitive be-
cause of their inability to bind sheep red blood cells in 
the presence of the drug, are responsible for antigen-
specific suppression or regulation in an in vitro plaque-
forming cell a..'lsay. We now show that 25 to 45% of these 
theophylline-sensitive T cells were !a-positive by im-
munofluorescence with a rabbit antiserum raised 
against purified B lymphobla!>'t surface antigenic mate-
rial. These data suggested that 4 to 7% of peripheral 
blood T cells carry Ia determinants. The presence of Ia 
determinants on this T <;<:ll subset was confirmed by gel 
analysis of radioiodinated surface material. Further-
more, in mixed lymphocyte culture, the theophylline-
sensitive cells demon..'ltrated HLA-D determinants and 
were 10-fold more potent stimulators than equal num-
bers of B lymphocytes. The presence of Ia determinants 
on these T cells indicates the expression of major histo-
compatibility complex~related regulatory gene products 
on a specific human T lymphocyte subpopulation. 
By using a variety of allo and heteron.nti.•{era, DR or !a-like 
detenninunts have b('('n demonstrated on human B lympho-
cytes and monocytes (1-3). The heteroantiserarecognizea basic 
structure, common to all allotypes, which is composed of two 
components, 27,000 daltons and 35,000 dalton.~ in this respect 
it is similar to murine Ia (4). The main lymphocyte-activating 
determinant in the mixed lymphocyte reaction (MLR). encoded 
by the HLA-D region, appears to be identical or closely linked 
with Ia (5). In the mouse, Ia is known to pl.:ly a major role in 
the regulation of the immune respon..'!C. and in thi" species a 
number of groups have described Ia determinants. expres..<:ed 
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predominn.ntly on a T cell subset. responsible for suppression 
of the immune response (6-8). 
We have isolated a subpopulation of human T cells that 
contain antigen-specific suppressor cells when assayed in a 
direct plaque-forming cell (PFC) a..'ISay (9). These cells, identi-
fied by their inability to bind sheep red blood cells (SRBC) in 
the presence of theophylline, have been labeled theophylline-
sensitive T lymphocytes {T-sens)~ (10). In this report we dem-
oru;trate that 25 to 45% of T -sens are !a-positive and express 
HLA-D determinants. 
MATERIALS AND METHODS 
Cell surface markers. The E-rosette as.qays in which were 
used untreated or anrinoethyli'IOthiouronium bromide- (AET) 
treated SRBC and incubation with theophylline have been 
described previously (11). After theophylline treatment, all E-
rosette a.."qays were carried out by u..<Ung AET-treated SRBC 
(E,.,I-:1"). Surface immtUJ.oglobulin- (slg) positive cells were iden-
tified by using: direct immunofluorescence, and monocytes were 
enumerated after a-naphthyl esterase (NSE) staining and latex 
particle ingestion. C3 receptor-bearing cells were assessed by 
u..<Ung a rosette technique with intermediates generated by 
incubating ox red blood cells (Eo~) with rabbit IgM anti-ox anti-
serum and normal mouse serum as the source of complement 
(12). 
1.-«.>lation of lymphocyte subpopulations. The i.'IOlation tech-
nique is illustrated in Figure 1. Heparinized or defibrinated 
peripheral blood was subjected to L'IOpaque-Ficoll gradient cen-
trifugation (9). The mononuclear cells (PBL) were depleted of 
adherent cells by incub<ttion in plastic Petri dishes for 30 min 
at 37°C in the presence of 20% FCS. The nonadherent cells 
(NAC) were incubated with 3 mM theophylline for 45 min at 
37°C. SRBC were then added in the presence of 30% FCS, and 
the mixture was spun for 5 min at 200 X G. maintained at 4°C 
for 30 min. gently resuspended, and placed on gradients of 
Isopaque-Ficoll. After 30 min centrifugation at 400 X G. the 
interface containing T-sens and non-T cells were recovered and 
treated separately from the pellet containing theophylline-re-
sistant T cells (T -res). The interface cells were incubated with 
E 0 ,AC3 (1:40 ratio) for& min at 37°C, kept at room temperature 
for 30 min, gently resuspended, and layered onto an L-..opaque-
Ficoll gradient. After centrifugation at 200 X G for 30 min, the 
'Abbr<Jviatioru~ used in this paper. AET, o.minocthy!i._"iithiouronlum 
bromide: MHC, mD.jor hL'<tocompatibility complex: NAC, nonnd.hercnt 
celL"~; NSE, o:-naphthyl esterMC (nonspecific esterll>le); PBL. peripheral 
blood mononuclear cells: T-r~ theophylline-resistant T-lymp-bocytes: 
T-scns, theophylline-sensitive T-lymphocytes; E,.IIT, AET-trcated 
SRBC: slg, surface immunoglobulin; E.,., ox red blood cells: SDS, 
• B.Z. is a ,;cholar of th~· Medical Rc!!Carch Council of Canada. sodium dodecylsulfate. 
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interf.ace cells and pe'uet were recovered. The SRBC nod E"" in 
the cell pellets were lysed in Tri$-.::unmonlum chloride (13). 
Preparation of the anti-fa antiserum. Membrane vesicles 
were prepared from cultured B lymphobln.sts by solubilization 
in Tween 40 (14). The vesicles were solubilized in 0.5% Triton 
X-100. and the materinl was applied to a column of Sephadex 
G-200 equilibrated in 0.01 M Tris-HCl (pH 8.0) and I% deoxy-
cholate. The position of B cell-specific antigen originally char-
acterized as a molecule of 30 to 35,000 daltom; was recognized 
by precipitation of labeled mnterial with an absorbed anti-B 
lymphoblast serum (15, 16). Subsequently, material with a m.w. 
of 20 to 50,000 was rox:overed, and rabbits were immunized wlth 
50 J.l-g of this material in complete Freund's adjuvant. A second 
immunization with 10 p.g in incomplete adjuvant was carried 
out, and the animals were bled 7 days later, The serum obtained 
was absorbed three to five times with cultured T lymphobla.sts 
until the absorbed nntiserum no longer precipitated swface 
labeled material from these lines. This absorbed antiserum was 
capable of precipitating the B cell antigen, which was resolved 
into two components of27.000 and 35,000 daltons from cultured 
B lymphoblasts, chronic lymphatic leukemia. celL.:;, E-rosette-
neg::.tive acute lymphoblastic leukemia (ALL) cells and acute 
myelocytic leukemia cells. Precipitation studies withE-positive 
lymphobla_<;tic leukemia, chronic myelocytic leukemia. ceiL--. thy-
mocytes, four different T cell lines, or the K562 line were 
negative. 
Identification of Ia on T lymphocyte,o;; 
Indirect immunofluorescence. The fJISt incubation was car-
ried out with a 1:60 dilution of the anti-Ia nntiserum followed 
by labeling with a 1:10 dilution of fluoresceinated goat anti-
rabbit IgG (Meloy Laboratories). Because of the weak staining 
of the T cells (compared with B cells or monocytes) and for 
convenience. all cell preparations were incubated overnight 
with the anti·la reagent. This did not significantly alter the 
number of positive cells in the different cell preparations but 
did improve the intensity of staining in T·sens. Control incu-
bations were with a preimmuni?.ation serum from the same 
rabbit. 
Lact<Jpero:xidase·catalyzed radioiodin.ation. T-sens were la-
beled by the lactoperoxida..'!C method, and the labeled antigens 
were solubilized in 0.5% Triton X-100. The lysates were pa.._o;:;sed 
over a DEAE column and precleared with normal rabbit serum 
and Staphylococcus aUreu..<: Cowan strain I, Specific immuno-
precipitations were carried out with lg, Ia, and .82-microglobulin 
antisera and a control normal rabbit serum, followed by incu· 
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bation with S. aureu..">. The precipitated materials were eluted 
in 10%sodium dodecylsulfate (SDS), reduced (2 mM 2-mercap-
toethanol), and boiled for 2 min. The eluates were analyzed on 
10% SDS·acrylamide gels {17). 
Mixed lymphocyte reaction.."> (MLR). One-way MLR were 
perl'ormed in microtiter plates by using a constant number of 
responder cells: obtained by L'\Opaque-Ficoll gradient centrifu-
gation of peripheral blood from normal donors (5 X to•;well) 
(18). Varying numbers of irradiated stimulator cells in the 
mixtures were incubnted for 7 days. The stimulatory capacity 
of individual cell suspensions was expres.."!Cd as a percent of the 
maximal stimulation in any one experiment. At a concentration 
of 3 X lOr. cells, both T -sens and C3-positive cells were able to 
stimulate responder cells maximally (range: 47,000 to 158,000 
cpm), and these responses were taken as maximal stimulation 
(100%) in any given experiment. 
RESUL'l'S 
Tnble I summari7..es the results of four experiment.•;; niter the 
cell separation protocol illustrated in Figure 1. The population 
designnted T -sens contained 81 ± 9% EAI-:T· and of th&:e more 
than 90% were identified as theophylline-sensitive. Less than 
5% were positive for C3, slg, NSE, or latex particle ingestion. Of 
these celL..:;, 25 to 45% were positively stained with the Ia 
antiserum, whereas T-res contained <5% In-positive cells. The 
C3·positive fraction contained >90% !a-positive cells. Absorp-
tion of the anti-Ia anti..'!Crum with B lymphobla.<:ts removed the 
reactivity against both the T·sens and the C3-posltive frnctions. 
In agreement with previous result::: for cell recoveries (19), T· 
sens represented approximately 20% of PBL. These data indi-
cated that !a-positive T cells could be identified in T·sens. and 
it was calculated that 4 to 7% of peripheral blood T-cells were 
ill-positive. 
The presence of Ia on T -sens was conf1rmed in two additional 
ways. After incubation ofT-sens with a.nti·la, EA~:T were ndded, 
and rosettes formed. Often T lymphocytes were covered with a 
large "morula" of SRBC and did not pemllt visuulization of Ia 
on their swface. However, the addition of 1% formaldehyde 
during the incubation with SRBC permitted the detection of a 
receptor for SRBC on most of the cells identified as Ja.positive. 
In the mixed NAC suspem:ion, we were able to detect the SRBC 
receptor on 10 to 15% of the !a-positive cells but not in the C3-
positive cell preparation. 
The presence of Ia determinants on T-sens w~ demoru;trnted 
after lactoperoxida..<:e·cata.lyled iodination of T -sens. Figure 2 
illustrates the pattern of one such immunoprecipitation with 
the anti·la anti'!Crum and a control serum. The presence of the 
27,000- and 35,000-dalton component_.:; confirms the presence of 
the !a-like determinants on T-sens. Parallel immunoprecipita-
tions with anti-immunoglobulin reagent._..:; detected the presence 
ofslgD/slgM on only un..'!Cparated, NAC, and C3-positive prep· 
arations. 
It has generally been accepted that B lymphocytes and 
TABLE I 
Charactcri::atWn of th,• T·~<en,, 
~ PoMitive C~ll~ 
'" 81 ±9" 34±10 
NSE' 
3::!::2 
" Re!:;u!tfl arc cxpre&~ a.-: the mean ± 1 S.D. of four experiments. 
• NSE: 01·naphthyl (">>tcrase stain for monoeytL'.~. 
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Figure 2. SDS..acrylamide gd a.n.olysis. of rwiiolabeled surfuce n:w· 
terinl from T -sens. Solid lim:, immunoprecipitate obtained with the 
rnbbit o.nti-la nnti<oerum. Dotted line. immunoprt'cipitnte obtained with 
the control rabbit serum. Arrows indicate the 27,000 and the 35,000 
bimoleeu.l.nr complex of la. and the markers represent human serum 
albumin (HSAl and human lgG heavy chain (y). 
monocytes are the most potent stimulator cells in MLR, and T 
cells have been reported to only stimulate weakly, if at all {20-
25). When the isolated subpopulations were used as stimulator 
cells in the MLR, it was obvious on analysis of cell dilution 
protocols that not only did T -sens (but not T -res) stimulate in 
MLR, they appeared to be more potent stimulators than the B 
cell fraction on a per cell basis (Fig. 3a). Further, the number 
of !a-positive cells in the B cell fraction was 2- to 3-fold greater 
than in the T-sens fraction, and when this capacity to stimulate 
in MLR was expressed as a function of the number of !a-
positive cells. it appeared that T -sens were about 10-fold more 
potent than the la-C3-positive B cells (Fig. 3b). 
DISCUSSION 
Certain pr<:>ducts of the major histocompatibility complex 
(MHC) in man such as HLA-A, B, and C antigens. can be 
readily identified by serologic techniques and appear to be 
expressed equally on all lymphocytes. In contrast. another 
series of antigenic determinants. designated DR (or !a-like), 
appear to be expressed preferentially on B lymphocytes and 
monocytes (5). Although the presence and functional role ofla 
antigens has been demonstrated on certain murine T lympho-
cyte populations (reviewed in 26), the presence of similar anti-
gens on human T cells is the subject of much discussion and, 
with one exception (27), appeaxs restricted to activated or 
proliferating T cells (28). 
We demonstrated !a-like determinants on a subpopulation of 
human T lymphocytes by immunofluorescence with a rabbit 
anti-la antiserum. This antiserum was raised against purified B 
lymphoblast surface antigenic material and was rendered spe-
cific for the 27 ,000/35.000-dalton bimolecular complex of Ia by 
suituble absorption. After a three-step_ depletion procedure, !a-
positive T cells were identified in the theophylline--sensitive T 
T-Res 
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Figure 3. Limiting dilution analysis ofMLR stimulating capacity of 
i..<oOlated lymphocyt.e subpopulations.. a, Values ~reiiSed as a percent 
of the mmcimum MLR induced in responder cells by any of the cell 
populatioru;. Mean (:tl SD.} of four experiments is shown. b, M above 
except that the MLR trt.imulatory cu.pac:ity-wAS expre&liCd on th(' basis 
of the number of !a-positive cells added as stimulator cells. 
cell subset, previously shown to mediate antigeo·specific sup-
pressor cell activity in an antigen--dependent PFC assay (9, 29). 
Approximately 20% of all peripheral blood T cells were isolated 
as T -sens cells. Since 25 to 45% of these cells were shown to be 
Ia.positive, we estimate that 4 to 7% of peripheral blood T cells 
carry !a-like determinants. This figure is vezy similar to that 
proposed by Fu et al. (27) by using a different antiserum and 
different separation techniques. 
The presence of Ia.like antigens on a significant proportion 
of theophylline-sensitive T cells was confirmed by surface la-
beling and immunoprecipitation studies. It is unlikely that the 
cells responsible for the binding were not T cells (but a B cell, 
monocyte, or null cell), since a) up to 90% ofT -sens cells had E-
receptors; b) less than 5% of these cells were non· T cells canying 
slg, C3, stained with the esterase reagent, or were found to be 
phagocytic; c) the intensity of staining on T cells was less than 
that observed on B cells; and d) in a double·marker assay, both 
Ia ruld SRBC were found on the same cells. 
The many contrad.ictozy reports on the identity of the cell 
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responsible for the major allogeneic stimulation in MLR (20-
25) prompted us to test the various subpopulations obtained 
during the depletion protocol. Genes localized in the I region of 
the H~2 complex of the mouse control several basic immuno-
logic phenomena, including the stimulation of allogeneic cells 
(26). Stimulation in the human MLR also appears to be con-
trolled by genes of the MHC localized in the D region of 
chromosome 6. Our studies showed that a minor population of 
T lymphocytes, the theophylline-sensitive cells, were potent 
stimulators in the MLR. whereas the majority of the T cells, 
namely theophylline-resistant lymphocytes, were inactive. The 
stimulation in MLR by theophylline-scn.<:itive cells could not 
be explained by a small degree of contamination by B cells or 
monocytes. In addition, the postulated "back stimulation'' of 
responder cells by mitogenic factors released by irradiated T 
cells is unlikely, since 'the theophylline-resi..'ltant T cells were 
incapable of stimulation: both T cell subsets did respond in 
MLR. 
In cell dilution experiments, theophylline-sensitive T cells 
appeared to be more potent stimulators than either the mixed 
nonadherent or purified C3-positive cell preparations. The stim-
ulatory capacity of the theophylline-sensitive cell..:; did not 
reflect (in a quantitative fashion) the expression of surface Ia 
molecules. since the B cell fraction contained more than twice 
the number of !a-positive cells. Thus. when differences in 
stimulatory capacity were expressed !1.8 a function of the number 
of !a-positive stimulator cells added, nt a level of 50% maximum 
MLR, the T -sens fraction was about 10-fold more potent than 
the B eell fraction. Although the results presented are confmed 
to peripheral blood T lymphocytes. similar results were ob-
tained by using tonsillar lymphocytes and an alternative deple-
tion protocol (9). 
The strong as.'!Ociation between specific HLA-D and !a-like 
(DR) antigens makes it difficult to differentiate between the 
possibility that the genes that code for them are situated on 
the sa.me locus or are on closely linked loci (30, 31). The MLR 
findings would suggest that either the Ia/D determinant is 
more exposed on T lymphocytes or that Ia and D are not 
identical but that the theophylline-sensitive fraction contains 
more D-bearing cells. It is also possible that all T -sens are In-
positive but some cells are below the threshold for detection in 
our system. 
In summary, we have demonstrated the presence of !a-like 
determinants on a small subpopulation of human peripheral 
blood T cells known to contain specific T -suppressor cells and 
their precursors. This same subpopulation of cells has also been 
shown to carry MLR-stimulating determinants. Although ad-
ditional studies are required to document that it is the !a-
positive cells that mediate these activities, we speculate that 
these "l~regi'on" determinants expres..<;ed on theophyllin0-sen-
sitive cells may be related to MHC-linked regulatory gene 
products equivalent to murine I~J determinants. 
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GROWTH CHARACTERISTICS AND FUNCTIONAL ANALYSIS OF HUMAN T-CELL COLONIES. 
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GERRY PRICE 
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INTRODUCTION 
The maturation of human !-lymphocytes from a pre-thymic precursor·stage to 
that of an immunocompetent T-cell is characterized by a sequence of identifi-
able stages1• Analysis of these stages has been possible using in vitro cul-
tures of human thymic epithelium, epithelium-conditioned medium, thymus extracts 
and agents capable of modulating intracellular levels of cyclic AMP. In addi-
tion, the primary immunodeficiency diseases affecting T-cell differentiation 
have provided invaluable models for study. Semi-solid culture systems have 
provided the means for analysing 
2 3 ferentiation of granulocytes ' , 
the processes of cell proliferation 
4 5 6 
erythrocytes ' and megakaryocytes 
and dif-
in vitro. 
Recently techniques have been adapted for the study of !-lymphocyte colony 
formation in man7- 9• We have developed an improved method for human T-cell 
colony formation in methylcellulose and have attempted to apply this technique 
to the study of T-cell differentiation. By adapting the system to microcultur~ 
we have simplified the system and reduced the requirement for large cell n~ 
bers permitting the determination of precursor cell frequencies in the tissues 
investigated. 
METHODS AND RESULTS 
Conditions for T-cell colony growth. The conditions for T-cell colony growth 
are listed in Table 1. Mononuclear cell suspensions were obtained from peri-
pheral blood, bone marrow, tonsil, thymus or thoracic duct lymph. The latter 
was obtained from an infant with chylothorax. E-rosetting T-lymphocytes were 
separated from non T-cells by E-rosette depletion10 The E-rosetting T-cells 
were further separated into Fc-IgG receptor positive (Ty+) or negative (Ty-) 
suspensions as described10 Alternatively theophylline-sensitive and theo-
phylline-resistant T-cell subsets were obtainedlO,ll. 
The 
(K.C. 
culture medium consisted of 20% fetal calf serum (FCS) in alpha medium 
-5 Biologicals, Lenexa, KA), 5 x 10 M ~-thioglycerol, and 40% PHA-condi-
tioned medium. The latter was prepared by incubating peripheral blood leukocy-
tes with 1% (v/v) PHA for 7 days in 10% FCS in alpha medium and obtaining the 
cell-free supernate. 
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Fig. 1. Photomicrograph of T cell aggregates on Day 2. 
Fig. 2. Photomicrograph of T-cell colonies containing 20-30 cells on Day 3. 
Fig. 3. Photomicrograph of T-cell colonies on Day 7 containing 100-200 
lymphocytes. 
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TABLE 1 
MICROCULTURE CONDITIONS FOR T-CELL COLONY GROWTH 
A. 60% 
CELLS 
Post-ficoll mononuclear cells 
CULTURE MEDIUM 
Alpha medium 
Methylcellulose 
20% FCS 
-5 5 x 10 M o:-thioglycerol 
B. 40% PHA-conditioned medium 
CULTURE CONDITIONS 
Microtest II plates 
0.1 ml/well 
In the microculture system, cells were suspended in 0~8% methylcellulose 
prepared in the culture medium and 100 ~1 added per well to Microtest II 
plates (Falcon Plastics, Oxnard, CA). 
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Growth Characteristics. Cell aggregates b~gan to appear within 24 hours 
of plating peripheral blood cells and colonies containing 20 or more cells 
were observed by day 3 (Fig. 1-3). The size of the colonies increased 
exponentially during the first week of culture with maximum size being 
reached by day 6-7 and containing a mean of approximately 150 cells/colony 
(Table 2). The colonies could be maintained for 14-18 days after which pro-
gressive degeneration ensued. 
TABLE 2 
* ESTIMATION OF COLONY SIZE 
Days 
* 
5 X 4 10 cells plated per 
in Culture Cells/ colony 
1 5 ± 1 
2 10 ~ 5 
3 22 ± 8 
4 65 ± 15 
5 95 :!: 18 
6 150 :!: 50 
7 145 ± 55 
10 155 :!: 50 
well 
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In the presence of the conditioned medium there appeared to be a linear 
relationship between the number of cells added per well and the number of 
colonies formed. Maximum colony formation was observed with between 3-5 x 104 
cells/well (Table 3); colony formation was rarely observed if less than 104 
cells/well were plated. 
TABLE 3 
NUMBER OF COLONIES FORMED AS A FUNCTION OF THE NUMBER OF CELLS PLATED 
* Cells/Well Number of Colonies 
5 X 104 390 :!: 95 
4 X 104 341 ±. 118 
3 X 104 301 :!: 103 
2 X 104 69 :!: 25 
1 X 104 2 7 ±. 26 
5 X 10 3 0 
* Assayed on day 7-10 
Role of Irradiated Feeder Cells. In an attempt to optimize colony formation, 
we determined the effect of the addition of irradiated (2500 rads) feeder cells 
on plating efficiency. In the presence of 3-5 x 104 irradiated feeder cells, 
plating efficiency was improved by a factor of 10. A variety of cell suspen-
sions were assessed for their efficacy as feeder cells. As shown in Table 4, 
irradiated cell suspensions from peripheral blood or tonsil were effective 
as were the T and non-T-cell fractions and lectin-induced lymphoblasts from 
these tissues. All of the B-cell lines were effective but none of the 4 T-cell 
TABLE 4 
EFFECT OF DIFFERENT FEEDER CELLS 
84 
Source of Cells 
Peripheral blood 
Tonsil 
T-cell fraction (E+) 
Non-T-cell fraction (E-) 
PHA-induced Lymphoblasts 
ConA-induced Lymphoblasts 
PWM-induced Lymphoblasts 
B-cell Lines 
T-cell Lines 
Enhancement of 
Colony Formation 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
lines tested could substitute as feeder cells. The mechanism by which the 
feeder cells improved plating efficiency remains unanswered and studies 
evaluating the role of cell-cell contact or soluble factors in supporting 
colony formation are underway. 
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Tissue Distribution ofT colony Precursor Cells (Table 5). Although the 
number of colonies varied from individual to individual? T-cell colonies were 
routinely generated from all normal peripheral blood and tonsil cell suspen-
sions. In genera~. bone marrow suspensions demonstrated little capacity for 
colony formation and thymocytes and thoracic duct cells were negative. In an 
attempt to identify the T-cell subset containing the T-colony precursor cell 
(TCPC) , both peripheral blood and tonsillar lymphocytes were further separated 
by rosette depletion. The E-rosetting T-cells from both tissues were always 
shown to contain TCPC ~hereas the E-rosette negative or non-t-cell fractions 
were uniformly negative. 
T-cell subsets contained 
In tonsil~ only the theophylline-resistant 
+ TCPC and the theophylline-sensitive and Ty 
and Ty-
subsets 
were negative. In limited experiments with peripheral blood~ both the theo-
phylline-sensitive and theophylline-resistant T-cell subsets contained TCPC. 
The discordance between peripheral blood and tonsil was surprising and remains 
unexplained at the present time. 
TABLE 5 
TISSUE DISTRIBUTION OF T-COLONY PRECURSOR CELLS 
Cell Source 
Peripheral blood 
Tonsil 
Bone marrow 
Thymocytes 
Thoracic duct 
T-Cell Subset 
Theophylline-sensitive 
Theophylline-resistant 
+ Ty 
Ty 
Colonies 
+t+ 
++ 
+ 
Peripheral Blood 
++ 
++ 
++ ++ 
+t+ 
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T-cell Colony Forma~ion in Patients with Immunodeficiency. The inability 
of thymocytes or thoracic duct lymphocytes to give rise to T-cell colonies 
suggested that not all cells which are responsive to PHA, as measured by 
de novo DNA synthesis, can give rise to colonies. In addition, since thymo-
cytes and thoracic duct T-cells are less mature than peripheral blood or 
tonsillar T-cells1 •12 , the T-colony precursor cell may be a mature T-lympho-
cyte. This is in agreement with the failure to detect TCPC in bone marrow, a 
source of precursor T-cells13 
Indeed our studies of patients with immunodeficiency, either before or 
after reconstitution, support the following conclusions a) TCPC are mature 
T-cells, b) not all PHA-responsive T-lymphocytes can form colonies, c) TCPC 
are PHA responsive (as measured by DNA-synthesi~ and d) the presence of 
TCPC may be used as evidence for significant functional T-cell differentiation. 
As shown in Table 6 we were unable to demonstrate TCPC in any of the following 
patients: Patient A- a patient with normal numbers ofT and B cells with 
combined immune deficiency. There was a complete failure of lectin-induced 
proliferation. The underlying abnormality appeared to be secondary to an 
impairment of plasma membrane-cytoskeleton interactions as evidenced by a 
capping abnormality (Gelfand EW et al, in preparation). Patient B - a patient 
with severe combined immune deficiency who following reconstitution with a 
1 14 thymic epithelial cell transplant " showed normal numbers of E-rosettes and 
a near-normal PHA response. Despite this laboratory evidence for reconstitu-
tion and clinical well-being, his T-cells did not form colonies. Patient C -
is a patient with severe combined immune deficiency associated with a defici-
ency of the enzyme, adenosine deaminase. Following red cell transfusion 
therapy we observed a dramatic increase in numbers of E-rosetting T-cells, 
tbe development of a significant PHA response and clinical well-being. Despite 
these findings, TCPC were not demonstrated. 
TABLE 6 
T COLONY FORMATION IN IMMUNODEFICIENCY 
% E-Rosettes PHA (cErn) No. of Cols/104 cells Elated 
Control 58 48,000 350 
A 48 600 0 
B 57 16,000 0 
c pre-RBC <1 0 0 
post-RBC 25 31,000 0 
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Functional Capacity of T-colony Cells. Surface marker analysis of the colony 
cells identified them as being of T-cell lineage. Although some of the origi-
nal T-cells plated carried receptors for Fc-IgG, Fc-IgM, C3 and approximately 
50% of the E-rosetting cells were theophylline-sensitive11 , none of the colony 
cells could be shown to carry these receptors (Table 7) and all the E-rosettes 
were theophylline-resistant. In contrast to peripheral 
thymocytes, E-rosette formation by the colony cells was 
blood, but similar to 
0 15 
stable at 37 C ; 
unlike thymocytes the cells were negative for terminal deoxynucleotidyl 
16 
transferase and the human thymus leukemia antigen, HThy-L 
TABLE 7 
CELL SURFACE MARKER STUDIES 
% Rosettes 
E C3 Fc-IgM Fc-IgG sig 
Normal PBL 40-65 15-25 65-80 20-25 5-10 
Colony cells >90 >90 <1 <1 <1 <1 
The T-colony cells were capable of proliferating in response to the addition 
of phytohemagglutin, concanavalin A and to allogeneic cells. The cells were 
incapable of mediating antibody dependent cytotoxicity against antibody coated 
17 M4 melanoma cells or chicken erythrocytes In addition spontaneous cytoto-
xicity for the K562 cell line was also absent; however, spontaneous cytotoxi-
city for the M4 cells was consistently demonstrated. 
Using a xenogeneic (rabbit) antiserum raised against human Ia-like determi-
nants, we have shown that approximately 40% of the theophylline-sensitive T-
cell subset are !a-positive in indirect immunofluorescence18• Moreover these 
T-cells appear to be_ potent stimulators of the mixed lymphocyte response (MLR). 
In preliminary studies, 40-80% of T-colony cells appeared.to be !a-positive 
by both cytotoxicity and immunofluorescence using this rabbit anti-Ia antiserum 
As shown in Table 8 the T colony cells were potent stimulators in MLR as well. 
The degree of stimulation between autologous combinations (~ or BBTX) may 
reflect some carry-over of cell bound PHA (or another conditioned medium 
component) resulting in stimulation of autologous cells or truly represents 
a form of autologous MLR. 
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TABLE 8 
MLR STIMUlATORY CAPACITY OF T-COLONY CELLS 
• 
" 0 ~ 
• .., 
" • ~ 
~ 
"' 
X - denotes irradiation and 
S1JMMARY 
0 
~X 
BTX 
"x 
Bx 
-3 
cpm x 10 
Responders 
A B 
.4 .3 
19.2 48.9 
51.7 19.4 
-3 30.8 
33.7 l-2 
T, colony cells 
The microculture system provides a reliable, simple and 
for studying human T-cell colony formation. Unlike other 
sensitive method 
7-9 
methods , no 
preculture period is required and we were able to eliminate the requirement 
for a two layer (of agar) culture system. T-colony precursor cells appear to 
arise from distinct T-cell subsets that are present in peripheral blood and 
tonsil but not thymus or thoracic duct. Through limiting dilution analysis, 
we have estimated the frequency of T-colony precursor cells in peripheral blood 
to be in the order of 1 per 100 mononuclear cells; thus the frequency of TCPC 
is surprisingly low. The methylcellulose technique now provides the means for 
the further analysis and isolation of the T-colony precursor cell and determi-
ning its function and distribution in various disorders of T-cell immunity. 
The appearance of TCPC following attempt"ed innnune reconstitution may signal 
true functional differentiation of the T-cell compartment. The demonstration 
of !a-like determinants on the T~colony cells offers the means for studying 
the biochemical nature and potential functional role for human T-cell Ia. 
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A diagnosis of partial combined immunodeficiency was made in two Turkish siblings 
with a history of multiple pyogenic infections and persistent candidia10is. They demon-
strated severe hypo--y-globulinemia, with B-lymphocytes, but deficient plasma cell dif-
ferentiation. T-Lymphocytes were decreased in number and did not respond to antigens. 
but did proliferate in cultures with lectins and allogeneic cells. HLA-A and -B detenni-
nants were not detected on blood lymphocytes. but they were expressed by cultured 
lymphoblasts, cultured fibroblasts, and were present in serum. MLR-Stimulatory capac-
ity was intermediate and only two of six anti-HLA-DRw7 antisera demonstrated B-cell 
reactivity. ,8-2-Microglobulin (B2M) was not detected on the surface ofT-lymphocytes. 
but was found in cross-sectioned T-cell membranes. B-lymphocytes carried B2M nor-
mally. The absence of HLA-A and -B determinants on lymphocytes of patients with 
similar immunodeficiency syndromes suggests a role for HLA determinants in lympho-
cyte differentiation. 
INTRODUCTION 
Primary combined immunodeficiencies in man are a heterogeneous group of 
disorders in which the immune response can be blocked at various stages of 
differentiation ofT- and B-lymphocytes (I, 2). Recent investigations support the 
view that defective T -cell maturation leads to deficient B-cell response to an-
tigenic stimulation (3). Animal experiments have revealed the important role of 
gene products of the major histocompatibility complex (MHC) in interactions 
between T-cells, B-cells, and macrophages (4). A role of HLA determinants in 
human T-cell differentiation in the thymus has been suggested recently (5). 
Therefore, abnormal expression of MHC products could be expected to be related 
to the development of immunodeficiencies. The clinical and laboratory data of two 
siblings with partial combined immunodeficiency and no detectable HLA antigens 
on their lymphocytes are reported. 2 A similar patient has been described recently 
(8). 
1 To whom requests for reprints should be addressed: Division of Immunology. Department of 
Pediatrics. Sophia Children's Hospital. Rotterdam, The Netherlands. 
2 Short descriptions of these patients have been presented previously by the authors (6, 7). 
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FIG. I. Schematic representation of the clinical course of patient A.D. The arrows indicate episodes 
of systemic sepsis. The numbers represent the microorganisms cultured during each episode of infec~ 
tion: ( 1) £. coli: > 106 microorganisms/ml duodenal fluid, (2) Gardia Iambiia. (3) Candida albinms. (4) 
S. aurt:us, later on: Klebsiella. (5) Pm•tmwcystis carinii (probably). (6) H. injluen::.a. Pseudomonas 
aeruginosa. (7) Herpes simplex hominis, type II. 
MATERIALS AND METHODS 
Family History 
The family of the two children reported here originated from an isolated village 
in Turkey. There were four children: the eldest. a female, died in Turkey at 4 
months; the second child, a male, remains in good health; the two other children 
(patient A.D. and patient K.D.) wiJI be described. 
Patient A.D. This female child was admitted at 12 months of age to the Sophia 
Children's Hospital, Rotterdam. Gram negative septicemia (Enterococcus), in-
tractable diarrhea (Escherichia coli. Candida albicans. Giardia Iamblia), and ex-
tensive mucocutaneous candidiasis were diagnosed. At age 2 years she had sev-
eral bouts of bronchopneumonia (Staphylococcus aureus. Klebsiella. 
Haemophilus influenza) and interstitial pneumonitis (Fig. 1). She had a further 
two episodes of septicemia (H. influenza. S. aureus). The symptoms were relieved 
only when antibiotic treatment was supported by plasma therapy. Necrotizing 
lesions on the nates associated with herpes simplex hominis type II occurred 
once. There was no evidence of systemic spread of viruses. Patient A.D. died at 
age 3 from a severe attack of bronchiolitis and bronchopneumonia. At necropsy 
normal-sized tonsils and lymph nodes were found but the thymus weighed 5 g 
(normal 20-30 g). 
Patient K.D. The youngest child, a boy, was admitted at 5 months of age, 
because of relapsing pneumonia (S. aureus, H. influenza. Klebsiella). He also 
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developed recurrent diarrhea (C. albicans, G. Iamblia), mucocutaneous can-
didiasis, and systemic sepsis (Klebsiella). These symptoms subsided on antibiotic 
therapy after ordinary plasma therapy was started. However a pneumonitis per-
sisted. Open-lung biopsy revealed no Pneumocystis carinii. Patient K.D. died at 
age 3 due to rapidly developing bronchiolitis. 
Both patients had severe growth retardation after the age of 4 months, but 
growth rates improved after plasma therapy was initiated. Both had slightly blue 
sclerae, thick black hair. and normal nails. Lymph nodes were palpable, and 
tonsils were present. Radiological examination showed normal thvmic shadows, a 
normal-sized spleen, and no skeletal abnormalities. 
Serological Studies 
These investigations were performed on sera obtained before plasma therapy. 
Immunoglobulins. Quantitation of immunoglobulins G, G 1-4, M, A, and Din 
serum and of IgA and secretory piece in saliva was performed by single radial 
immunodiffusion. Normal ranges were derived from age-related reference groups, 
investigated by comparable (9) or the same (I 0) antisera. lgA in serum was also 
measured by radioimmunoassay (II). lgE levels in serum were compared with a 
reference serum in a radioimmunoassay (12). 
Complement. Various complement components were investigated in either 
quantitative single radial immunodiffusion (Ciq, C4, C3, C5, and Factor B) or 
functional assays (Factor B, C2). 
Lymphocytotoxic antibodies. The presence of serum antibodies against lym-
phocytes was assayed by indirect immunofluorescence (13), agglutination (14), 
and microcytotoxicity methods (15), using a panel of donor lymphocytes. 
Granulocyte Functions 
The function of granulocytes was measured by the uptake of immune complexes 
(16), oxidative metabolism (16), and intracellular killing of bacteria (17). 
Immunofluorescence Studies 
Cytoplasmic fluorescence on bone marrow cells and membrane fluorescence on 
peripheral blood lymphocytes (PBL) were performed using methods and antisera 
described by Vossen (18). Normal ranges were derived from age-related reference 
groups (18). In order to detect all slg-positive B-lymphocytes in PBL a goat-anti-
Fab-antiserum with specificity for Fab fragments of alllg classes was labeled with 
fluorescein (FITC) (19). 
HTLA-Human thymus-lymphocyte antigen. In order to detect human thymus-
lymphocyte antigen (HTLA) on PBL and on tissue cells, respectively. the antisera 
described by Asma eta/. ( 19) and by Brute! de Ia Riviere eta/. (20) were used. The 
first antiserum was directly labeled with rhodamine (TRITC). When used in a 
double-staining method, the cells were first incubated with anti-Fab-FITC and 
then incubated with anti-HTLA-TRITC. In normal PBL I%· of the cells show 
double staining, and 2% do not stain with either antiserum. Control values were 
derived from age-related reference groups (19). The second HTLA-antiserum was 
applied to tissues in an indirect fluorescence assay. The first step, a I :20 dilution 
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of the HTLA-antiseru:n was followed by a 1:75 dilution of swine-anti-rabbit IgG-
FITC (21). Tissue fluorescence was carried out by methods previously described 
(21). 
f3-2-Microglobulin (B2M). Two anti-,13-2-microglobulin antisera were used. One, 
kindly provided by Dr. Radl, REPGO-TNO, Ryswyk, The Netherlands, was pre-
pared by immunizing a rabbit with B2M isolated from human urine. This antise-
rum had the following specificities in membrane fluorescence assays: normal 
PBL-100% of the cells positive: acute lymphoblastic leukemia cells-100% posi-
tive: erythroid cells-negative: epithelial cells of a bladder tumor-negative; 
mouse spleen lymphocytes-negative. This antiserum was labeled with TRITC 
and used in 1:100 dilution in the membrane fluorescence as well as tissue fluores-
cence studies. 
When used in a double-staining technique, the cells were first incubated with 
anti-B2M-TRITC and then with anti-Fab-FITC. The number of double-marked 
cells was counted and expressed as a percentage of the B2M-positive cells. When 
the degree of staining by the fluorescent anti-B2M serum was compared, the same 
numbe.rs of patient's cells and normal PBL, incubated with the same amount of 
antiserum, were used in parallel. This anti-B2M serum was also radiolabeled with 
•:sy to measure the difference in B2M expression on patient's lymphocytes and 
control PBL. The second anti-B2M serum, obtained from Dakopatts, Denmark 
(Batch 10-472), was applied in an indirect fluorescence technique on tissues in a 
dilution of 1:100, followed by a 1:120 dilution of swine anti-rabbit IgG-FITC. 
Cross-section of blood lymphocytes. In order to be able to visualize the inner 
side of membranes of peripheral blood T-lymphocytes, PBL were immersed in 
gelatin, snap-frozen in liquid nitrogen, and cut into 4-JLm cryostat sections (22). 
This cross-section of PBL was compared with PBL in suspension, using both 
anti-B2M antisera in parallel. 
Cell Membrane Markers Detected by Rosette Techniques 
Other cell membrane markers were investigated using sheep red blood cells (E 
rosettes), human D+ red blood cells sensitized with anti-D serum (EA rosettes) 
(23), and sensitized sheep red blood cells coated with mouse complement (EAC 
rosettes) (24). 
Cell-Mediated Immunity 
Skin rests. In vivo cell-melliated immunity was investigated by a dini-
trochlorobenzene (DNCB) patch test using various amounts of DNCB (1-, 3-,. 10-, 
and 30-JLg DNCB) 3 weeks after sensitization, and by intracutaneous tests with 
PPD, Candida antigen, mumps antigen, Trichophyton, and streptokinase-strep-
todornase (SK-SD). 
Lymphocyte transformation rests. In vitro proliferation of lymphocytes in re-
sponse to stimulation with lectins, anti-lymphocyte serum (ALS), allogeneic cells 
(MLR), and Candida antigen was assayed as described by Schweitzer er a/. (25) 
and DuBois era/. (26). Cultures in triplicate were performed in microliter plates. 
The lectins used were: phytohemagglutinin (PHA), Pokeweed mitogen (PWM), 
and concanavalin A (Con A). Cells were pulsed 16 hr before harvesting with 0.4 
JLCi fH]thymidine (Radiochemical Center, Amersham). Results were expressed 
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in counts per minute (Cpm) thymidine incorporation per 4 x 104 lymphocytes. In 
the MLR, stimulator cells were either treated with mitomycin or irradiated (2500 
rad). Control values were derived from the response ofPBL of two healthy donors 
cultured in paralleL The in vitro response of patient K.D. 's PBL to stimulation 
with diphtheria toxin and tetanus toxin was investigated 3 weeks after a booster 
injection with these antigens. 
Antibody-dependent cytotoxicity (ADC). The killing capacity of patients' PBL 
was assayed using sensitized target cells derived from a melanoma cell line (24). 
Cell-mediated lympholysis (CML). The in vitro development of cytolytic capac-
ity was investigated in a cell-mediated lympholysis assay (CML) (27). PBL of 
donor X were first stimulated by irradiated PBL of donor Yin a mixed lymphocyte 
culture. In parallel. PBL of donor Y were transformed to lymphoblasts by culture 
in the presence of PHA. The cytotoxic capacity of stimulated X cells was then 
assayed using '''Cr-labeled Y-lymphoblasts as targets (27). This CML assay was 
used in two ways: first, to measure the cytotoxic capacity of stimulated K.D. 
lymphocytes against nonsensitized unrelated donor lymphoblasts, and second, to 
investigate whether unrelated donor lymphocytes were able to lyse patient K.D. 's 
lymphoblasts. Thus, because HLA-A and -B determinants on the target cells hav~ 
been shown to play a role in the lytic phase of the CML (27). this second mode of 
the CML was used to detect HLA antigens on patients' lymphoblasts. The lysis of 
target cells was measured and calculated according to the formula: 
cpm release in experiment - cpm spontaneous :, 1Cr release 
. X 100. 
cpm maximum release - cpm spontaneous release 
The cpm represented the release of "Cr from 104 target cells (27). 
PWM induced B-ce/1 maturation. In vitro differentiation capacity of patients' 
PBL was investigated in a PWM induced T-cell dependent B-cell maturation assay 
(28). After 10 days culture with PWM the cultured cells were spun in a cytocen-
trifuge and fixed and stained with fluorescinated anti-immunoglobulin sera. The 
numbers of positive staining cells were enumerated by counting 10" blasts cells. 
Control values were derived from experiments on control PBL, run in paralleL 
Immunogenetic Studies 
Techniques used to detect HLA determinants. HLA-A, -B, and -C determinants 
were investigated ·by· the standard typing technique with the NIH 
lymphocytotoxicity method using 120 different HLA antisera (15), and by an 
agglutination assay in EDTA blood performed with 30 different HLA antisera (14). 
The standard cytotoxicity method was also applied to E-rosette depleted B-cell 
enriched PBL and to PBL which had first been incubated for 24 hr in tissue culture 
medium supplemented with 20% pooled human serum. The HLA phenotypes of 
the parents and the plasma donors were determined by the standard HLA typing 
technique. Because every patient had one plasma donor only, the following assays 
were performed using antisera against HLA determinants, predicted from the 
phenotypes of the parents or donors. 
HLA determinants on platelets. HLA determinants on platelets were investi-
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gated by a platelet complement fixation test (29) and a platelet inhibition assay. In 
the last assay platelets of both patients were used to adsorb HLA antisera, after 
which the adsorbed antisera were investigated in the standard lymphocytotoxicity 
test against a pool of donor lymphocytes (30). 
HLA determinants on lymphoblasts. Patients' lymphocytes were transformed 
to lymphoblasts by 3-day culture in the presence ofPHA, after which the lympho-
blasts were labeled with "Cr. These target cells were incubated with HLA anti-
sera and then with normal PBL effector cells, after which the "Cr release from the 
target cells was measured (31). 
HLA antigens in serum. The presence of HLA antigens in serum was investi-
gated by using radiolabeled HLA antisera in an adsorption-inhibition assay with 
a panel of typed donor lymphocytes (32). 
fiLA-determinants on fibroblasts. Fibroblasts of both patients were cultured for 
6 weeks and assayed by a selected panel of HLA antisera, used in an indirect 
immunofluorescence assay (13), a cytotoxicity method using fluorochromatic 
labeled fibroblasts (33), and a "Cr release assay (34). 
B-Cell allotypic determinants. Enriched B-cell suspensions were tested with 45 
antisera against B-cell allotypic determinants (DR-determinants) in an indirect 
fluorescence method (13). 
Additional Assays 
Thymus-dependent serum factor (SF) was assayed by methods described by 
Astaldi et al. (35). Karyograms were made according to routine techniques, in-
cluding the Reverse, Atebrine, and Giemsa banding assays. 
RESULTS 
Immunological Investigations 
Immunoglobulins. Antibodies. and Complement Components 
Severe hypo-y-globulinemia was diagnosed in both patients (Table 1). All im-
munoglobulin classes and subclasses were below the normal level for age except 
for a normal level of lgM in the serum of patient A.D. In saliva no lgA could be 
found whereas a normal amount of secretory piece was present. No titers of 
isohemagglutinins, nor antibodies against a variety of bacteria, parasites, fungi, 
viruses, or various tissues were found. No antibodies against allogeneic lympho-
cytes were detected. Complement components (C2, C4. C3, Factor B. C5) showed 
normal levels with exception of slightly lowered levels of C lq (60% of normal). 
Cellular Immunity 
Hematology. In each patient leukocyte counts were about half the normal age-
related value. Absolute lymphocyte counts varied between 1.0 and 3.0 x 10" per 
liter (age-matched controls: 5.0-7.0 X 109 per liter). Neutrophils were abnormal 
in size and morphology, suggesting disturbed myeloid cell maturation (36). Func-
tional assays of granulocytes revealed normal values. Absolute monocyte counts 
were slightly decreased, whereas numbers of eosinophils were consistently in-
creased. 
Plasma cells and B-lymphocytes. Bone marrow biopsies showed only few 
plasma cells. These were shown to contain lgM mainly (Table 2). Only patient 
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TABLE I 
IMMUNOGLOBULINS (mg/100 ml) 
Patient Normal 
lg-(Sub)class" A.D.9 range 
G <60 350-1140 
GI 50 350-1180 
G2 <15 75-210 
G3 12 15-145 
G4 <2.5 <2.5-90 
A 0.11 13-100 
Se-A <0.5 >30 
Sc-piece 6.4 4-20 
M 80 40-230 
D <0.7 0-3 
E (IU/ml) <I 10-500 
" Se-A and Sc-piece. secretory lgA and secretory piece. 
1
' Not determined. 
Patient 
K.D. o 
<40 
,, 
-
6 
0.13 
4 
<0.7 
<I 
Normal 
range 
140-930 
100-850 
60-200 
5-160 
<2.5-90 
4-80 
>20 
2-25 
20-120 
0-2.5 
10-500 
A.D. had normal numbers of IgM-containing cells. The IgM cells were plasma 
cells, morphologically and by fluorescent staining. In PBL suspensions of both 
children, B-lymphocytes, bearing Ig of various classes were detected (Table 2). 
With an anti-Fab-antiserum 40% of PBL were shown to be B-lymphocytes (see 
also Table 9). The relative high percentages of B-lymphocytes were shown to 
reflect normal absolute numbers when corrected for the lymphopenia. Slightly 
elevated percentages of Fc-bearing lymphocytes were detected by EA-rosette 
assay: 31 ± 4% (controls 26 ± 3%), whereas complement receptor-bearing lym-
TABLE 2 
CYTOPLASMlC IMMUNOGLOBULINS IN BoNE MARROW CELLS 
Patient Normal Patient Normal 
lgCC" A.D. 9 range K.D. o range 
G 10 35-268 0 33-151 
A 0 49-348 0 10-163 
M 226 34-203 7 16-272 
D 3 0-20 0 0-27 
SU"RI"A"(T'IM'MUNOGLOBULINS ON BLOOD LYMPHOCYTES 
Patient Normal Patient Normal 
IgBC" A.D. Y range K.D. o range 
G 6 1-10 7 0-25 
A 0 0-2 I 0-4 
M 22 7-22 18 13-31 
D 33 8-31 22 15-41 
" IgCC. immunoglobulin-containing lymphocytes and plasma cells: numbers are expressed per I(f' 
lymphocytes and plasma cells. 
1
' IgBC. immunoglobulin-bearing cells; expressed in numbers of lg·positive cells per 100 lympho--
cytes. 
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phocytes were slightly decreased: 16 :t 10% (controls 23 :t 4%). T-Lymphocyte 
percentages were 50-60% (control 70-90%) when investigated byE-rosette and 
anti-HTLA fluorescence assays (see also Table 9). This implied that absolute 
T-lymphocyte numbers were about one-third of the normal values for age. 
Histopathology of the Immune System 
Thymus. Thymic biopsy of patient K.D. showed decreased numbers of Has-
sail's corpuscles and of cortical lymphocytes. The architecture of cortex and 
medulla was essentially normal. By fluorescence the thymic cortex contained few 
HTLA-positive cells (Table 3). Postmortem histology of A.D.'s thymus showed 
atrophy with Hassall's corpuscles. The cortex was deple.ted of lymphocytes with 
few HTLA-positive cells. Thus, both children had a lymphocyte-depleted but 
essentially normal thymus. The atrophy of A.D: s thymus appeared to be caused 
by agonal stress. 
Lymph nodes. Lymph nodes of both patients, excised shortly after severe in-
fection, had normal weight and architecture. There were few follicles and no 
germinal centers. Sporadic plasma cells, sca.ttered through the medulla and 
.through rare follicles, contained only IgM and IgD. The paracortical areas were 
depleted of lymphocytes, but showed some clusters of HTLA-positive cells. 
Spleen. Splenic tissue, obtained at necropsy of patient A.D., showed underde-
veloped periarteriolar lymphocyte sheaths containing HTLA-positive cells. Clus-
ters of lymphocytes, staining positively forK- and ;I.-chains, appeared to be orga-
nized follicles. These scarce follicles, without germinal-center reaction, contained 
some plasma cells, positive for IgM and IgD only. 
Intestinal wall. There were few Peyers' patches in both patients. The intestinal 
wall contained scarce follicles with no center reactions. Plasma cells, containing 
IgM and IgD only, were occasionally found in these follicles and throughout the 
intestinal wall. 
!gG 
lgA 
IgM 
lgD 
KandA 
HTLA 
B2M 
Thymus 
+ 
+ 
TABLE 3 
IMMUNOHISTOPA THO LOGY 
Immunoglobulin-containing lymphocytes and plasma cells" 
Spleen Lymph nodes Intestinal 
A.D. 9 A.D. 2 K.D. o wall 
(+) 
+ + (+) + 
+ + + 
+ + (+) + 
Membrane panem of immunofluorescence 
+ + + + 
+ + + + 
Lung 
A.D. 't 
(+) 
+ 
+ 
+ 
+ 
" Numbers of immunoglobulin-containing cells and plasma cells were classified as follows: -
negative. no positive staining cells found:(+), dubious, only a few cells found: +,positive. but lower 
numbers of cell~ than normal: + +. positive. nonnal numbers of cells. Membrane pattern of immuno--
fluorescence: tymphoid cells with a ring of fluorescence around rhe celJs. 
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TABLE 4 
LYMPHOCYTE TRANSFORMATION TESTS" 
Patient Patient 
A.D. 9 K.D. o 
PHA 27.4 (2.7) 16.7 (1.8) 
PWM 10.6 ( 1.1) 6.4 (I. I) 
Con A 7.9 ( 1.5) 7.8 ( 1.6) 
ALS 18.3 (1.2) 16.9 (2.0) 
(})'' 0.2 (0.1) 0.2 (0.1) 
MLR-R' 11.2 ( 1.5) 9.9 (1.4) 
Candida 0.4 (0.3) 0.2 (0.2) 
Diphtheria 0.3 
Tetanus 0.2 
" Mean and (standard deviation) of at least four separate experiments. 
1
' 0. No mitogen added. 
Control 
24.3 (3.6) 
7.1 ( 1.1) 
8.0 ( 1.2) 
17.8 (1.9) 
0.2 (0.1) 
12.4 (1.4) 
3.5 (2.6) 
5.6 
7.2 
,. MLR-R. MLR of patients" lymphocytes in response to allogeneic lymphocytes. 
Lung. Although patient A.D. had severe recurrent lung infections, she had only 
a few plasma cells, most containing lgM and few IgG. 
Cell-Mediated Immunity in Vivo 
Skin tests with DNCB were dubious in both children when challenged with 30 
Jl.g DNCB only. Negative intracutaneous skin tests were obtained with a variety of 
antigens including Candida antigen. 
Lymphocyte Functions in Vitro 
Lymphocyte transformation tests. Lymphocyte proliferation was normal when 
stimulated by lectins, ALS, and allogeneic cells (Table 4). Although both patients 
had extensive mucocutaneous candidiasis, their lymphocytes did not proliferate in 
culture with Candida antigen. A booster injection of diphtheria and tetanus was 
not followed by an in vitro lymphocyte response to these antigens. 
Cytolytic capacity in vitro. Patients' PBL showed normal cytolytic activity 
against sensitized target cells (ADC). In the CML assay K.D. 's PBL were capable 
of developing cytotoxicity against unrelated donor lymphoblasts (Table 5) (P + X • 
->X). 
T-Ce/1 dependent B-ce/1 differentiation in vitro. PWM induced B-ee!! maturation 
was almost absent, although a few !ymphoblasts were shown to contain lgM 
(Table 6). Low numbers of Ig-containing cells did not exceed 15% of the number 
of control PBL. 
Immunogenetic Studies 
HLA-A, -B, and -C Determinants 
Lymphocytes. On lymphocytes of both patients no HLA-A, -B, and -C deter-
minants could be detected with all HLA antisera available using the standard 
typing technique and an agglutination assay (Table 7). The standard typing tech-
nique was also applied to patients· PBL, after 24 hr culture in medium, to exclude 
covering ofHLA determinants by (auto)antibodies, and to enriched B-lymphocyte 
suspensions, with negative results. 
99 
Effectorb 
P +X a 
X+ RR 
X+ YK 
TABLE 5 
CELL-MEDIATED LYMPHOL YSIS" 
Target 1112.5 
p 1.1 
X II. I 
p 11.0 
X 3.1 
y 17.4 
X 4.0 
Ratio 
1!6.25 
1.3 
2.6 
6.1 
1.9 
12.1 
2.3 
"HLA phenotypes =donor X: A3, Wl9, B7. Wl7: donor Y: A2. II. BW40, 15. 
113.12 
-1.1 
0.6 
11 P. patient K.D .. X and Y .. unrelated donors. Pn. Xn. Y H: Irradiated stimulator cells in the MLR 
phase of the CML assay. 
Further assays were performed selectively for HLA determinants predicted 
from the phenotypes of the parents and plasma donors (Table 8). 
Platelets. Platelets of both patients were shown to be negative for HLA deter-
minants, in a platelet complement fixation test. However, by the more sensitive 
platelet adsorbtion inhibition assay some HLA antigens were shown to be present 
but the amount of HLA antigens detected in this way appeared low. 
Cultured lymphoblasts. When patients· lymphocytes were first transformed to 
lymphoblasts and then investigated by HLA antisera in a lymphocyte-dependent 
cytotoxicity assay, the lymphoblasts were shown to express some HLA determi-
nants. This assay was not reliable, because the possibility of false positive reactions 
due to extra antibodies in the reagents used could not be excluded. However, 
support for the expression of HLA determinants on transformed patients lym-
phoblasts came from the CML studies: MLR-Stimulated unrelated donor lym-
phocytes were shown to develop cytotoxicity against lymphoblasts of patient 
K.D. (Table 5) (X+ PR-+ P). 
Serum. In contrast to the cell membrane studies, the patients" sera contained 
HLA antigens. Only HLA-A locus derived antigens were detected. Because the 
patients were on plasma therapy at that time, the HLA-A3 and A9 antigens in 
patient A.D.'s serum could theoretically have been derived from her plasma 
donor. However, donor antigens were not detected in K.D. 's serum (e.g .. A2 in 
K.D.). Furthermore, when plasma transfusions were interrupted for 3 weeks the 
TABLE 6 
PWM INDUCED B-CELL MATURATION" 
Patient A .0. Patient K.D. Control 
+PWM +PWM +PWM 
lg' 15 15 125 
IgM 5 25 
!gA 2 <5 45 
" Values are expressed in numbers of Ig-containing cells per 10:1 blast cells. 
" Ig. immunoglobulins, all classes. 
-PWM 
<5 
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TABLE 7 
ATTEMPTS TO DETECT HLA ANTIGENS" 
• " pO,;iti•t r~I•On 011 lympf!Oeyle!. 
• " ;lO)SOfOW' r~OC!Ion 
w..o~ r~oC!ion 
~ ~ v<!ry -ok •~ac:tion 
D= n~r;ll<"t'fl'OCIIOtl 
"Lymphoc.vtes: Standard HLA typing on lymphocytes, on enriched B-cell suspensions. and on 
PBL after 24 hr incubation in culture medium and typing by an EDTA agglutination assay. Platd<'fs: 
Platelet complement fixation and platelet inhibition assays. Lymplwblasts: PHA-induced lympho-
blasts investigated by an antibody-dependent cytotoxicity method. Serum: HLA antigens in serum. 
detected by radioimmunoassay. Fibroblasts: Indirect immunofluorescence. and tluorochromatic-
labeled or ;,'Cr-labeled target cell release in a cytotoxicity assay. 
HLA-A9 and A-ll persisted in K.D.'s serum. These determinants could not have 
been derived from the donor. 
Fibroblasts. Three methods were used to investigate HLA antigens on cultured 
fibroblasts. Only the HLA-A antigens were detected. For the HLA-B antigens 
some weak reactions were demonstrated. 
These studies made it possible to draw tentative HLA-A and -B genotypes 
TABLE 8 
HLA-A AND -B DETERMINANTS ON LYMPHOCYTES OF THE PARENTS AND THE PLASMA DoNORS" 
Locus A B 
" P. father of patients: M. mother: D A.n .• plasma donor of A.D.: DK.u .• plasma donor of K.D. See 
Table 7 for explanation of symbols. 
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(Tables 7 and 8). It was concluded from these data that the children inherited the 
same haplotype from the mother (A9-B 15) but different haplotypes from the 
father. The HLA-B antigens from the father were not reliably determined. The 
occurrence of BW21 in both patients could be explained by assuming either the 
existence of a paternal recombination or technical error. 
HLA-D and HLA-DR (Allotypic B-ce/1) Determinants 
D-Determinants. In one-way MLR with unrelated donor lymphocytes, the 
stimulating capacities of patients' lymphocytes were positive but moderate 
(40-60% of norrnallevels). 
DR-Determinants. Two of six anti-DRw7 sera were positive with enriched B-
cell suspensions of the patients. The other anti-DRw7 sera showed weak or nega-
tive reactions. The majority of the other anti-B-cell sera was negative. Removal of 
the monocytes by iron depletion did not alter these results. 
B-2-Microglobulin 
Peripheral blood cells. By immunofluorescence B2M was detected on ouly 40% 
of patient K.D. 's PBL and these cells were identified as B-cells (Fab-positive) by a 
double-staining technique (Table 9). The density of the fluorescent staining for 
B2M on B-cells was reduced. Likewise patients' monocytes, identified by phase 
contrast microscope, showed reduced fluorescence for B2M. The reaction of 
radiolabeled anti-B2M serum with mononuclear cells was half of normal. Throm-
bocytes did not show B2M staining. Cultured fibroblasts were positive. Of PBL. 
50-60% were not stained by the anti-B2M sera. Because 95% of B2M-staining 
cells in PBL were shown to be B-lymphocytes (Fab-positive) it was concluded 
that T-lymphocytes did not have B2M on their membranes. 
TABLE 9 
LYMPHOCYTE ($UB)POPULATIONS AND OTHER CELLS WITH SURFACE ,8-2-MICROGLOBUUN'' 
Patient Control 
Antiserum K.D. o Mean (ranges) 
Peripheral blood 
Mononuclear cells B2M 36-46' 100 
Lymphocytes Fab 41 17 (10-26) 
HTLA 54 81 (68-89) 
Fab-positive lymphocytes HTLA I} I}' 
B2M-positive lymphocytes Fab 95'1 17 ( 10-26)'' 
Density of B2M'" 
B2M-positive lymphocytes B2M + ++ 
Monocytes B2M + ++ 
Thrombocytes B2M ++ 
Cultured fibroblasts B2M + ++ 
~Values expressed as numbers of positive cells/100 cells in isolated cell suspensions. 
" Results of two investigations. 
,. Percentage of Fab-positive lymphocytes. which also stained with a-HTLA. 
" Percentage of B2M positive cells, also staining with a-Fab. 
,. + +, Nonnal density per cell: +. lowered density per cell: -. no reaction. 
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FIG. 2. Paracortical area of an inguinal lymph node of patient K.D. stained with a fluoresceinated 
anti~,6~2~microglobulin serum. x 160. 
Immunohistopathology of B2M. With the use of two different anti-B2M anti-
sera, a clearly positive honeycomb pattern of fluorescence was seen in the 
thymus, spleen, intestinal wall, and lymph nodes (Fig. 2 and Table 3). Compared 
with tissues from other patients, the intensity of the fluorescent staining per cell 
appeared to be normal. Lymphoid cells were positive for B2M, as were epithelial 
cells and to a lesser degree endothelial cells. T-cells in the thymus, spleen, and 
lymph nodes were shown to carry B2M. 
B2M on T-lymphocytes. There was a clear discrepancy between B2M staining 
on T-lymphocytes whether in tissues or in cell suspensions; the former were 
positive, while the latter were negative. When patient K.D.'s PBL suspensions 
were immersed in gelatin and the cells were further processed as tissue, all the 
mononuclear cells stained positive for B2M. Viable cell suspensions of K.D.'s 
PBL investigated in parallel.showed only 40% of the cells positive (Table 9). 
Furthermore, the lower density of B2M on PBL membranes was not seen when 
PBL were processed as tissue specimen. It was concluded that T-lymphocytes 
either failed to express B2M on their membranes or lost B2M as soon as it ap-
peared at the cell surface. At the same timeT-lymphocytes contained B2M in or at 
the inner side of the membrane, only visible when cells were cross-sectioned. 
Additional Data 
Thymus-dependent serum factor (SF) was hardly detectable ( 1.5-2. 7 pmol 
cAMP per 10 7 thymocytes; normal values 35 ± lO pmol) (34). The erythrocytes of 
both patients had high levels of the enzymes adenosine deaminase and purine 
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nucleoside phosphorylase. Both children bad normal karyograms. Chimerism in 
K.D. · s peripheral blood was excluded by investigation of I ()3 blasts. Glyoxalase 
was detected (phenotype 2-1) as well as phosphoglucomutase-3. Patient K.D.'s 
serum inhibited three anti-Chido and two anti-Rogers sera, which implied that he 
possessed these blood group antigens. 
DISCUSSION 
Two Turkish siblings with a history of multiple pyogenic infections and persis-
tent candidiasis had a severe hypo--y-globulinemia. One patient (A.D.) produced 
IgM in sufficient amounts, the other (K.D.) had a low leveL This was reflected in 
the numbers of IgM plasma cells found in bone marrow biopsies. Despite the 
presence of B-lymphocytes carrying immunoglobulins of all classes, both patients 
showed a failure of B-cell differentiation to IgG- and IgA- containing cells. This 
might indicate a disturbance in the switch from IgM to IgG and lgA production (2). 
This particular B-cell differentiation phase is considered to be induced by an-
tigenic stimulation and to be mediated by T-cells (3). There was no defect in the 
early stages of T-cell differentiation (stem cell __,_ T-precursor __,_ thymus-
lymphocyte) as can be concluded from positive in vitro proliferative responses to 
lectins and the relatively normal percentages of E-rosette-forming cells and 
HTLA + cells. The grossly normal thymus histology also excluded severe T-cell 
defects. The absence of thymus-derived serum factor might indicate deficient 
maturation ofT -cells from the intrathymic stage on. The low absolute numbers of 
T-lymphocytes also indicated insufficient maturation. Furthermore, defective 
T -cell function was shown by the lack of lymphocyte proliferation after antigenic 
stimulation. Lack ofT -cell dependent B-cell maturation, induced by PWM stimu-
lation, does not distinguish between a T -cell function defect or an intrinsic B-cell 
defect. 
The final diagnosis was partial combined immunodeficiency, characterized by 
severe hypo--y-globuiinemia with B-cells present and partial T -cell deficiency, 
mainly expressed at the level of post-thymic functions. Immunogenetic studies 
revealed a lack of HLA-A and -B determinants on lymphocytes. A structural 
genetic defect in the HLA region on chromosome 6 was unlikely for the following 
reasons: Gross defects in chromosomes 6 in the area of the HLA loci were 
excluded by normal karyograms and by the presence of various gene products 
coded in that area (complement components: C2, C4, Factor B: enzymes: 
phosphoglucomutase-3, glyoxalase; and blood groups: Chido, Rogers): selective 
defects within the HLA region appeared to be excluded by the presence of 
HLA-A and -B determinants on platelets, on lymphoblasts, and especially in 
serum and on cultured fibroblasts. The studies on lymphoblasts were hampered by 
technical difficulties. The lymphocyte-dependent cytotoxicity assay was unreli-
able due to the possibility of additional specificities in the HLA antisera used. The 
CML assay, especially the lytic phase in this assay, is supposed to be mediated by 
HLA-A and -B determinants on the target lymphoblasts but does not exclude a 
role for other target cell determinants. However, a lymphoblast cell line derived 
from patient K.D.'s blood lymphocytes also expressed the predicted HLA-A and 
-B determinants (37). The studies on the D- and OR-determinants were inconclu-
sive. The intermediate stimulatory capacity did not prove the presence of the 
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D-locus determinants, because theoretically tbis might have been mediated by 
determinants coded by minor D-loci witbin or outside the HLA region'. Because 
only two of six well-characterized HLA-DRw7 antisera showed clearly positive 
reactions, it could not be concluded that patients had the HLA-DRw7 determi-
nant. In conclusion, the immunogenetic studies showed a lack of HLA-A and -B 
determinants on lymphocytes, which appeared not to be caused by a structural 
gene defect. 
Lack of HLA-A and -B determinants on lymphocytes has been described in two 
other cases. One was a patient with Hodgkin's disease, in which the "'loss" of 
HLA determinants was transient (38). The other, an Algerian infant, was strik-
ingly similar to the Turkish siblings (8). He had partial combined immunodefi-
ciency, characterized by severe antibody deficiency, with B-lymphocytes, normal 
mitogenic response oflymphocytes, and a low absolute T-cell number. There was 
an absence of HLA-A and -B antigens on lymphocytes but they were present in 
serum. The parents were consanguineous. HLA typing data of the family showed 
one healthy sibling with the same genotype as the patient, which excluded linkage 
of either the immunodeficiency or the lack of HLA determinants with a particular 
HLA genotype. 
Although there was no known parental consanguinity in the Turkish family, the 
coincidence of two siblings of different sex in one family from an isolated Turkish 
village, argues for an autosomal recessive genetic trait. 
The association of lack of HLA determinants with similar lymphocyte differ-
entiation defects in patients from two separate families suggests a causal relation-
ship between HLA determinants expression and normal immune function. In view 
of the existing knowledge (4, 5) it is tempting to speculate that an autosomal 
genetic trait leads to an HLA determinants expression defect, which in its turn 
leads to a lymphocyte differentiation disorder. 
The studies of B2M may indicate how the genetic defect is exposed by the 
absence of HLA-A and -B determinants. B2M is required for the expression of 
HLA-A and -B determinants on the surface oflymphocytes, as has been shown by 
hybridization experiments with Daudi cells (39). The fmding of B2M without 
detectable HLA determinants on patients' B-lymphocytes argues against a defect 
in HLA antigen expression by mere absence of B2M. However, the fact remains 
that T-cells did not express B2M on their surface, although they appeared to 
contain B2M in the membrane. This might be explained by postulating either an 
immunologically undetectable structural defect in B2M or a membrane defect, in 
both cases leading to defective "anchorage" of B2M on the T-cell membrane. 
This anchorage defect would then cause rapid loss or'B2M from the membrane 
and defective fixation of HLA determinants, which is normally accomplished in 
cooperation with B2M (40). The presence of B2M in patients' sera suggested that 
B2M reached the surface but actually did not imbed in the lymphocyte membrane. 
Although B-cells appeared to express reduced amounts of B2M on their surface, it 
is difficult to explain why there was a difference between B- anq T-cells other than 
by assuming that there is a difference in B2M anchorage and/or B2M-mediated 
HLA determinant fixation on B-and T-cells. Also cell membrane turnover might 
be different. That cell turnover disorders can lead to loss of HLA determinants, 
has been shown in fibroblast cultures from patients with progeria (41). Normal 
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expression of other cell membrane markers such as Ig on B-lymphocytes, E-
receptors on T-lymphocytes, and the Fe and complement receptors suggests that 
any membrane defect, if present, is selective. 
In conclusion, the described association of a partial combined immunodefi-
ciency, absence of HLA-A and -B determinants on lymphocytes, and a loss of 
B2M from T-lymphocytes, indicates an interrelationship between lymphocyte 
differentiation and HLA determinants and BZM on lymphocyte membranes. 
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ABNORMAL LYMPHOCYTE CAPPING IN A PATIENT 
WITH SEVERE COMBINED IMMUNODEFICIENCY DISEASE 
ERWIN W. GELFAND, M.D., jANET M. OLIVER, Pa.D., Ruun K. SCHUUR.MAN, M.D., 
D . wm S. MAntt.soN, M.D., AND HANs-MICHAEL DosCH, M.D. 
Abstract Despite the presence of normal numbers 
and distribution ofT and 8 lymphocytes and normal 
levels of serum immunoglobulins, a five-month.ald In-
fant failed to show any evidence ofT "C&U or B-een im-
munity. In trying to identify a specific membrane ab-
normality as a potential cause of the immunologic 
dysfunction. we examined the lateral mobility of 
the cell-surface receptor for concanavalin A. In con-
trast to normal cells. in which the receptor is dis-
tributed uniformly over the cell surface. the pa-
tient's lymphocytes showed an unusually high ac-
SEVERE combined immune deficiency (SCID) is a heterogeneous and uniformly fatal disorder 
characterized by the failure of specific humoral and 
cellular immunity to develop. 1... With rare excep-
tion,'·' it presents with a marked impairment in the 
expansion of cells ofT lineage; normal numbers of pe-
ripheral blood lymphocytes and, indeed, devated. 
numbers of B lymphocytes often prevail despite the 
uniform presence of profound hypogammaglobulin-
emia. Thus, the combined deficiency often reflects the 
failure of T-precursor cells to mature; they !!how 
acrots at various stages of development, includ· 
ing a primacy failure of function of thymic epithelial 
cells.J.• 
We report on an infant with an unusual, inherited 
form of SCID in the presence of normal numbers ofT 
and B cells. These cells had surface receptors that 
were indistinguishable from normal; after interaction 
with a number of ligands, however, there was no 
T -<ell proliferation. In trying to find a specific 
membrane abnormality that resulted in failure to 
transmit or translate triggering signals from the sur-
face membrane to the nucleus, we examined the 
Frolll the! Oivilion of lmmWIOlOIY. RGeV<:.b. lmtitlltc:, H01p1tal for Sick 
ChildreD. Toronto. and tbc: l>eputmeat of Phyaiolo&Y, Univftty ot Co-n-
II«UQ..I Hc:aJ.\b Coruer, Farmm~toll. CT (addn:a ~'~~Print roqllf:IU to Dr. 
Gelfand at the Oivi.lion of llllm!IDOlol)', Re1t:an:b. llwiNie. The Hospital 
for Siclc: Cllildlcn. $$$ Univonlty Ave.. Toronto, Ontano M5G IX3). 
S11ppornod by lflllltl from tbc Mo1ial Raoan:b Fo1111dation ofCmada 
(MT 487$). from tbo National FOWidatioD-Matl::b of Dimes (6-109), from 
the Nationallnwtuta. of Hc:al.th (CA-185$4) and from the Amoriean Can-
cer SocXty (BC-11')) (Dr. GdJand is • n:o:ipioqt of a Q11ocD Elizabeth 11 Sc:t-
cntiltAward. and Or. Olivu ora FacWty RCiellf'Ch Awm1 !rom the Amen-
c::a.a. Callc:er Socioty). 
cumulation of concanavalin A receptors in surface 
caps. This capping abnormalitY appeared in both 
T and e lymphocytes and was exaggerated by 
colchicine. an inhibitor of microtubule assembly. 
These findings support the theory that plasma-
membrane-cytoskeleton interactions have a role in 
the expression of specific immunity; the findings 
also identify new areas that should be considered 
in trying to understand the primary Immunodefi-
ciency diseases. (N Engl J Med 301:1245-1249, 
1979) 
lateral mobility o£ a surface ligand, concanavalin A 
(con A)/ in the membranes of the patient's lympho-
cytes. Under normal conditions, con A binds to uni-
formly distributed receptors and maintains a uniform 
surface distribution during short-periods of incubation 
at 37°C. • The patient's lymphocytes showed an un-
usually high accumulation of con A rtteptors in sur-
face caps during brief incubation with fluorescein-<on 
A. This capping abnormality was exaggerated by ex-
posure of the cells to colchicine, which inhibits micro-
tubule assembly. Our findings support the theory that 
the lymphocyte cytoskeleton has a role in the expres-
sion of nonnal immune ~pensiveness, and reveal 
new clues to the pathogenesis of primary, inherited 
disorders of the immune system. 
A live-month-old boy, the secondbom of a ~neows mar-
riage, was rd'o:m:d to the Hospital for Sick Children with :JUSpeeted 
immunodeficiency. beca.UJe a brother h.ad died at the age of three 
yean from parainlluenza Type 3 pneumoniW aftef' a lifclo~ 
history or infec:tions. L.aboratory evaluation of the brother bad 
~ed. an alnence of lympboc:ytc•proliferativc ~ponsc to lcetitu 
and allogeneic cdb: be bad normal immunCIIJ!Obulin lcvcb but 
weak. if any, antibody ~nscs. 
On admi»ion the patient was wcll. developed. wcll. nourished, 
and at the 60th percentile for height and 75th percentile for w~ht. 
There were no abncmnal finding:~ otber than a. difTUJe, Kaiy, 
macular ruh and a generalized paucity oflymphoid IU&11es. Results 
of routine laboratory tesu were entirely normal. Leveb of adeno-
sine dcaminase .1;nd nucleoside phosphoryla:se in the red celb (kind· 
ly auayed by Dr. E. Giblen. Seattle. WA) were normal. 
When the p.atient was seven monda old, after the ,tudia 
dc::!Ciibed here were eornplctecl and the ~i:l of combined im· 
munoddieiency wa:~ established, he received a b<?ne-marrow tn.n:s-
Reprinted from the N~w £nrfand Jofd1101 of M~kW 
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plant from hU father- who w:u HIA-D a:~rnpatible. Five days after-
the trarupLmtation, fever, diatrllea, =d. a morbi!lifonn ~kin rash 
developed in the infant, indicating acute graft-versus-host <fue;ue. 
He died. foW" wedcs later with marked hyper!Jilirubinacia. 51cin !e-
sioru roemb!ing toxic epidermal nceroly:Jis, and total marrow 
apluia. 
METHODS 
Cell Su•penslon• 
ButTy-coat leukocyte:.: Wet'~: obt:tined from heparini.l:ed blood and 
suspended. in rn.odillo:d Hanb' medium. The lwkocyte suzperuions 
contained .approximately 70 to {10 pel' Cent polymorphonuclear cells 
.:~nd 20 to JO per cem Jymphocytell 01.nd monocyto. Mononuclear· 
cell suspensioou from peripheral blood or bone rn.atTOw were ob-
ta.ined after I.sopaque-Ficoll gra<fient centrifugation.' Thee cell 
su.3pemioru contained 70 to 85 per cent lymphocyte. 15 to 20 per 
cent moi'IO<:'jle:s, and los than 5 per cent granulocyte. 
Immunologic EvailoNition 
Serum im:nunoglobulim, 00hcmagglutinif13, tctanu.3, diphthe-
ria, and polio (Types I, 2, OU!.d 3) antibody titer:s Wet'~: obtained wirh 
sundan:l t"echnique. 
Del.:ayed cuuneou.3 reactivity w01.s ~eel with O:Jndith;. aibil4N, 
strepto.k.ina:se-strepwdomase, dCIT(I.1.tophyton, diphthcria·temnus, 
01.nd phytohemagglutinin. Lymphocyte proliferation in I'C:Iponse to 
phytohem;,ggluunin, con A. pokeweed mitogen. and allogeneic cells 
w.u detcnn.ined .u p~ouslv dc:scribed.> Cultures conmmin~ for-
rnalini~ aumo:o, Cow01.n str.t.in I. were grown ln 10 per 
cent fet.'l! calf SCMJm (Schuurman RKS, Gelfand EW, Dr»ch H·M: 
unpublished d:na). 
Confluent monol.:aya cultures of bwna.n tl:ymic epithelium, 
supen:~.~;.te:s of thac C\lltw'a (h~.~mUJ-thyrnw c:on<firioned medium), 
thym05in fn.etion V (kindly provided by Dr. C. Joseph, :-Jutlcy, 
Nj), 01.nd theophylline were used in studies of the induction. of 
T -ceU differentiation. • 
Identification of !ym.pbocyta bearing receptors for she<:p erych-
rocyta, the third component of com.plemem, the Fe fn.gment of 
igC, or lurfa.cc im:nunoslobulin w.u performed a:1 previously de-
'ICI'ibe<l.'·•·•• The nu.tllbel' of ro~~ette-fonning or immunotJloOuJin. 
bearin~ cdb wa:J exprascd as 01. pen:entag:e of total mononuclear 
cdb. The presence of HIA-!ikc and lot-like determinants was u-
=<1 by complemcnl-clcperu;lent Cytotoxicity with moncospecific 
and olig~c alloantUen.uns (kindly performed by Mrs.J. Falk, 
Toronto, Ontario). z., and d2-m.i.crog!obulin 01.ntigcru ~abo de-
tected by 11\CanJ of incti.reet irrununofiU()I'Oedlce with xcnoanti• 
JCI'Ufltll. 
Stuclle• of C..p Formation by Auoro~~eence Mk:roraeopy 
Bull'y-coat..:ellt ("" 10' lc~a permillllital were Labeled with 
rhodotmine ~t otntihunur.n lgM (Clppd 1-lboratories, Cochran-
ville, PA) for two rninuta 01.1 37°C, 01.nd then Labeled with fiuOC'e3-
cdn-con A (30 l'g per millilita) for 10 minutes 01.1 37°C.'The cells 
wen: then washed and fuced with 2 per cent p~U'aflmnaldehyde for 
10 minuta. The nuclei Wet'~: Labeled with 2 1'8 per millilita of 
Hoecbst 33258 .u previously docrib«i" The Hocchn fiuoro-
chl'orne wu employed for the observ01.tion of nuclear morphology 
otnd identific;.tion of lymphocytes in auxed popuU.rions of cdb (Fia:. 
it); the =ti·lgM reagent enabled us to categoritt lymphocytes as B 
or T cellt (Fig. 1b). The swiace distribu1ion of fluorescein cOli A 
w.u catcgOrittd a:J uniform when fiuo~ was distributed ovet 
the whole surfa.ce in either ot di.ll'we pllttem or, Ia$ frcqllemly, in 
J~ouface pa.~. Capped ceU• showed concentration of fiuorncein 
exclusively Ol.t the pole of the cell. The typie:l.l distribution. ~ 
s.ho""tl in Figure l "· Small monocyta ~ identified by their 
tendency to imc-nalli:e the a:~n A. The aequeru:e in whicll the three 
lllbeb (Hoeclac, fiuoroedn CQD A, and anti-lgM) were examined 
em:w-ed that T and B cells wae ob:aened .a.t random. Prelim.in.ary 
~rnents showed no diii'~es in eon A cappins of !ympho-
cyto ~ normal.a.dult cdlt and cdls from two infanu matched 
for "'SC with the p.~~.tient. 
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' Figure 1. Distribution of Con A on Human Lympnocytes 
(X650). 
Frames a. b, and c snow tne distribution o!11uoreacence due 
10 (a) fluorescein-eon A. (b) rnodam!ne antihuman lgM, aM 
(C) Hoecnst 33258 on typ1ca1 butty-coat leukocytes not 
treated witn drugs. The celts are all rymphocyres, as ju<:lged 
from nuclear morpl'lology (c). The control cells (A) cons1st of 
a T cell (lgM-n&gative) witn a patcny surface distribution of 
con A and a 8 cell witn a uniform surlace distribution ot con 
A and a separate patcny distribution ot ant!-rgM. Tno 
patient's cells (B and C) conSist o1 a capped 8 cell w1tn co-
capping of antl-lgM and a un1form1y labeled T cell (8) anti a 
capped T cell (C). 
lmmunoloQic Studlec 
Serum immunoglobulin quantitation revealed a 
mean IgG of40Q.mg per 100 ml, lgAof85 m~ per 100 
ml, IgM of 70 mg per 100 mi. and IgE of <tOng per 
milliliter. No abnormal proteins were detected by 
serum immunoelectrophoresis. Five to 12 per cent of 
peripheral blood mononuclear cells were stained with 
the fluorescein anti-IgM or anti-IgD reagents, and 
plasma cells were detected in the bone marrow. The 
patient was in blood group 0, but isohernagglutinins 
were not detected. Despite repeated immunization 
with diphtheria-tetanus-pertussis-trivalent poliomye-
litis vaccine (Connaught Laboratories, Toronto, On-
tario), no antibodies were detected and the Schick test 
remained positive. 
There was no evidence of delayed cutaneous reac-
tivity to any of the antigens tested. Absolute lympho-
cyte counts never fell below 3000 per cubic millimeter 
and appeared morphologically normal under the light 
microscope. Surprisingly, E~rosette formation, in~ 
eluding the expression of theophylline sensitivity in 
approximately 40 to 45 per cent of the patient's 
E-rosetting cells. was normal (Table 1). Peripheral 
blood mononuclear cells also normally expressed re-
ceptors for the third component of complement (C3) 
{mean, 27 per cent) and for Fc~IgG (mean, 30 per 
cent) as well as {J2 microglobulin and appropriate 
H!A and Ia~lilce determinants. 
As shown in Table 2, the patient's T cells did not 
respond to phytohemagglutinin, con A, pokeweed mi-
togen, allogeneic cells, or a number of specific anti-
gens including C. alhi&tms, streptokinase-streptodor~ 
nase and tetanus toxoid. In constrast, there was a 
statistically significant response to formalinized Stb.pl:-
yl«oa:us aureus, a T -cell independent B-e ell mitogen 
Table 1. E-Aosette Formation In a Patient with Combined 
lmmunodetlclency. 
Pa~t 
Control 
48:1:10 
58:1:6 
~M-... ;~<l SO of lZ apori,_.., 
tE {A£1) ...,_-f~ witb oMop.,...._,.._ u.c.1 wttb at~W~G<Wylioo­
tbiO\ItOIU""' b"""ide. 
;£ {.-,..) """"* roootiCI f"""'"<' In tbo ~ o( ] mM tboophyW.... 
(Schuunnan RKB, Gelfand EW, Dosch H-M: un~ 
published data), and this was confU'O'led in the patient 
in cell~separation studies. The failure to respond in 
culture to phytohemagglutinin and con A was con-
firmed with blast-count analysis and studies of 
[ 14C]leucine incorporation. In mixed lymphocyte 
cultures the patient's cells stimulated normally, and 
there was no evidence of suppressor cells or suppres-
sive substances in the patient's serum. Lymphocyte 
proliferation in both parents was normal. 
Because lymphocyte numbers and proportions of 
E~rosening T cells were both normal. the combined 
immunodeficiency did not appear to reflect the ab-
normality of T -cell differentiation that has been 
described in most patients with SCID. 4 The normal 
induction of E-rosette formation with the patient's 
cells after incubation with thymic epithelial cells, thy-
mic epithelium conditioned med.iUOl,.. thymosin, and 
theophylline demonstrated the presence of all iden-
tiftable precursor T cells at all stages. 4 
Fluor-.cenc:e Mieto.copy (Ag. 1} 
Since the translational mobility of membrane pro-
reins and the phenomenon of capping have been 
implicated in the triggering of cell activation, the 
patient's leukocytes were examined for an abnor-
mality in the mobility of con A bound to surface gly-
coprotein receptors. A striking difference between 
normal cells and the patient's cells in the surface dis-
tribution of con A was immediately apparent (Table 
Table 2. Lymphocyte Proliferation ln a Patient wlth Com~ 
blned Immunodeficiency.'" 
MITOOIN/A/<T101N 
None 
Phf\Obcmasslutini11 
C011ca111.Valii1A 
Pokeweed 
Foi'Dl..tiruzod s IDU'n<J 
AutoiQIOill ceJb 
Alloccueic oc.111 
0,4±0.1 
0.6:1:0.3 
0.6:1:0.3 
0.3-*0.1 
!6.3:1:8.1 
0.5~.4 
!.5:1:0.6 
O • .S:t:0.2 
68.4i:l.S.6 
42.7d.J 
18.4:1:!M 
18.1:1:8.2 
0.4.1:0.1 
41.9~.9 
'Vol-- ('HJtb,ym>Ciio>e ~_..... •tbo- :t;l $0o(al 
lcu!.6al)OO'I-tr.. 
3 ). A mean of 30 per cent of the patient's cells showed 
the spontaneous accumulation of con A into a surface 
cap, whereas only 9 per cent of the normal· cells did so. 
In addition, more than 60 per cent of the patient's 
cells showed con A capping after exposure (30 
minutes at 37"C) to 10 .uM colchicine, an alkaloid 
that inhibits microtubule assembly.• In contrast, only 
26 per cent of the control cells capped after incuba-
tion with this drug. Lymphocytes from the patient's 
mother were essentially normal. In none of these stud~ 
ies could we define an abnormality in the distribution 
of con A-receptor complexes on the membranes of 
either the patient's polymorphonuclear leukocytes or 
monocytes. 
The abnormal formation of con A caps and the ex-
aggerated response to. colchicine observed in the 
patient's lymphocytes applied to both purified T and 
B cells (Table 3}. Although, in general, B cells from 
the patient or controls were more readily capped by 
con A than were T cells and were more susceptible to 
enhancement of capping by colchicine. both T and B 
cells from the patient showed a rate of spontaneous 
con A capping that was three times the normal rate 
(Table 3). After colchicine, the number of BandT 
cells that capped in the patient was twice the number 
of normal B and T cells that capped (Table 3). 
Table 3. Olstrtbutlon of Con A-Receptor Complexes In a 
Patient with Combined Immunodeficiency. , __ 
'~ Puat<T.-QI.,.Cot<A~ 
-~ ' ·~ ·~ ·~ 
BWYa Plt>cn~ 29.7:i:l.5 20.5:1:0.7 47.6.1:3.5 
Normal 3.7.ZI.2 8.5Z0.9 1J.5:t:4.1 
M•<=W 
' ' " ColchiCine (lQ-> M) 
""'-
6J.O:i:9.6 4l.52:6.J 7S.5tl.l 
N.....W 26.3ZJ.O 27.5:1:6.4 41.02:6.7 
M•....W 
" " " ~-~utbo-..l$0ol)-----.lt-.la>ror 
.. -....~ ...... -r.- ..... p"""",&lldr_.....-.u_..........,..,......_ 
""'~ ---oftbo oliPII)I-.-. ...... .,.,... -
L)'III~--..Bod b)r t'-lloo~ TbiO~O(-A"'" 
-of otlooo4 200 lyoo~wu .-.-.;Beet u.............,.  orcopp.d. 
F.....,llllt ... ~tbo~oliOW~c:apo,Fbo.ally,-OIIIIwaoa­
d!IIMCI fOO' tbo ,.._ or ~of n--..o wttb ~too! u11-l1M ~ 
COiollb ... --D- Wl'l>l100tpl-m ~00' ~11¥11(8) 
r,rnl)lloCyloth<Od--•-.---'"-""'_....,orT~ 
&nG ora l)'lllpftoc:ylu ""PI*L 
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DI:SCVa8ION 
We have described a patient who, despite having 
normal numbers of cells with markers characteristic of 
T and B lymphocytes, lacked the functions normally 
attributed to these cells. The family history and labo-
ratory assessment of lymphocyte function favored the 
diagnosis of :severe combined immunodeficiency. The 
patient's brother had died after a lifdong history of inM 
fections. an absence of in vitrO or in vivo evidence of 
cell-mediated immunity, and the presence of normal 
level,: of immunoglobulins but feeble antibody roe. 
sponses. Although many patients with SCID have 
nonnal or elevated numbers of B lymphocytes)·1 ~· 1 • 
and even normal levels of serum immunoglobulins, 1s 
the presence of normal numbers ofT cells is unusual. 
Thus, these patients represent one variant of SCID 
that in many ways differs from the usual form. which 
is associated with a marked reduction in T cells and 
profound hypogammaglobulinemia. 
The presence of all stages of precursor T -cell 
development in bone marrow correlated with the nor-
mal lymphocyte count as well as with nonnal propor-
tions of T cells. This relation implied that the T ooeell 
compartment was able to proliferate and expand nor-
mally in response to T -cell-inductive signals and that 
the defect was a more specific: one unrelated to an ab--
normality ofT -cell differentiation itself. Both T and B 
lymphocytes had a variety of normal receptors and 
surface determinants, including receptors for both 
phytohemagglutinin and con A.·Funhermore, at least 
one early lymphocyte response to both lectin binding 
and exposure to the calcium ionophore A23187 -
the uptake of calcium ions by the cells - was 
indistinguishable from the response in controls, 
indicating normal ligand-receptor interaction and 
activation of the cells (studies carried out in collabora-
tion with Dr. M. H. Freedman, Toronto, Ontario). 1• 
The specific redistribution of membrane--receptor 
complexes after interaction with exogenous agents 
such as antibody or lectin may represent a primary 
event in signal transduction across membranes.H·1• 
Since Edelman et al. described con A-cap formation 
induced in the splenic lymphocytes of mice, 1' interest 
has focused on the potential role of capping in cell-cell 
interactions, cell activation, and cdl function. :ro.:: 
Analysis of the patient's lymphocytes after brief ex-
posure to con A at 37'"C revealed a unique abnor~ 
rnality: his lymphocytes showed a marked increase in 
both spontaneous and colchicine-induced surface con 
A-cap formation. This capping abnormality was 
expressed on both B and T cells even though 
T -lymphocyte function appeared more profoundly 
impaired in the family. T cells may have provided suf-
ficient helper activity to permit some B cells to dif~ 
ferentiate into immunoglobulin-secreting plasma 
cdls, but not in response to challenge by specific anti-
gens. 
The basis of the capping abnormality in these lym-
phocytes remains undefined. Since colchicine exag-
gerated the abnormality, the most obvious explana-
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tion is a defect in the assembly of cytoplasmic micro-
tubules, analogous to the defect in leukocytes from 
patients with the Chediak-Higashi syndrome.~) 
Ho~ever, preliminary studies with the electron micro-
scope suggested that the patient's lymphocytes con· 
tained a normal density of both centriole--associated 
and peripheral microtubules. Another possibility is a 
direct alteration of membrane fluidity that encour-
ages con A-receptor movement in SCID lympho-
cytes. Studies of the composition of phospholipid, 
fatty acid, and cholesterol in erythrocytes, as well as 
fluorescence-depolarization studies with diphenyl~ 
hexatriene, showed no differences between normal red 
cells and those from the patient (Berlin RD, FeraJP: 
unpublished data). However, specific changes in the 
membranes of both B and T lymphocytes that do not 
extend to other blood cells cannot be ruled out. Since 
concentrations of microfdaments generally underlie 
the caps, an additional explanation is an intrinsic de--
fect in the structure or regulation of lymphocyte 
microfilaments that encourages cap formation. 
These observations provide direct support for the 
hypothesis that interactions between plasma mem-
brane and cytoskeleton have- a role in regulating the 
expression of specific immunity. The profound effect 
of these interactions on lymphocyte function was 
emphasized by the development of acute and fatai 
graft-versus-host disease after attempted reconstitu-
tion with bone marrow from the HLA-D-compatible 
father. Funher analysis of the functional interaction 
between membrane and cytoskeleton components 
may not only clarify the molecular basis of this dis-
order, but may also provide imight into the possible 
therapeutic approaches to this and other diseases. 
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INTRODUCTION 
Primary combined immunodeficiency disease is a heterogeneous 
group of disorders affecting both T- and B-lyrr~hocyte differentia-
tion1. ~No types of lymphocyte membrane defects have been descri-
bed in association with T- and B-l~phocyte dysfunction: 
a) Lack of exoression of Beta-2-microglobulin (E2M) and B2M-asso-
ciated-HLA- determinants on lymphocytes 2 ' 3 ; 
b) Abnormality of lymphocyte-surface-receptor capping4 
These disorders will be discussed in view of the role of the lym-
phocyte plasma membrane in no=mal T- and B-lymphocyte functions 
and properties. 
Specific antibody secretion is the endresult of a series of 
interactions between antigen, mononuclear phagocytes, T-lympho-
cytes and 3-lymphocytes. These interactions are stcdied in vitro 
following antigenic or mitogenic activation of peripheral blood 
mononuclear cells. The endpoint of the interactions is best meas~­
red by the induced maturation of B-lymphocytes. This is aLmost 
exclusively a T-dependent phe~omenon which means ~~at T-lympho-
cytes serve as obligatory regulators of the induction of B-lympho-
cyte maturation. However some exceptions do exist: in vitro acti-
vation of human B-lyrnphocytes by EB virus 5 , ~acardia antigen6 ar.C 
formalized Staph. Aureus Cowan A strain (STA) ?,S are all T-inde-
pendent. The soluble rnitogens PHA, spA (protein A, derived from 
Proc. I~t. Symp. Primary Immunodeficiencies, Ed. M. Seligmann 
·:!.H. :J:itzi.;, Elsevier/:Iorth Holland, 1980 (in press) 
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Staph. Aureus) and PWM activate T-lyrnphocytes first. B-lyrnphocyte 
~turat~on is the consequence of the generation of T-helper cell 
activity. This helper cell function is radio-resistant in ~~e as-
says discussed here8 , which allows detection o£ ~~e helper func-
tion at the B-cell level. 
Although mitogens are widely used to study human T- and B-
lymphocyte function the understanding of the molecular events in-
duced by mitogens at the level of ~~e plasma membrane is still 
fragmentary 9 . Lymphocyte activation is initiated following the li-
gand binding to membrane glycoproteins 10 . Ligands al$0 induce 
the movement of lymphocyte surface ~acromolec~les to fo~ patches 
or caps composed of receptor-ligand complexes. A relationship 
between the capping phenomenon and lymphocyte activation has been 
demonstrated al~~ough the exact mechanism is st~ll elusive 10 , 11 . 
It has been suggested that the HLA determinants, a major source 
of cell surface glycoproteins, are receptors involved in ~he bin-
ding of ligands 12 • 
The HLA-A, -B and -C determinants are expressed on the ma~ra­
nes of almost all human cell types in association witr. and pro-
bably anchored by B2M. Thus far, they have been shown to bind an-
tigen to lymphocytes 13 and to be essential for T-cell mediated 
killing of virus infected cells 14 . 
A role for HLA-A and -B determinan~s in the cooperation between 
~- and 3-lymphocytes has also been suggested by s~udies on ~~e ge-
neration of an~igen specific suppressor T-cells 15 . Whe~ ~itogenic 
assays are used no MHC restriction can be demonstrated: alloge-
neic T-B-cell mixtures give results comparable to those ob~aineC 
from autologous or HLA-identical combinations. 
The Ia-like HLA-D/DR determinants are largely found or. B-lym-
phocytes, mononuclear phagocytes, a small percentage of resting T-
l~~phocytes16, and on activated T-lymphoblasts 17 These dete=mi-
nants are expressed on the membrane independently of and not asso-
ciated with B2M. Their role in human immune responses has thus 
far been demonstrated in macrophage-T-cell interactions in a se-
condary Dnmune response agair~t certain antigens {HSV, PPD)lS,l 9 . 
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The delineation of lymphocyte membrane abnormalities in asso-
ciation with primary immunodeficiency has revealed the potential 
roles of B2M associated HLA determinants and of surface receptor 
capping in human T- and B-lyrnphocyte differentiation and respon-
siveness. 
PATIENTS AND .IMMUNOLOGICAL STUDIES 
Lack of exnression of HLA determinants associated wi~~ combined 
imrnunodeficiencv 
The B2M-associated HLA defect was studied in two unrelated 
families, one of Turkish origin, the other Algerian. Consangui~i­
ty was likely in the Turkish family and certain in ~~e Algerian. 
The affected children were of both sexes; first symptoms presen-
ted after the age of 3-4 mon~~s; all children had severe and per-
sistent diarrhea, mucocutaneous candidiasis, interstitial pneumo-
nia and bacterial infections of various types. No systemic viral 
infections could be substantiated. In fact, proven viral infec-
tions (e.g. Herpes SLmplex in the Turkish patients) evolved and 
cleared in a normal way. 
Predominance of the defect in lymphocvtes. The lack of expres-
sion of B2M associated HLA determinants is summarized in Table 1. 
The defect was mainly restricted to resting lymphocytes. Plate-
lets were also deficient in surface HLA. Other cells in the pa-
tients (e.g. fibroblasts) did express HLA antigens thus explaining 
the presence of HLA antigens in the serum. 
TABLE 1 
B2M AND HLA DETERMINANTS IN THE HLA DEFICIENT PATIENTS. 
ELA-A and -B HLA-D/DR Lvmohocytes: ~B~2M~--- -=~~~~~~----~~~~
T-lymphocytes 
S-lymphocytes 
Lvmphoblasts: 
PF..A induced 
Cell line 
(+)or-
n.d. 
(+) 
n.d. 
+ 
(+) n.d. 
(+) n.d. 
+ n.d. 
Legends: • positive, normal amount; (+) positive, low amount 
- negative; n.d. not determined. 
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Lymohoblasts express small amounts of HLA-A and -B dete~inants 
In a standard cytotoxic assay against PHA-induced patient lympho-
blasts as well as in CML studies (i~ which the targets were pa-
tient lymphoblasts) , small amounts of SLA-A and -B determinants 
were detected. This was further substantiated by ~~e expression of 
HLA-A and -B determinants on EBV-transforrned B-ly~phoblastoid cell 
lines grown from PBL of these patients. From these investigations 
the HLA genotypes of the patients could be delineated (Table 2) . 
Both Algerian patients had healthy siblings wi~~ the same HLA 
genotypes, but normal phenotypic expression on lymphocytes. The 
presence of HLA determinants in serum, on lymphoblasts and on fi-
broblasts excluded a genetic defect in the MHC locus on chromo-
some 6. 
TABLE 2 
HLA GENOTYPES 
A E 
Turkish 1 3' 9 15, W21 
Turkish 2 9,11 15, (W21) 
Algerian 1 2, 9 W35, W35 
Algerian 2 ll,W30 5' W21 
Non B2M associated HLA determinants. HLA-D/DR was detected ~y 
MLR typing and indirect immunofluorescence using allotypic anti-
B-cell sera. These determinants were present on both B-lymphocy-
tes and mononuclear phagocytes. Thus HLA determinants associated 
with B2M.were absent and the determinants not associated with B2M 
were present, suggesting a possible role for B2M in the defect. 
Beta 2 Microblobulin~ B2M was not present on viable T-lyrnpho-
cytes. Tissue sections of T-cell areas in various lymphoid organs 
showed the presence of B2M which, however, was found between ~~e 
cells rather than really fixed in the cell me.'tlbranes .. It was con-
cluded that the deficient fixation of B2M in T-cell membranes was 
either due to a structural defect of B2M or to an intrinsic lym-
phocyte membrane abnormality. 
-4-
118 
On the a-lymphocytes of the Turkish patients B2M was expressed in 
a far lower amount than normal - without the parallel detection 
of HLA-A or -B. The Algerian patients did not show any B2M on the 
surface of B-lymphocytes. After ZBV-induced ~ransformation of pa-
tient PBL the lymphoblastoid cells, especially after several pas-
sages, did express BL~ together with the HLA-A and-B deter.mi-
nants2'20. 
Relationship between HLA determinants and the immune svstem. 
The B2M associated HLA membrane defect did affect the development 
of T-lymphocytes in the complete form of the disease observed in 
the Algerian family. The thymuses were small, hypoplastic and wi~~ 
few thymocytes in one patient, and virtually absent in the o~~er. 
The serum thymic factor activity was abnormally low and the num-
ber of T-cell precursors able to undergo "in vitro differentation" 
was also decreased. Numbers and functional activity of T-lympho-
cytes were extremely reduced in peripheral blood and no antibody 
production was demonstrable. The spleen and lymph nodes contaL~ed 
few lymphocytes. No plasma cell was found (Table 3}. 
In ~~e Turkish patients the development of T- and B-lymphocytes 
was less affected. Thymus histology was essentially normal, but 
the ~~ymic cortex contained few lymphocytes. Serum thymic factor 
·.vas extre.lnely low and target cells for serum factor were virt.ual-
ly absent. Absolute numbers of circulati~g T-lymphocytes were 30% 
of normal. T-lymphocyte homing in peripheral lymphoid organs was 
also disturbed in that T-dependent areas in spleen and lymph no-
des were sparse populated. However circulating T-lymphocytes had 
normal responses to mitogenic activation and it was concluded 
that the lack of surface HLA glycoproteins did not interfere with 
normal ligand receptor interactions and subsequent lymphocyte 
activation. This was in striking contrast to the response to se-
veral antigens (Candida, Diphtheri~, Tetanus toxoid, Poliovirus}: 
even after booster immunization in vivo with DTP and despite per-
sistent candidiasis proliferative responses we:e undetectable. 
This L~plied that 32M-associated HLA determinants may play a 
role in the T-cell response to antigens. 
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TABLE 3 IMMUNOLOGICAL DATA 
T-lvmohocvtes 
E-rosettes 
Mitogenic response 
Antigenic response 
Thymus architecture 
T-cells in lymphoid 
organs :-thymus 
-lymph nodes 
Helper function~ 
B-lymchocvtes 
B2M-HLA defect 
very low-low 
very weak-normal 
absent 
hypoplastic-normal 
low numbers 
virtually absent 
absent 
sig + B-cells low-normal 
STA response weak 
T dependent responsesx absent 
Germinal centres absent 
Plasma cells absent-some IgM 
Serum Lmmunoglobuli~s IgM only 
Soecific antibodies absent 
capping abnormality 
normal 
negative 
absent 
normal 
normal 
nonr.al 
absent 
nor:nal 
normal 
normal 
absent 
normal 
~orrnal, all classes 
absent 
Legends: %tested by PWM induced B cell maturation or T-B cell 
cooperation studies (see text). 
HLA determinants and cytotoxic reactions. The lack of HLA de-
ter~nants did not lead to deficient killing by the lymphocytes. 
In vivo the Turkish patients showed a normal response to Herpes 
S~plex virus and had no signs of systemic viral spreading. In 
vitro, antibody dependent (ADCC) and non dependent (C~) cytotoxic 
functions were norr.tal. Thus in Cytotoxic interactions the HLA de-
terminants apparently are not necessary at the effector cell level. 
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Caooing abnormality associated with severe combined immunodefi-
ciencv. 
A male infant from a consanguineous marriage was referred be-
cause his brother had died as a result of combined immunodeficien-
cy. The patient was in good health at 5 months of age. Immunologi-
cal investigations showed normal numbers of E-rosettes and sig+ 
B-lymphocytes. In serum normal irmnunoglobulin levels 'Nere not ac-
companied by specific antibodies against various bacteria or vi-
ruses4. 
Proliferative capacitv of lvmphocvtes and capping of mitogen 
receotors. Responses to various T-cell mitogens (PHA, PWM, ConA, 
ALS, spA) were repeatedly absent (Table 3). Because .studies 'Nit:h 
calcium-ionophore A2318i showed no di==erence between patient and 
control lymphocytes, the early events in lymphocyte triggering 
by ligand-receptor interacti~n were interpreted as normal. This 
was. however not followed by measurable DNA or RNA synthesis. Thus 
the transduction of ~~e proliferation signal was deficient. 
When lymphocytes were incubated with fluorescei~ated ConA, 
increased capping of the ligand-receptor complex was demonstrated 
on T-lymphocytes as ~well as on B-lymphocytes. The response a= 
lymphocytes to the polyclonal B-cell mitogen STA was also normal. 
This might indicate that if a mitogen is fixed to a carrier·- in 
this case the protein A moiety to the cell wall of the Staph. Au-
reus bacterium - increased capping is prevented and normal acti-
vation follows. 
The ~turation capacity of patient's B-cells was also demonstra-
ted in the following experiments. Allogeneic irradiated T-cells 
were mixed with patient's cells and incubated with various ~i~o­
gens. Neither the irradiated T-cells nor patient's cells alone 
showed any response. The mixtures however were clearly responsive 
(Fig. 1). The level of response was comparable to the response of 
the control allogeneic T-B-cell mixtures. Taken together wi~~ the 
positive response of patient's lymphocytes to stimulation wi~~ 
STA, ~~ese investigations showed a no~al maturacion capacit1 of 
the patient's B-lymphocytes. 
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Fig. 1, T-dependent ond T-independent Fig.2. Helper T-eell activity. 
maturation of 8-lymphocyte~. 
Legends: SCID ~ Severe combined ~unodeficiency; E+ and E- = T-
and B-lymphocytes obtained byE rosette depletion techniques (Ref. 
7,8); both E+ and E- are allogeneic to patients lymphocytes and 
each other. 2 x 10 5 cells in 0.2 ml RPMI 1640 - 10~ FCS were incu-
bated for 3 days;1= irradiated (2500 rads). Responses were mea-
sured by 3H-thymidine incorporation (Ref. 7,8). 
Lymphocyte differentiation. The patient had normal levels of 
serum immunoglobulins and plasma cells were present in various 
lymphoid organs, although these organs were underdeveloped. B2U 
associated HLA determinants were expressed normally on the lympho-
cyte membranes as well as HLA-0/DR, Ia-l~ke ant~gen, B2M, sig ana 
receptors for SRBC, C3 and ConA. These findings ~ly that the 
capping disorder did not interfere with ~~e normal development of 
either T-lymphocytes orB-lymphocytes. Furthermore the presence 
of plasma cells synthesizing ~unoglobulins in vivo suggests that 
the patient's T-cells must have been able to provide some non-spe-
cif~c helper cell activity. 
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The following experiments were performed to investigate the 
helper function (the experiments are reciprocal of those descri-
bed above) . Patient T-lymphocytes obtained by E-rosette-depletion, 
were mixed with allogeneic B-lymphocytes and incubated with va-
rious mitogens. None of the cell populations alone showed a proli-
ferative response but the mixtures were also negative (Fig. 2). 
All themitogens ~HA, spA, PWW gave the same (negative) results. 
The figure also shows the results of st~ulation by STA. TheE+-
fraction of SCID cells did not react whereas the unseparated popu-
lation did. Allogeneic E--lymphocytes had a high response to STA 
which was not changed by adding E+-SCID ce1ls. Taken together with 
the results using unse~arated SCID lymphocytes, these exper~ents 
i~dicate the absence of helper effects in vitro when T-dependent 
mitoge~ were used. The patient did not have any measurable res-
ponse to specific antigens either in vivo or in vitro. Thus, al-
though T- and B-lymphocytes were developed in this SCID and al-
though T-lymphocytes likely could bind antigen, the capping abnor-
mality appeared to interfere with the antigen-induced ~une res-
ponsiveness, because a) T-cell proliferation is a necessary event 
or b) antigen presentation to B-lymphocytes is hampered as a re-
sult of the increased capping. 
DISCUSSION 
Two types of lymphocyte membrane defects were bo·th associated 
with combined immunodeficiency disease. Both membrane disorders 
suggested an anchorage defect, the HLA deficiency by a defect in 
B2M fixation and the capping abnormality by a defect in receptor-
capping modulation. In both instances specific antibody produc-
tion failed. T-cell differentiation was essentially Un~paired up 
to the level of postthymic T-cells in the sense that circulating 
E-rosetting lymphocytes were present. Likewise B-cell maturation 
was intact since sig+ E-cells were present and the response to 
STA, a T-cell independent polyclonal B-cell mitogen, was positive. 
Despite the presence of T-cells and B-cells both types of Lmmllno-
deficiency were characterized by a lack of antigenic responsive-
ness. 
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B-lymphocyte differentiation appeared less impaireC especially 
~n the Turkish patients since normal absolute numbers of sig+ 
B-cells were detected in peripheral blood and bone marrow, where-
as the Algerian patients had low numbers of circulati~g B-cells. 
However numbers of plasma cells and levels of serum ~unoglobu­
lins were abnormally low and PWM failed to induce plasma cell ma-
turation~ Thus T-dependent B-cell maturation was significantly 
compromised although T-cells were present and able to prolifera-
te~ The recent demonstration of a weak but positive response of 
patient PEL to STA activation indicated t~ B-cells had normal 
proliferative capabilities. Taken ~ogether, these data argue for 
a role of HLA determinants in T-B-cell cooperation. 
In vivo the very low numbe=s of plasma cells found were main-
ly IgM containing cells and possibly reflect some degree of T-in-
dependent maturation. The IgM secreted in vivo lacked speci=icity 
for the various antigens tested. The presence of follicles in 
lymph nodes appeared to be an important factor in IgM plasmacell 
maturation, in that one of the patients, who had low IgM serum 
levels and low IgM plasma cell numbers, virtually lacked folli-
cles, whereas the other had some follicles, normal numbers of 
IgM plasma cells and a normal serum IgM level. The complete ab-
sence of germinal centre activity in these follicles might re-
flect an essential role of germinal centres in T-dependent B-cell 
maturation. 
In summary the findings indicate the potential for an impor-
tant role of HLA-A and -B determinants in antigen recognition by 
T-lymphocytes. Lack of HLA determinants appeared to interfere 
with ~~e response to antigens and mitogens at ~he level of T-B-
cell cooperation. In addition the differentiation of T-lymphocy-
tes was L~paired already at the i~trathymic stage but not comple-
tely blocked. The Turkish patients particularly showed some de-
gree of T-cell maturation to the post-~~ymic stage. T-cell homing 
in peripheral lymphoid organs was severly impeded and T-ciependent 
B-cell maturation to plasma cells was vir~ually absent. HLA deter-
minants therefore appear to be important in T-cell differentia-
tion, T-cell homing and T-B-cell collaboration especial:y ~n the 
response t~ antigens. 
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In both, the antigenic response was shown to be defective at ~~e 
level of the T-lymphocyte. 
In the aLA deficient patients T-lymphocytes had either a nor~al 
or a very reduced proliferative response to rnitcgens, possibly 
depending on the numbers of T-cells in PBL. In the capping abnor-
mality the reaction to antigens was absent because of a lack of 
induction of .Proliferation, shown by negative responses to mite-
gens, whereas the receptor-ligand interaction, as such, was undis-
turbed. Likewise the negative antigenic response in the Algerian 
HLA deficient patients could be explained by the low mitogenic 
responses. However the Turkish patients had normal mitogenic res-
ponses but failed to respond to antigens. 
HLA-A and B-glycoproteins on the lymphocyte membrane have been 
shown to act as receptors for Semliki Forest virus 13 . Thus ~~e 
lack of response to antigens either in vivo or in ~ritro might be 
explained by the absence of 32M associated HLA determinants. At 
the same time it was evident that these glycoproteins were not the 
receptors for mitogens. 
In the capping disorder the lymphocyte surface was intact. Nor-
mal surface determinants and receptors, especially the receptors 
for mitogens were present. Clear proof for antigen receptor bin-
ding was not obtained, since lymphocytes were unable to prolife-
rate in response to antigens. The lack of proli=eration was shown 
to be associated with abnormally increased capping of ligandrecep-
tor complexes on the lymphocyte membranes. Proliferation (of B 
cells) was dem6nst.rated by the response to STA. It was suggested 
~~at this bacterium, being in essence a rigid large carrier of mi-
togenic protein A molecules (spA) , prevented inc~eased capping 
which allowed normal induction of proliferation, ~hereas soluble 
spA was unable to activate lymphocytes. The increased capping also 
affected normal T-B-cell cooperation when T-dependent mitogens 
were used. In these assays helper effects were absent, whereas it 
was demonstrated that the patient's B-lymphocytes could be activa-
ted by allogeneic T-lymphocytes. 
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In these assays only part of the in vivo situation could be 
s~ulated. The finding of plasma cells and ~unoglobuli~s in vi-
vo, suggests that some helper function was present in vivo, per-
haps non-specific in origin without the elucidation of antige~­
specific responses. 
An alternative view of both membrane abnormalities may explain 
the differences between the in vivo and in vitro studies. The 
sparse population of T-cells in central and especially peripheral 
lymphoid organs of the HLA deficient patients was striking. In 
contrast all T-dependent areas in the lymphoid tissues of the pa-
tient with the capping abnormality were normally populated. At the 
same time it was concluded that in both disorders, T-cell diffe-
rentiation was essentially unimpaired up to the post-thymic stage1. 
This argues for a crucial role of HLA determinants in homing of 
T-lymphocytes and pre-T-cells. Some experimental evidence for this 
argument is available. Syngeneic cells have a bet~er homing per-
for.mance than H2disparate (congenic) cells in reconstitution expe-
r~ents (21, 22). The difference in homing capabilities of the 
HLA deficient lymphocytes and the HLA bearing lymphocytes in the 
capping abnormality might thus explain the presence of plasma 
cells and serum Lmrnunoglobulins in vivo in the patient with the 
capping abnormality because T-cells were capable of migrating to 
the environment where B-cell maturation normally is induced. 
In summary: These studies indicate that both a normal cytoske-
leton and the presence of HLA determinants may be necessary for 
normal ~une responsiveness. The HLA defect with either a lack 
of antigen-receptor interaction or severely disturbed homing of 
T-cells and the capping disorder with defective a~tigen-receptor 
complex fixation, but essentially normal homing, are both exam-
ples of the crucial role of the T-lymphocyte membrane in cell di=-
ferentiation and in antigen-specific Lmmunity in vitro and in 
vivo. 
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ADDENDUM 
Huius farinae sunt et isti, qui libris edendis farnam im-
mortalem aucupantur. Hi cum omnes mihi plurimum debent, 
tum praecipue ii, qui meras nugas chartis illinunt. Nam 
qui erudite ad paucorurn doctorum iudicium scribunt, quique 
nee Persium nee Laelium iudicem recusant, mihi quidem mi-
serandi magis, quam beati videntur, ut qui sese perpetuo 
torqueant: addunt, mutant, adimunt,,reponunt, repetunt, 
recudunt, ostendunt, nonum in annum premunt, nee umquam 
satisfaciunt acfutile praemiurn, nempe laudem eamque per-
paucorum, tanti emunt, tot vigiliis, somnique, rerum omni-
um dulcissimi, tanta iactura, tot sudoribus, tot crucibus. 
Adde nunc valetudinis dispendium, formae perniciem, lippi-
tudinem aut etiam caecitatem, paupertatem, invidiam, vo-
luptatum abstinentiam, senectutem praeproperam, mortem 
praernaturam, et si qua sunt alia eiusrnodi. Tantis malis 
spiens ille redimemdum existimat, ut ab uno aut altere 
lippo probetur. 
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